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Modern approaches to organic synthesis often look to break down target molecules into key 
molecular fragments. These fragments, or “building blocks”, require reactive functional groups 
that enable the target molecule to be assembled efficiently and selectively through the 
formation of new C–C or C–heteroatom bonds. This thesis outlines investigations into novel 
coupling reactions, which harness the inherent strain energy of small-ring cyclic building 
blocks. 
The key reaction mechanisms explored are strain-release-driven 1,2-rearrangement reactions. 
Firstly, investigations into the 1,2-metallate rearrangement of boronate complexes with an 
activated cyclopropane α to boron are described (Figure Ia). In addition, the strain-release of 
azabicyclo[1.1.0]butane was explored as the driving force for the 1,2-metallate rearrangement 
reaction (Figure Ib). Finally, investigations into a novel strain-release semipinacol 
rearrangement reaction were undertaken (Figure Ic). 
All three reaction mechanisms facilitated the formation of a new C–C bond and provide access 
to novel molecules with interesting sp3-rich scaffolds and diverse functionality.  
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1. General introduction 
1.1. The concept of strain in organic chemistry 
1.1.1. Strain-release as a tool in synthetic chemistry 
Strain is a fundamental property of organic molecules; different elements of molecular strain 
combine to influence bond strengths, molecular conformation and hybridisation. The inherent 
strain of small cyclic compounds has an immense effect on their reactivity, with strain-release 
an important driving force for reaction mechanism.  
The use of strain-release as a tool in the synthesis of valuable fine chemicals has long been a 
popular strategy. When considering a retrosynthesis, it is somewhat counterintuitive to 
reconnect atoms to give strained molecules that undergo strain-release reactions in the forward 
sense. However, one can select common strained building blocks, with predictable, selective 
strain-release reactivity as convenient synthons. The further development of strain-release 
methodology from these key strained molecular building blocks will continue to unlock this 
modern approach to organic synthesis.  
1.1.2. Elements of strain in cyclic molecules 
The concept of ring strain was first introduced by Baeyer in 1885 who hypothesised that 3- and 
4-membered ring-containing alicyclic molecules would be less stable than acyclic analogues.1 
This instability arises from the requirement that the bond angles deviate from the ideal 109° of 
a tetrahedron (Figure 1a). This theory of bond-angle strain (or Baeyer strain) is indeed correct, 
however, Baeyer incorrectly deduced that rings with greater than 5 ring atoms would also 
experience bond-angle strain because of the assumption that the rings would be planar.2 We 
now know that cyclic molecules can adopt puckered conformations to relieve bond-angle 
strain. The primary example being cyclohexane, which adopts the chair geometry to achieve 
internal bond angles of 109°.  
However, alicyclic molecules with greater than 6 ring atoms do in fact have higher ring strain 
but not for the reasons Baeyer proposed. This is because the inherent strain of cyclic molecules 
is comprised not only bond-angle strain but also torsional strain (or Pitzer strain) and trans-






Figure 1. Elements of strain in cyclic molecules. 
Torsional strain involves the steric repulsion of atoms 4 bonds apart. These interactions, along 
with hyperconjugative stabilisation effects, lead to antiperiplanar being the preferred 
conformation over other eclipsed or gauche conformations in a molecule such as butane (Figure 
1b). The relief of torsional strain is the reason cyclobutane adopts the puckered butterfly 
geometry with staggered substituents over the planar square geometry with eclipsed 
substituents. The internal bond angles of the puckered geometry are in fact smaller, so the relief 
of torsional strain is at the expense of bond-angle strain.2,3 
Trans-annular strain is also steric in nature and relates to the repulsion of substituents on non-
adjacent atoms in a ring (Figure 1c).4 Alicyclic molecules with larger rings experience 
trans-annular strain as most conformations bring groups on opposite sides of the ring within 
close proximity. Trans-annular strain is not present in small ring molecules such as 
cyclopropane and cyclobutane, however, the combination of high bond-angle strain and 
torsional strain means that these alicyclic compounds have greater internal energy, or strain 
energy (SE).2 
1.1.3. Strain energy 
Total ring strain is a combination of Baeyer, Pitzer and Prelog strain and can be determined by 




free reference.2 This calculated value is the defined strain energy (SE) and is a useful tool when 
considering how the thermodynamic stability of a molecule is affected by ring strain. 
Table 1. The calculation of strain energy (SE) for cyclopropane using cyclohexane as the “strain-free” reference. 
 
Relative to other cyclic molecules, cyclohexane is defined as having a strain energy of zero, as 
the internal bond angles are an optimal 109° and the substituents are all in a staggered 
orientation. By dividing the ΔHf of cyclohexane by six, the value obtained is considered the 
ΔHf of one strain-free methylene unit (Table 1). This value can be used to determine the strain-
free reference for other cyclic molecules to calculate their strain energy. For example, the 
strain-free reference of cyclopropane is three of these methylene units. Taking the ΔHf of 
cyclopropane and subtracting the reference determines the strain energy of cyclopropane to be 
27.4 kcal mol-1 (Table 1). 
As the calculation of strain energy requires the approximation of a strain-free reference, 
reported values can vary between studies. In addition, ΔHf can be determined both 
experimentally and computationally using various techniques.5 Nevertheless, strain energy is 
still useful to compare the relative thermodynamic stabilities of cyclic structures. SE values of 
selected cyclic molecules are reported in Table 2.2 As cyclohexane is established as the strain-
free reference, its strain energy is defined as 0 kcal mol-1. From cyclohexane, there is a trend 
of increasing strain energy with decreasing ring size due to increased Baeyer and Pitzer strain. 
Moving to rings larger than cyclohexane is also accompanied by increasing strain energy due 
to greater Prelog strain. This trend continues up to cyclononane, after which the sufficiently 
large rings can adopt conformations with few trans-annular interactions.  
Bicyclic small-ring molecules can have greater strain energy than the sum of the individual 
rings. For example, bicyclo[1.1.0]butane6 (1) has an SE value of 63.9 kcal mol-1, which is 
higher than the sum two cyclopropanes. This is because the two rings are not independent and 




similar effect is observed in spiro[2.2]pentane (2), which has a strain energy 8.4 kcal mol-1 
higher than the sum of two cyclopropanes.2 
Table 2. Reported strain energies of selected cyclic molecules.2 
 
The introduction of unsaturation into rings increases the strain energy as the optimal angle of 
a trigonal planar sp2 centre is 120°, which is severely distorted in molecules such as 
cyclopropene (3) and methylene cyclopropane (4).2 
1.1.1. Cyclopropane 
The strain energy of a molecule such as cyclopropane refers to a measure of relative 
thermodynamic stability, however with regards to reactivity, kinetic stability must be 
considered. In fact, strained molecules are also kinetically activated compared to unstrained 
molecules as structural deformation leads to a change or distortion in orbital hybridisation. 
A simple model for the bonding of cyclopropane states that due to the extremely acute bond 
angles, the C–C bonds are “bent” and a significant proportion of electron density is located 
outside the internuclear axis (Figure 2a).7 In addition, to maximise orbital overlap, the C–C 
bonds have more p-character and so are more olefinic than unstrained C–C bonds.8 This change 
in hybridisation accounts for the difference in reactivity of cyclopropane compared to acyclic 
saturated alkanes. For example, cyclopropanes can stabilise α-carbocations better than other 
acyclic alkyl groups as the C–C σ-bonds with high p-character can donate into the adjacent 
empty p orbital of the carbocation (Figure 2b).9 
Furthermore, the high p-character of the C–C bonds in cyclopropane is associated with high 
s-character in the C–H bonds of cyclopropane. The pKa of cyclopropane is therefore lower 





Figure 2. a) The “bent bond” model of cyclopropane. b) The stabilisation of an α-carbocation by cyclopropane. c) 
Approximate acidity of cyclopropane relative to ethylene and propane. 
This thesis focuses on the reactivity of activated cyclopropanes and azabicyclo[1.1.0]butanes 
(5) with reference to some bicyclo[1.1.0]butanes. Therefore, a further introduction into these 
strained molecules is outlined below.  
1.2. Selected strained molecular building blocks 
1.2.1. Donor-acceptor cyclopropanes 
While kinetically and thermodynamically activated with respect to acyclic saturated alkanes, 
cyclopropane is still a relatively inert motif, as forcing conditions such as transition metal 
oxidative insertion12 are required for C–C bond cleavage. The kinetic activation of 
cyclopropanes with certain substituents enables more facile and selective C–C bond cleavage 
reactions. Specifically, the vicinal substitution of a cyclopropane with an electron-donating and 
electron-withdrawing group gives structures referred to as donor-acceptor cyclopropanes (DA 
cyclopropanes, 5, Scheme 1).13,14 Such species have broad strain-release reactivity arising from 
the polarisation of one of the cyclopropane C–C bonds. These reactions are summarised in 
Scheme 1, where D is an electron donating group, such as an electron rich aryl group, and A is 
an electron withdrawing group, such as a carbonyl functionality.  
 




DA cyclopropanes can be visualised as a tight zwitterionic species (6) where a build-up of 
positive charge at C1 is stabilised by the electron donating group, while a build-up of negative 
charge at C3 is stabilised by the electron withdrawing group. The chemistry of DA 
cyclopropanes is governed by polar reactions occurring at these two sites.  
For example, nucleophilic addition to C1 or electrophilic addition to C2 is a common reaction 
profile of DA cyclopropanes, which leads to the selective formation of diversely substituted 
acyclic molecules (7, Scheme 1a). Similarly, dipolar cycloaddition reactions are possible to 
give ring expanded products (8, Scheme 1b), and DA cyclopropanes can rearrange, which leads 
to the formation of heterocycles (9, Scheme 1c). 
Reported syntheses of cyclopropanes often employ highly energetic species such as reactive 
carbenoid precursors. In the context of DA cyclopropanes, the most common reaction of this 
type is the addition of a transient metal carbene bearing an electron withdrawing group to an 
electron rich alkene (Scheme 2).  
 
Scheme 2. Synthesis of donor-acceptor cyclopropanes. 
The transient metal carbene (10) is formed by the decomposition of electron deficient diazo 
compounds or phenyliodonium ylides in the presence of a transition metal catalyst.15,16 This 
intermediate reacts readily with electron rich alkenes to yield cyclopropanes bearing both an 
electron donating group and an electron withdrawing group. The most frequently employed 
metal catalysts for this transformation are rhodium or copper complexes. In addition, 
enantioselective variants with chiral rhodium or copper complexes have been developed to 
access enantioenriched DA cyclopropanes.17,18 
Focussing on nucleophilic addition to DA cyclopropanes, the activation of the electron 
withdrawing group of a DA cyclopropane with a Lewis or Brønsted acid enables nucleophilic 
attack at C1 with concurrent C–C bond cleavage under exceptionally mild conditions.19–24 
Scheme 3a shows an example published by Charette and co-workers whereby the di-acceptor 
motif of DA cyclopropane 11 is activated by a nickel Lewis acid catalyst.19 This promotes 





Scheme 3. a) Lewis acid catalysed nucleophilic addition of amines to donor-acceptor cyclopropanes. b) 
Intramolecular rearrangement side reaction with certain Lewis acids. 
The authors observed that enantioenriched DA cyclopropanes underwent nucleophilic addition 
to give ring-opened products 12 with no loss of enantiomeric excess (ee) at C1. This is due to 
a stereospecific SN2 mechanism, whereby the nucleophile attacks the cyclopropane C–C σ* 
antibonding orbital leading to an inversion of stereochemistry.19 This chirality transfer 
mechanism is typical of DA cyclopropane chemistry and has been widely demonstrated as a 
useful tool in the synthesis of acylic molecules with sterodefined centres.25 
However, Charette and co-workers also demonstrated that the choice of Lewis acid has a 
significant effect on the reaction outcome.19 When strongly Lewis acidic, monodentate boron 
trifluoride etherate (BF3.Et2O) was employed as a catalyst, the formation of racemic 
intramolecular rearrangement product 13 was observed alongside the desired product (Scheme 
3b). This is due to the formation of a full carbocation at C1 and enolate at C2, rather than a 
configurationally stable zwitterionic intermediate. The nucleophilic oxygen can then attack 
either side of the planar C1 carbocation leading to racemate 13.19 This example demonstrates 
the importance of balance between reactivity and selectivity in the chemistry of DA 
cyclopropanes that enables the synthesis of enantioenriched ring-opened products.   
1.2.2. Bicyclo[1.1.0]butane 
The kinetic activation of cyclopropane is also made possible by its incorporation into a bicycle. 
Bicyclo[1.1.0]butane, or BCB (1, Scheme 4), is comprised of two cyclopropane rings that share 
a bridging C–C bond.6 The bridge bond is so strained that the bonding orbital is highly distorted 
with considerable p character for a formal σ-bond. The consequence is that the bridge bond 
reacts in a similar way to a C=C π bond, for example, BCB reacts readily with bromine to give 





Scheme 4. General reactivity of bicyclo[1.1.0]butanes. 
The reactivity of BCBs bearing an electron withdrawing group (15) mirrors that of electron 
deficient alkenes as they can act as Michael acceptors in nucleophilic addition reactions 
(Scheme 4b).27–31 Furthermore, the addition of nucleophilic radicals has been reported, 
whereby the BCB resembles a Giese acceptor (Scheme 4c).32,33 Both such strain-release 
reactions lead to the selective formation of functionalised cyclobutanes, which are a privileged 
class of molecular scaffold. 
Another reactivity mode of electron deficient BCBs is their deprotonation at the bridgehead 
position. Due to the highly strained bridging C–C bond, the bridgehead C–H bond with its high 
degree of s character can be easily deprotonated with LDA.27,34 Subsequent electrophilic 
trapping gives 1,3-disubstituted BCBs (16, Scheme 4d). The use of BCBs to access other 
valuable strained building blocks has also been demonstrated, for example, the reaction of 
1,3-disubstituted BCBs with difluorocarbene to give bicyclo[1.1.1]pentane derivatives 17 
(Scheme 4e).35,36 Furthermore, the rearrangement of BCBs to give cyclobutenes is well 
documented and noted as a common reaction pathway of BCBs (Scheme 4f).27,30,37  
The first high yielding synthesis of a BCB derivative was performed by Wiberg and co-workers 
and involved the base mediated cyclisation of 3-bromocyclobutane-1-carboxylate 18 to give 
BCB ester 19 (Scheme 5a).6 As cyclobutanes are themselves difficult to prepare, modern 
approaches to BCBs often utilise cyclopropanes as precursors. For example, BCB bromide (21) 
is easily accessible from dibromo cyclopropane 20 via lithium-bromine exchange with 
methyllithium followed by intramolecular cyclisation (Scheme 5b).38 Alternatively, the 




enantioselective intramolecular cyclopropanation of 22, catalysed by dirhodium complex 23, 
afforded BCB 24 in 95% enantiomeric excess (ee). 
 
Scheme 5. Selected synthetic routes to bicyclo[1.1.0]butanes. 
A specific example of nucleophilic addition to an electron deficient BCB is shown in Scheme 
6.39 Here, Fox and co-workers reported a copper catalysed nucleophilic addition of methyl 
magnesium chloride to electron deficient BCB 25. The SN2-like nucleophilic addition of the in 
situ formed cuprate to C3 occurs selectively on the exo face to give enolate 26. The enolate is 
then quenched by the addition of allyl iodide to give highly substituted cyclobutane product 
27. The electrophile addition occurs preferentially from the less hindered face affording the 
product in an 8:1 diastereomeric ratio (dr). 
 
Scheme 6. Nucleophilic addition to an electron deficient bicyclo[1.1.0]butane. 
1.2.3. Azabicyclo[1.1.0]butane 
An interesting analogue of bicyclo[1.1.0]butane is azabicyclo[1.1.0]butane, or ABB (5, Figure 
3), where one bridgehead C–H unit is replaced by a nitrogen atom.40 While under-investigated 
with respect to BCB,41 ABB-containing molecules have attracted significant recent attention 
due to their strain-release reactions that yield azetidines, which are valuable synthetic targets 
in medicinal chemistry.42–47 
The strain energy of ABB has not been reported to date, however, the strained structure 
resembles that of BCB. Comparing the structures of triphenyl ABB 28 and dicyano BCB 29, 




1.52 Å and 1.50 Å respectively. Furthermore, the dihedral angles of the intersecting planes of 
the two 3-membered rings for 28 and 29 have been determined as 119° and 126° respectively. 
 
Figure 3. Structure of azabicyclo[1.1.0]butane and similarity to bicyclo[1.1.0]butane. 
The first synthesis of an azabicyclo[1.1.0]butane derivative (31) was reported by Hortmann 
and co-workers in 1972, which involved the aziridination of azirine 30 with sulfonium 
methylide (Scheme 7a).50 An efficient synthesis of the parent unsubstituted ABB (5) was 
established by Nagao and co-workers in 1999, which proceeds in only two steps from allyl 
amine 32 (Scheme 7b).51 The first step is the dibromination of allyl amine to give ammonium 
salt 33; the addition of 3 equivalents of strong base then leads to the formation of ABB via two 
consecutive intramolecular cyclisation reactions. 
 
Scheme 7. Selected synthetic routes to azabicyclo[1.1.0]butanes. 
ABB has a heteroatom with a lone pair of electrons that can be readily activated with reagents 
such as hydrogen bromide (Scheme 8a).51 The nitrogen is first protonated to give strained 
ammonium 34, which is extremely electrophilic and reacts with strain-release by the 
nucleophilic addition of the counteranion to give 1,3-azetidine 35. The equivalent reaction also 
occurs with electrophiles such as thioacetic acid and ethyl chloroformate.51,52 
The ABB nitrogen lone pair can also interact with electron deficient alkenes such as 36 
(Scheme 8b).53 This leads to the formation of zwitterion 37 that undergoes intramolecular ring 





Scheme 8. General reactivity of azabicyclo[1.1.0]butanes. 
ABB has also been shown to undergo direct nucleophilic addition at the bridgehead carbon by 
strong nucleophiles (Scheme 8c).28,54 This gives metalated azetidine 39 that can undergo a 
subsequent reaction at nitrogen to give 1,3-substituted azetidine product 40. An example of one 
such reaction is shown in Scheme 9. In a one-pot procedure, ABB is first generated from 
ammonium salt 33 by the addition of phenyllithium. The addition of tert-butyl magnesium 
chloride in the presence of a copper catalyst results in the strain-release alkylation of ABB. 
Finally, the addition of p-toluenesulfonyl chloride (TsCl) leads to the formation of alkylated 
azetidine 41 in 85% yield.54 
 
Scheme 9. Direct nucleophilic alkylation of azabicyclo[1.1.0]butane. 
1.3. Outline of projects 
The investigation of new strain-release driven transformations of the strained building blocks 
introduced above was undertaken. This was done with the aim of establishing efficient, 
modular routes to diversely decorated molecules with interesting molecular scaffolds.  
Chapter 2 discusses the strain-release C–C bond cleavage of a novel class of DA cyclopropane 
where the donor group is a tetrahedral boronate complex (42, Scheme 10a). Such species 
undergo a 1,2-metallate rearrangement upon activation of the DA cyclopropane with a Lewis 





Scheme 10. Outline of the strain-release transformations discussed in chapters 2, 3 and 4.  
A similar reaction mechanism operates in the transformation discussed in Chapter 3, where the 
1,2-metallate rearrangement of azabicyclo[1.1.0]butyl boronate complexes 44 is investigated 
(Scheme 10b). This reaction leads to the formation of 1,3,3-substituted azetidines 45. The 
applicability of this reaction was demonstrated by the short synthesis of cobimetinib, an anti-
cancer pharmaceutical drug containing the azetidine motif.  
Chapter 4 discusses the divergent strain-release reactivity of azabicyclo[1.1.0]butyl carbinols 
(46, Scheme 10c). Upon the addition of an activating agent, activation of ABB followed by 
nucleophilic addition of the counter anion to the bridgehead position occurs to give halohydrin 
47, which can be easily converted to spiroepoxy azetidine 48. Alternatively, a semipinacol 
rearrangement proceeds to give keto azetidine 49. The semipinacol rearrangement is 




2. Strain-release of donor-acceptor cyclopropyl boronate 
complexes 
2.1. Introduction to boronic esters 
2.1.1. Boronic esters in organic synthesis 
Building block approaches to organic synthesis require molecular fragments that can be 
efficiently assembled through the formation of C–C or C–X bonds. Boronic esters serve as 
stable but versatile functional groups used as precursors for these key cross-coupling steps in 
a synthetic route. One such reaction that employs the boronic ester functional group is the 
Suzuki-Miyaura reaction.55 Since the first publication by A. Suzuki in 1979,56 the reaction has 
been developed extensively and is now the most popular palladium catalysed cross-coupling 
reaction used in the pharmaceutical industry.57 An advantage of this process is that 
organoboron reagents are cheap and accessible, while boron containing by-products generally 
have low toxicity and are easy to remove.57  
 
Scheme 11. Selected stereospecific transformations of alkyl boronic esters. 
Since the discovery and development of the Suzuki-Miyaura reaction, the unique balance 
between reactivity and stability of boronic esters, particularly pinacol boronic esters, has 
enabled the development of a host of C–C or C–X bond forming reactions from these versatile 
reagents. Many recent advances in this field involve enantiospecific transformations of readily 




shapes (Scheme 11).58,59 These reactions often employ the enantiospecific 1,2-metallate 
rearrangement mechanism of boronate complexes. 
2.1.2. 1,2-Metallate rearrangement of boronate complexes 
While more stable to chromatography than unhindered boronic esters or boranes, pinacol 
boronic esters still possess a vacant p orbital centred on boron that can be readily attacked by 
nucleophiles. This results in the formation of a tetrahedral boronate complex with a formal 
negative charge (50, Scheme 12). If the carbon atom α to boron in a boronate complex is 
suitably electrophilic, a 1,2-metallate rearrangement can occur, whereby one substituent on 
boron migrates to give a homologated boronic ester. This mechanism leads to the formation of 
a new C–C or C–X bond with a retained boronic ester functional group. 
The 1,2-metallate rearrangement can be triggered by the loss of a leaving group α to boron 
(Scheme 12a). Alternatively, a boronate complex with unsaturation α to boron can be activated 
by the addition of an electrophile that induces the 1,2-shift (Scheme 12b). Overall, this reaction 
constitutes a 3-component coupling reaction. Finally, the use of a strained organometallic 
species leads to the formation of a boronate complex with a strained ring α to boron, which can 
undergo a strain-release-driven 1,2-metallate rearrangement reaction (Scheme 12c). 
 




2.1.3. Leaving-group-driven 1,2-metallate rearrangement of boronate 
complexes 
The Matteson homologation reaction is one example of a leaving-group-driven 1,2-metallate 
rearrangement (Scheme 13a).60 The lithium-halogen exchange of bromochloromethane gives 
lithium carbenoid 51 that, in the presence of a boronic ester, undergoes borylation to form 
boronate complex 52. Subsequently, chloride in the α position acts as a leaving group to 
facilitate a 1,2-metallate rearrangement. For this to occur, the migrating alkyl group and the 
leaving group require an antiperiplanar arrangement for electron density to be donated into the 
C–Cl σ* antibonding orbital. This means that when enantioenriched boronic esters undergo 
this transformation, the products are produced with complete enantiospecificity.58 
Significantly, this reaction has the advantage of the conservation of the boronic ester functional 
group in the product, which serves as a useful functional handle for further chemical 
manipulations.58 
 
Scheme 13. 1,2-Metallate rearrangement of boronate complexes with α leaving groups. 
An extension to the Matteson homologation reaction is the use of sterically hindered carbamate 
or benzoate esters as leaving groups. This is generally referred to as lithiation–borylation 
methodology (Scheme 13b).61–63 The advantage of this system is that configurationally stable 
lithiated carbenoids, such as 54, can be accessed in high ee by (−)-sparteine-mediated lithiation 




boronate complex 55. Subsequent enantiospecific 1,2-metallate rearrangement leads to 
homologated products such as 56, which contains two contiguous stereocentres. 
Vinylogous Matteson homologation reactions have also been reported (Scheme 14).65,66 Here, 
the leaving group is positioned in the γ position of vinyl boronate complex 58, which is formed 
by the addition of n-butyllithium to vinyl boronic ester 57. The 1,2-metallate rearrangement 
occurs through conjugation, driven by the loss of the leaving group upon activation with a 
Lewis acid. 
 
Scheme 14. Vinylogous Matteson homologation; 1,2-metallate rearrangement with conjugated γ leaving groups. 
The oxidation of boronic esters with basic hydrogen peroxide also involves an enantiospecific 
1,2-metallate rearrangement mechanism (Scheme 15).58 The mixture of hydrogen peroxide and 
sodium hydroxide leads to the formation of hydroperoxyl anions that react with boronic esters 
to form boronate complex 59. A 1,2-metallate rearrangement then occurs, driven by the loss of 
the hydroxyl leaving group, to give borate 60 followed by alcohol 61 upon hydrolysis.   
 
Scheme 15. Enantiospecific oxidation of boronic esters. 
2.1.4. 1,2-Metallate rearrangement of boronate complexes with unsaturation α 
to boron 
Boronate complexes with unsaturation α to boron are generally nucleophilic and thus react with 
electrophiles through a 1,2-metallate rearrangement mechanism. The primary example of this 
is the Zweifel olefination reaction that stereospecifically transforms a boronic ester into an 
alkene (Scheme 16a).67–69 Here, the addition of vinyllithium to an alkyl boronic ester leads to 
the formation of vinyl boronate complex 62. The double bond of 62 reacts with iodine to form 
iodonium ion 63 that undergoes a 1,2-metallate rearrangement with alkyl migration to give β-




A similar mechanism has been successfully applied to the sp2-sp3 coupling of aliphatic boronic 
esters with electron rich aromatics such as furan (Scheme 16b).70,71 The addition of furan-2-
yllithium to a boronic ester gives boronate complex 66 that undergoes a 1,2-metallate 
rearrangement upon the addition of electrophilic N-bromosuccinimide (NBS). Boronic ester 67 
then eliminates, with the loss of bromide, to give rearomatised coupled product 68.70 
 
Scheme 16. Sp2-sp3 coupling of boronic esters and sp2 organolithiums through electrophilic activation of the π 
system of the boronate complex. 
Other sp2-sp3 couplings of this kind have been developed with the activation procedure chosen 
to target the specific aromatic coupling partner.72–75 Another example is the coupling of a 
boronic ester to pyridin-4-yllithium (Scheme 16c).72 Boronate complex 69 was activated by 
acylation of the pyridine nitrogen upon the addition of 2,2,2-trichloroethoxycarbonyl chloride 
(TrocCl, 70). This leads to the stereospecific formation of dearomatised intermediate 71 after 
a 1,2-metallate rearrangement. Oxidation of the boronic ester with hydrogen peroxide/sodium 
hydroxide triggers an elimination to give coupled product 72 with a driving force of 
rearomatisation. 
More recently, Studer and co-workers reported the nucleophilic addition of an indolyl boronate 




transformation that combines the reactivity of DA cyclopropanes and the 1,2-metallate 
rearrangement of boronate complexes.  
 
Scheme 17. Dearomative nucleophilic addition of an indolyl boronate complex to a donor–acceptor 
cyclopropane. 
Enantioenriched diester substituted cyclopropane 73 is activated through coordination to a 
Lewis acid. Nucleophilic indolyl boronate complex 74 then undergoes a 1,2-metallate 
rearrangement with nucleophilic addition to the electrophilic C1 atom of the cyclopropane. 
Resulting enolate 75 is then trapped in situ by methyl iodide which liberates the Lewis acid 
catalyst. Coupled product 76 was obtained as a single diastereomer with inversion of 
stereochemistry at C1.76 
2.1.5. 1,2-Metallate rearrangement of boronate complexes with a ring α to 
boron 
While the Zweifel olefination reaction does involve the activation of a boronate complex with 
unsaturation α to boron, the key 1,2-metallate rearrangement step is triggered by the cleavage 
of a three-membered iodonium ring (63, Scheme 16a). The cleavage of a strained ring α to 
boron is another type of driving force that has been explored to trigger the 1,2-metallate 
rearrangement of boronate complexes.  
In this manner, the homologation of boronic esters with enantioenriched lithiated epoxides has 
been reported (Scheme 18a).77 Diastereoselective lithiation of (+)-epoxybutane is achieved by 
the addition of lithium tetramethylpiperidide (LTMP), and in the presence of a boronic ester, 




1,2-metallate rearrangement to give alkoxide 78. To avoid elimination of the boronic ester, this 
species was oxidised in situ to give diol product 79 with high diastereoselectivity. 
 
Scheme 18. 1,2-Metallate rearrangement driven by the cleavage of strained saturated heterocycles. 
Aziridinyl boronate complex 80, formed under similar conditions to 77, has also been reported 
to undergo a 1,2-metallate rearrangement/ring opening reaction. This protocol affords 
enantioenriched β-amino alcohols 81 after boronic ester oxidation (Scheme 18b).78  
Furthermore, the α-lithiation of azetidinium 82 by lithium diisopropylamide (LDA), in the 
presence of a boronic ester leads to the formation of azetidinium boronate complex 84. This 
species was shown to undergo spontaneous ring opening to give γ-dimethylamino tertiary 
boronic ester 85 (Scheme 18c).79 However, attempts to access 85 enantioselectively by the 
lithiation of an enantioenriched sample of 82, were unsuccessful. It was reasoned that 
intermediate ylide 83 is configurationally unstable and so borylation can occur from either face 
to give racemic products.  
These three examples are efficient approaches to a C–C bond forming reaction. Here, the 
strained heterocycle not only induces the 1,2-metallate rearrangement but also introduces 
valuable functionality into the sp3-sp3 coupled products, in the form of hydroxy or amino 
groups. 
To expand on this concept, it was reasoned that a 1,2-metallate rearrangement could be an 
efficient method to homologate boronic esters with carbocylic motifs. The driving force for 
such a transformation is the cleavage of the highly strained bridging C–C bond of BCB. This 




lithium (BCB-Li, 87, Scheme 19a).80,81 When a mixture of 86 and a boronic ester is treated 
with tert-butyllithium, rapid lithium-sulfoxide exchange occurs to generate BCB-Li that 
undergoes borylation to form strained boronate complex 88. This species has been shown to 
react with electrophiles through a 1,2-metallate rearrangement – reminiscent of the reactivity 
of vinyl boronate complexes. For example, 88 reacts with brominating agent 89 to give 
cyclobutyl boronic ester 90. Due to the high p-character of the bridge bond of 88, a lobe of the 
bridge bond HOMO occupies the exo face of the bicycle so, to avoid steric interactions, the 
addition of the electrophile occurs stereoselectively on the same face as the migrating group.80 
The use of palladium complexes as electrophiles has also been demonstrated (Scheme 19b).81 
Here, BCB-boronate complex 88 was reacted with aryl triflates in the presence of a palladium 
catalyst. Oxidative addition of the aryl triflate gives an electrophilic palladium-(II) species that 
reacts with 88 stereoselectively to give cyclobutyl palladium complex 91. This undergoes 
reductive elimination to regenerate the active palladium catalyst and yield cross-coupled 
cyclobutyl boronic ester 92.   
Cyclopropyl boronate complex 93 was subjected to the same reaction conditions but did not 
undergo the 1,2-metallate rearrangement/ring opening mechanism (Scheme 19c).81 This is 
significant as unlike BCB-boronate 88 and the heterocyclic examples shown in Scheme 18, 93 
is not activated enough to trigger the 1,2-metallate rearrangement. 
 




2.2. Project proposal 
2.2.1. Project outline 
This project looked to investigate the reactivity of cyclopropyl boronate complex 95, which 
resembles a DA cyclopropane, where the donor group is the electron rich boronate and the 
acceptor groups are esters (Scheme 20).  
 
Scheme 20. Reaction design for the 1,2-metallate/ring opening of cyclopropyl boronate complexes. 
It was reasoned that boronate complex 95 could be accessed either by addition of an 
organolithium reagent to a cyclopropyl boronic ester, such as 94, or by the addition of a lithiated 
cyclopropane to a boronic ester. A 1,2-metallate rearrangement of 95 would result in the 
formation of a new C–C bond at the expense of a strained cyclopropane bond. The product of 
such a reaction would be 96, a secondary γ-carbonyl boronic ester. The use of either an 
enantioenriched sample of 94 or an enantioenriched configurationally stable lithiated 
cyclopropane would give enantioenriched products. This is because the 1,2-metallate 
rearrangement mechanism is enantiospecific and if 95 is configurationally stable, the 
mechanism would resemble the nucleophilic addition to DA cyclopropanes that proceeds 
through an enantiospecific SN2 pathway. 
The investigation into the proposed reaction summarised in this chapter is also outlined in the 
following publication: C. H. U. Gregson, V. Ganesh, V. K. Aggarwal, Org. Lett., 2019, 21, 
3412–3416.82 
2.2.2. γ-Carbonyl boronic esters 
Enantioenriched carbonyl boronic esters are an attractive chemical target as both the boronic 
ester and the carbonyl group are powerful functional handles for further chemical 
manipulations. However, there are few reports of the preparation of such building blocks with 
the boronic ester positioned γ to the carbonyl group in high enantiomeric excess.  
One example is the rhodium catalysed hydrogenation of vinyl boronic ester 97 to give 




ee, there is no concurrent functionalisation. On the other hand, similar products can be obtained 
using lithiation–borylation methodology (outlined previously in Scheme 13b), whereby β-
carbonyl boronic ester 99 is homologated with a lithiated benzoate ester (Scheme 21b).84 This 
method introduces a new carbon-carbon bond with good enantioselectivity but relies on the use 
of stoichiometric (−)-sparteine for enantioinduction.  
Morken and co-workers developed alternative methodology which utilises a conjunctive 
cross-coupling mechanism to afford enantioenriched γ-carbonyl boronic esters from vinyl 
boronate complexes (Scheme 21c).85 Here, β-carbonyl boronic ester 100 is transformed into 
γ-carbonyl boronic ester 101 with simultaneous coupling to an aryl triflate. The mechanism 
involves a 1,2-metallate rearrangement driven electrophilic addition of a chiral aryl 
palladium(II) species. The enantioenriched coupled product is then liberated through reductive 
elimination. While this is a powerful technique for the synthesis of functionalised γ-carbonyl 
boronic esters, the products are limited to those containing a benzylic group α to the boronic 
ester.85 
 




2.3. Results and discussion  
2.3.1. Synthesis of di-acceptor cyclopropyl boronic ester starting material 
To investigate the reactivity of an activated cyclopropyl boronate complex, the enantioselective 
synthesis of cyclopropyl boronic ester 94 was undertaken (Scheme 22).  
A procedure for the synthesis of the equivalent di-methyl ester derivative of 94 is reported by 
Gevorgyan and co-workers starting from di-methyl diazo malonate.86 A slightly modified 
procedure starting from di-tert-butyl diazo malonate (102) was employed in the synthesis of 
94 (Scheme 22). The first step involves rhodium catalysed cyclopropenation of trimethylsilyl 
acetylene with di-tert-butyl diazo malonate. The product of this reaction is TMS substituted 
cyclopropene 103. 
 
Scheme 22. Synthesis of enantioenriched di-activated cyclopropyl boronic ester 94. 
The major side product, γ-lactone 104, is formed through an intramolecular C–H insertion 
reaction of the transient rhodium carbene.87 This side-reaction was not observed by Gevorgyan 
and co-workers in their synthesis of the methyl ester analogue of 103. This is because the 
product would be a strained β-lactone. 
The next step is desilylation with K2CO3 to afford desired cyclopropene 105.
86 This species 
was subjected to rhodium-catalysed enantioselective hydroboration to give optically active 
cyclopropyl boronic ester (R)-94 in 91% yield. The assignment of absolute configuration is in 
relation to that determined by Gevorgyan and co-workers for the methyl ester analogue of 94.86 




2.3.2. Determining the enantiopurity of the starting material 
Cyclopropyl boronic ester 94 does not contain a UV chromophore, which prevents the 
determination of its enantiopurity by chiral HPLC analysis since UV detection is required. 
Therefore, either the derivatisation of 94, to chemically incorporate a chromophore without 
interfering with the stereogenic centre, or other methods for determining enantiomeric ratio 
were necessary.  
 
Scheme 23. Proposed outcome of the oxidation of boronic ester 94. 
Enantiospecific oxidation of boronic esters is a useful method to introduce a chromophore, as 
the corresponding alcohol can be esterified with benzoyl chloride. However, in the case of 94, 
oxidation would give cyclopropyl alcohol 106 that would spontaneously rearrange to give 
aldehyde 107 with complete loss of stereochemical information (Scheme 23).  
Gevorgyan and co-workers determined the enantiopurity of the di-methyl ester derivative of 
94 by 1H NMR analysis with chiral NMR shift reagent Eu(hfc)3 – a chiral europium(III) 
complex.86 This technique takes advantage of the formation of fluxional coordination 
complexes in solution between the substrate and the enantiopure shift reagent.88 The resultant 
complex has two possible diastereomers, where the diastereomeric ratio corresponds to the 
enantiomeric ratio of the substrate. Even though the coordination complex is fluxional, 
resolution of the diastereomers, and thus determination of the diastereomeric ratio, can still be 
possible on the 1H NMR timescale. However, in the case of 94, the 1H NMR signals all fall 
within a 0.53 ppm chemical shift range, which rendered this technique unsuitable. This is 
because the presence of quadrupolar Eu(hfc)3 in solution causes line broadening, resulting in 
poor resolution of the substrate peaks 1H NMR peaks.  
An alternative NMR shift reagent, Pirkle’s alcohol ((R)-(−)-1-(9-Anthryl)-2,2,2-
trifluoroethanol, 108),89 was trialled. For reference, the 1H NMR spectrum of boronic ester 







Figure 4. 1H NMR spectrum in CDCl3 in the region of 0.9-1.6 ppm of: a) (±)-94, b) (±)-94 and (7.0 equiv) of 
108 and c) (R)-94 and (7.0 equiv) of 108. 
The addition of Pirkle’s alcohol (108) causes the signals to shift and split, with the largest 
deviation seen in the tert-butyl proton signals and the α-boryl proton signal (highlighted). The 




equivalents of 108 were needed to give baseline separation and thus an enantiomeric ratio of 
50:50 could be determined from the 1H NMR by integration of the resolved signals (Figure 
4b).  
Performing this experiment on the enantioenriched sample of 94 gave the 1H NMR spectrum 
shown in Figure 4c. The resolved peaks were integrated and the enantiomeric ratio was 
determined as 97:3. With reference to the work conducted by Gevorgyan and co-workers,86 the 
expected enantiomer formed in the synthesis of 94 is R enantiomer.  
2.3.3. Reactivity of di-acceptor cyclopropyl boronic ester 
Having established a route to access highly enantioenriched boronic ester 94, it was then treated 
with n-butyllithium. This resulted in full conversion to boronate complex 109a, which was 
observed by a peak at 6 ppm in the 11B NMR spectrum (Scheme 24). Despite employing a 
malonate to stabilize the anion resulting from the 1,2-metallate rearrangement, the boronate 
complex converted very slowly at room temperature to ring-opened boronic ester 110a. 
Activation conditions for this transformation were then screened, accompanied by direct 
oxidation to alcohol 111b using hydrogen peroxide/sodium hydroxide to aid NMR yield 
determination. 
 
Scheme 24. Reaction design for the screening of activation conditions to induce a 1,2-metallate 
rearrangement/ring opening sequence. 
The results of the reaction screening are summarised in Table 3. Under reflux conditions, 
boronate complex 109a was completely consumed after 16 hours. This corresponded to the 
formation of ring-opened boronic ester 110a and subsequently, alcohol 111a was obtained in 
45% NMR yield (entry 1). It was thought that in this case, the lithium counterion of the 
boronate complex was coordinating to the two carbonyl oxygens in a chelate which encourages 
the 1,2-metallate rearrangement to occur. A solvent switch to chloroform, a non-coordinating 
solvent, was then performed to enhance the Lewis acidity of the lithium counterion. However, 




triflate (LiOTf) and refluxing conditions resulted in the decomposition of the boronate complex 
within 30 minutes (entry 3). On reducing the temperature and the equivalence of LiOTf, the 
reaction yield was greatly improved, and alcohol 111a was produced in 80% yield (entry 4). 
Table 3. Screening of activation conditions for the 1,2-metallate rearrangement/ring opening of boronate 
complex 109a. 
 
When magnesium bromide solution in methanol (MgBr2‧MeOH) was used as a Lewis acid, 
60% yield of 111a was obtained (entry 5). It was found magnesium bromide etherate 
(MgBr2‧Et2O) was optimal and led to the formation of 111a in 91% isolated yield (entry 6). 
This Lewis acid is also commercially available as a solid, rendering its addition operationally 
simple. The enantiopurity of 111a was found to be 97:3 er after acylation with benzoyl chloride. 
This result confirms that the reaction is enantiospecific (100% es), which also confirms that 
boronate 109a is configurationally stable under the reaction conditions. 
The 1,2-metallate rearrangement/ring opening of boronate 109a was repeated, and after the 
addition of MgBr2‧Et2O at –78 °C, the reaction was warmed to room temperature and 
transferred to an NMR tube. The conversion to boronic ester 110a was followed by 11B NMR 
spectroscopy and found to be complete after 3.5 hours at room temperature. 
The scope of migrating groups for the 1,2-metallate rearrangement was then explored. Firstly, 
employing tert-butyllithium led to the formation of boronate complex 109b (Scheme 25), 
which required warming to room temperature to ensure complete boronate complex formation 
of the hindered substrate. After the addition of MgBr2‧Et2O, the desired product was only 
formed in 28% yield. This was found to be due to competing O-migration of one of the pinacol 
oxygen ligands on boron to give borinic ester 112. Evidence for this competing process was 
not only the observation of characteristic signals corresponding to 112 in the crude 1H NMR 
spectrum, but the presence of a peak at 46 ppm in the 11B NMR spectrum of the reaction 




compete due to the hindered nature of the tert-butyl group, which slows down the rate of C-
migration. 
 
Scheme 25. 1,2-Metallate rearrangement/ring opening reaction with tert-butyl migrating group. 
However, this side-reaction was minimized by performing a solvent switch to toluene before 
the addition of the Lewis acid which afforded 110b in 38% isolated yield with 98% es.  
Continuing with the reaction scope, phenyl and other aromatic migrating groups with 
meta-methoxy and para-trifluoromethyl substitution all performed well with good yields (88-
62%) and 100% es (110c-e, Scheme 26). Apart from commercially available phenyllithium, 
the other aryllithium reagents were prepared by lithium-bromine exchange with 
tert-butyllithium from the corresponding aryl bromide. The synthesis of 110c, was also 
successfully scaled to 1.09 mmol with no reduction in reaction yield. Unfortunately, due to 
protodeboronation on silica gel, products 110c-e bearing a benzylic boronic ester were isolated 
in lower yields than determined by crude NMR.  
Heteroaromatic migrating groups were then explored as substrates for this reaction. With furan-
2-yllithium, prepared by the direct deprotonation of furan with n-butyllithium, product 110f 
was obtained in 73% yield and 98% es. However, when employing lithiated N-methyl indole, 
no desired product 110g was obtained as protodeboronation of the product had occurred before 
purification. Switching to lithiated N-Boc indole did result in the successful isolation of product 
110h, however in only moderate yield (30%). This is thought to be due to reversible boronate 
complex formation enabled by the high stability of the organolithium. 3-Pyridyllithium was 
also a successful substrate, however the boronic ester product also underwent rapid 
protodeboronation during aqueous work-up. In this case, it was possible to oxidise the crude 
reaction mixture with hydrogen peroxide/sodium hydroxide and obtain alcohol 111i in 63% 
yield and 98% es.  
The lithium-bromine exchange of α-bromostyrene provided access to (1-phenylvinyl)lithium, 




formation of an allenyl boronate complex was also possible by the deprotonation of 
1,1-dimethyl allene followed by addition of 94. Under the optimised activation conditions, 
boronic ester 110k was formed in a good yield of 76% and 100% es. 
 
Scheme 26. Scope of organolithium coupling partners in the 1,2-metallate rearrangement/ring opening reaction. 
Furthermore, an iodo-steroid substrate was also suitable for the transformation. Following 
lithium-iodine exchange in the presence of 94, complete conversion to the boronate complex 
was achieved and, under the influence of MgBr2‧Et2O, gave steroid-derived boronic ester 110l 




It was postulated that a strained structure could also act as the migrating group, and BCB was 
considered since BCB-Li is readily accessible from sulfoxide 86 (Scheme 27).80 The addition 
of tert-butyllithium to a mixture of 94 and 86 resulted in the formation of boronate complex 
109m.  
 
Scheme 27. Postulated competing pathways when BCB was employed as a migrating group. 
One can imagine that 109m could undergo a 1,2-metallate rearrangement in either of two 
directions. If the Lewis acid activates the cyclopropane through chelation with the two carbonyl 
groups, the BCB substituent would migrate to give species 110m. By contrast, if the Lewis 
acid instead activates the strained bridge bond of BCB, the cyclopropane substituent would 
migrate to give species 113 after protonation. However, the major product of this reaction was 
cyclobutenyl boronic ester 114, observed in 48% NMR yield. This species does not contain an 
intact cyclopropane, which is evidence that the 1,2-metallate rearrangement was driven by 
cleavage of the cyclopropyl bond. Since the MgBr2‧Et2O used was not rigorously anhydrous, 
perhaps small amounts of water could act as a proton source and, under the acidic reaction 
conditions, could catalyse the isomerisation of 110m to 114. Indeed, it has since been 
demonstrated in a follow-up investigation by a fellow research group member that using freshly 
prepared, anhydrous magnesium bromide solution in diethyl ether, boronic ester 110m is 





Scheme 28. BCB as a successful migrating group under anhydrous conditions. 
This dominant direction of reactivity of the boronate complex can be reasoned in two ways. 
Firstly, the interaction of magnesium with chelating oxygen atoms is more favourable than 
with a C–C bond. In addition, the migratory aptitude of each alkyl substituent on boron should 
be considered. The cyclopropyl substituent contains two electron withdrawing groups so is 
likely to be less nucleophilic than the BCB substituent. It is thought that these two effects 
contribute to the formation of boronic ester 110m. 
Boronic ester 94 was originally chosen as a substrate as undesired 1,2-addition of the 
organolithium reagent to the carbonyl is unlikely to occur with the hindered tert-butyl esters. 
However, boronic esters are very Lewis acidic and a boronate complex has been known to form 
when phenyllithium is added to a boronic ester containing a less hindered ester group.90 To 
evaluate whether tert-butyl esters are a necessity in this reaction, boronic ester 115 comprising 
diethyl esters was employed (Scheme 29). In this case, the temperature was lowered to −98 °C 
to limit 1,2-addition, however ring-opened product 116 was observed in only 35% NMR yield, 
in comparison to 95% NMR yield for the tert-butyl ester analogue.  
 
Scheme 29. Reactivity of cyclopropyl boronic ester comprising two ethyl ester functional groups. 
2.3.4. Three-component reaction with catalytic Lewis acid 
It was expected that the enolate formed after 1,2-metallate rearrangement could be trapped with 
electrophiles in situ in a three-component coupling process. This approach is prevalent in 
reports of nucleophilic addition to DA cyclopropanes as it provides enhanced efficiency and 
enables sub-stoichiometric quantities of the Lewis acid to be employed.19–24,76 The use of 
anhydrous Lewis acid is a necessity to avoid protonation of the enolate. In our case it was 
operationally simpler to weigh out solid MgBr2‧Et2O in a nitrogen atmosphere glovebox than 





Scheme 30. Scope of electrophiles for in situ functionalisation. 
With this modification, initial attempts showed that the reaction was feasible with 20 mol% 
MgBr2‧Et2O in the presence of methyl iodide as the electrophile. This gave methylated product 
117a in 77% yield and 100% es (Scheme 30). 
Allyl iodide and Eschenmoser's salt (118) were also successfully employed as electrophiles 
giving 117b and 117c in 88% and 72% yield respectively with complete enantiospecificity. 
2.3.5. Product functionalisation 
It was important to evaluate the synthetic utility of the enantioenriched γ-carbonyl boronic 
esters synthesised using this methodology. However, many enantiospecific transformations of 
alkyl boronic esters begin with the addition of an organolithium reagent to access a boronate 
complex.58 This is problematic for the boronic esters shown in Scheme 26 as they possess an 
acidic malonate functional group. It was therefore necessary to modify existing procedures and 
account for the acidic group by using additional equivalents of organolithium reagent to form 




If necessary, the enolate component of the di-anionic boronate complex could then be 
protonated, with a proton source such as methanol, to provide the desired boronate complex 
for further reactivity.  
 
Scheme 31. Enantiospecific transformations of γ-carbonyl boronic ester 110c. 
With boronic ester 110c (Scheme 31b) Zweifel olefination was possible with 3.2 equivalents 
of vinyllithium and methanol added as a proton source. Upon addition of iodine/methanol, 
followed by sodium methoxide, alkene 120 was obtained in 96% yield.68 Similarly, sp2-sp3 
coupling to furan with 2.4 equivalents of furan-2-yllithium followed by a solvent switch to 
methanol and addition of NBS gave desired product 121 in 61% yield (Scheme 31c).70 
Furthermore, sp2-sp3 coupling to 3-fluoropyridine was also achieved with 2.5 equivalents of 
(3-fluoropyridin-4-yl)lithium (Scheme 31d). The 1,2-migration was triggered upon addition of 
TrocCl and oxidation with sodium hydroxide/hydrogen peroxide gave coupled product 122 in 




the scope of these existing enantiospecific transformations to tolerate an acidic functional 
group.  
The enantiospecific oxidation of boronic ester 110c yielded alcohol 111c (Scheme 32). This 
compound was then subjected to hydrolysis and lactonization with formic acid and subsequent 
thermal decarboxylation to give γ-phenyl-γ-butyrolactone (123).91 The optical rotation of 123 
corresponded to that reported for the S enantiomer which confirmed that the absolute 
stereochemistry of boronic ester 110c is S.92,93 This confirms that the 1,2-metallate 
rearrangement/ring opening sequence of cyclopropyl boronate complexes proceeds through 
inversion of stereochemistry at the α-boryl carbon. 
 
Scheme 32. Determination of absolute configuration of γ-carbonyl boronic ester 110c. 
2.3.6. Synthesis of mono-acceptor cyclopropyl boronic ester 
It was established that the cyclopropyl boronate complex with two electron withdrawing groups 
can undergo 1,2-metallate rearrangement/ring opening thermally or by activation with a Lewis 
acid. The necessity for two electron withdrawing groups was then investigated. 
Cyclopropyl boronic esters cis/trans-125 were chosen as model starting materials, bearing a 
phenyl substituent to lower the volatility of the product and aid in its isolation (Scheme 33). 
Cis- and trans-125 were synthesised using palladium-catalysed cyclopropanation of styryl 
pinacol boronic ester 124 with tert-butyl diazo acetate.94,95 This reaction yielded both 
diastereomers in close to a 1:1 ratio, which were separable by silica gel chromatography. Both 
isomers have the boronic ester and the phenyl substituent on opposite sides of the cyclopropane 
as this geometry was already set in trans alkene 124. The diastereomers differ based on which 
side the ester substituent is situated. The diastereomer with the ester group on the same side as 
the boronic ester was labelled the cis isomer and the diastereomer with the ester group on the 
opposite side as the boronic ester was labelled the trans isomer. The configurations of each 





Scheme 33. Palladium catalysed cyclopropanation of styryl pinacol boronic ester with tert-butyl diazo acetate. 
NOE signals to determine the configuration of each diastereomer. 
2.3.7. Reactivity of the mono-acceptor cyclopropyl boronic ester 
On treatment of each isomer of 125 with n-butyllithium, conversion to boronate complex 126 
was observed by the presence of a peak at 6 ppm in the 11B NMR spectrum (Scheme 34). 
However, in contrast to the boronate complex with two ester substituents (109), there was no 
change in the 11B NMR spectrum after 16 hours at room temperature and thus no thermal 1,2-
metallate rearrangement/ring opening. It was evident that stronger activation conditions would 
be required to cleave the less activated cyclopropane C–C bond to yield desired product 127.  
 
Scheme 34. Treatment of mono-activated cyclopropyl boronic ester with n-butyllithium. 
Activation conditions were then screened separately for each isomer. Attempts to activate 
boronate complex trans-126 with Lewis acids are shown in Scheme 35. The first conditions 
chosen were the addition of solid MgBr2‧Et2O at –78 °C and subsequent warming to 60 °C for 
16 hours (Scheme 35a). The formation of borinic ester trans-128 was observed by a peak at 
50 ppm in the 11B NMR spectrum of the reaction mixture. This is evidence that the Lewis acid 
coordinates preferentially to one of the pinacol oxygen atoms rather than the carbonyl oxygen 
atom, which causes cleavage of a B–O bond. Due to the instability of borinic esters to aqueous 




with no formation of desired product 127 observed. The same reactivity was observed for 
Lewis acids scandium triflate (Sc(OTf)3) and boron trifluoride diethyl etherate (BF3·Et2O) at 
room temperature (Scheme 35b). 
 
Scheme 35. Attempted Lewis acid activation of the mono-activated cyclopropyl boronate complex trans-126. 
It was speculated that the carbonyl oxygen atom is less hindered than the pinacol oxygen atoms 
as it is 3 bonds from a quaternary carbon rather than 1 bond. Therefore, a hindered Lewis acid 
was trialled in the hope that the difference in steric hinderance could influence the 
chemoselectivity to give preferential carbonyl activation to facilitate the 1,2-metallate 
rearrangement/ring opening reaction. Tris(pentafluorophenyl)borane (B(C6F5)3) has 
comparable Lewis acidity to BF3 but is considerably more sterically hindered.
96 However, 
employing this Lewis acid to the activation of boronate complex trans-126 gave no reactivity 
after 16 hours at room temperature (Scheme 35c). The boronate complex was consumed after 
26 hours at 60 °C, however, no desired ring-opened product was formed and only 
decomposition of the boronate complex had occurred. 
The reactivity of cis-126 was then investigated. Once again, the addition of either Lewis acids 
Sc(OTf)3 or BF3·Et2O led to borinic ester formation (Scheme 36). In the case of MgBr2·Et2O, 
different reactivity to the trans isomer was observed. The major product of the reaction was 
the protodeboronation product 129 formed in 45% NMR yield. However, in all cases, no ring-





Scheme 36. Attempted Lewis acid activation of the mono-activated cyclopropyl boronate complex cis-126. 
2.3.8. Reactivity study  
With the knowledge that two acceptor groups are required for the desired 1,2-metallate 
rearrangement mechanism to occur, it was considered whether the C–C bond α to the boronate 
needed to be part of a strained ring. To investigate this, boronic ester 132 with an open chain 
structure and two tert-butyl ester groups was chosen as a suitable substrate.  
To synthesise 132, di-tert-butyl 2-methylmalonate (130) was deprotonated with sodium 
hydride and the resultant enolate reacted with boronic ester 131 (Scheme 37). The formation 
of desired boronate complex 133 is likely reversible due to high steric hinderance around boron 
and the relative stability of the enolate. However, when boronate 133 is formed, a 1,2-metallate 
rearrangement can occur with loss of bromide to give desired product 132, albeit in low yield.97  
 
Scheme 37. Synthesis of di-acceptor open chain boronic ester 132. 
For reference, the reaction of di-acceptor cyclopropyl boronic ester 94 with n-butyllithium was 
followed by 11B NMR spectroscopy (Scheme 38a). Full conversion to boronate complex 109a 




and stirring at room temperature for 16 hours, the 11B NMR spectrum had one major peak at 
33 ppm. This corresponds to the formation of sp3 hybridised boronic ester 110a.  
As previously described, the reaction sequence for mono-acceptor cyclopropyl boronic ester 
trans-125 also proceeds through a boronate complex, however the addition of MgBr2‧Et2O led 
to the formation of borinic ester trans-128, identified by a characteristic 11B NMR chemical 
shift at 50 ppm (Scheme 38b). The reactivity of di-acceptor open chain boronic ester 132 was 
then investigated and compared to these previous reactions (Scheme 38c). Again, after 
formation of boronate complex 134, addition of MgBr2‧Et2O led to the formation of a borinic 
ester (135). As with the reaction of boronate trans-126, no evidence of the 1,2-metallate 
rearrangement product was detected in the crude 1H NMR spectrum.  
 





The shared reactivity of boronate complexes trans-126 and 134, which is orthogonal to the 
reactivity of boronate complex 109, demonstrates that both strain-release and the presence of 
two ester groups are necessary to drive the 1,2-metallate rearrangement. Without either 
structural feature, borinic ester formation dominates. 
2.3.9. Attempted dearomative 1,2-metallate rearrangement of an aryl 
cyclopropyl boronic ester 
2.3.9.1. Reaction proposal and experiment design 
As discussed previously in section 2.1.3, an analogue of the Matteson homologation is possible 
where the boronate centre and the leaving group are not adjacent to each other but distal and in 
conjugation. This is referred to as the vinylogous Matteson homologation and a specific 
example is shown in Scheme 39. Here, the 1,2-metallate rearrangement of aryl boronate 
complex 136 is induced by the presence of a benzylic leaving group in the ortho-position. The 
1,2-metallate rearrangement of 136 proceeds through dearomatized intermediate 137. This 
species was isolable but could further undergo a Lewis acid catalysed 1,3-borotropic shift to 
afford ortho-substituted benzylic boronic ester 138. 
 
Scheme 39. Sp2-sp3 coupling of boronic esters with ortho-lithiated benzylamines. 
It was hypothesised that a vinylogous variant of the cyclopropane ring opening reaction 
investigated herein could be possible. A boronate complex such as 140 could undergo such a 
transformation whereby the activation of the cyclopropane acceptor groups with a Lewis acid 
could trigger a dearomative 1,2-metallate rearrangement to give boronic ester 141 (Scheme 
40). Analogous to the literature example in Scheme 39, this species could also undergo a 
1,3-borotropic shift to give γ-carbonyl boronic ester 142. Boronate complex 140 could be easily 




previously synthesised 94, 139 instead has the boronic ester and cyclopropane in conjugation 
rather than bonded directly to eachother.  
 
Scheme 40. Proposed dearomative 1,2-metallate rearrangement/ring opening reaction and subsequent 1,3-
borotropic shift to give functionalised γ-carbonyl boronic esters. 
2.3.9.2. Synthesis and reactivity of 2-cyclopropylphenyl boronate complex 
The racemic synthesis of aryl boronic ester 139 was undertaken (Scheme 41a). Firstly, boronic 
ester 143 was accessed by the lithium-halogen exchange of 2-bromostyrene with 
n-butyllithium. This species was trapped in situ with iso-propoxy pinacol borate to afford 143 
in 97% yield. Cyclopropanation with di-tert-butyl diazo malonate (102) and catalytic Rh2(esp)2 
gave 139 in 72% yield.98 
 
Scheme 41. Synthesis of 2-cyclopropylphenyl boronate complex 139 and subsequent attempted 1,2-metallate 




Boronic ester 139 was treated with n-butyllithium at –78 °C to give boronate complex 144, 
followed by MgBr2‧Et2O (Scheme 41b). After 30 minutes at room temperature, no boronate 
complex was observed by 11B NMR spectroscopy. Two major products were formed in this 
reaction, 8-membered ring containing borinic ester 145 and boronic ester 146 (Scheme 41b). It 
appears that after the formation and activation of boronate 144 with magnesium bromide, the 
desired dearomative 1,2-metallate rearrangement (Scheme 42a) does not occur. Instead, one of 
the pinacol oxygen atoms undergoes a 1,4-migration to the electrophilic carbon of the DA 
cyclopropane to give 145 (Scheme 42b). Borinic ester 145 has a 11B NMR chemical shift of 
26 ppm. This is considerably lower than the typical chemical shift of 50 ppm for a borinic ester. 
In addition, 145 was isolated after column chromatography. This is despite the expected 
instability of borinic esters on silica gel due to their greater electrophilicity than boronic esters. 
These two pieces of evidence suggest that the oxygen lone pair of the ether in 145 coordinates 
to boron thus reducing its electrophilicity and 11B NMR chemical shift. 
The formation of ketone 146 under the reaction conditions is intriguing, as n-butyllithium 
appears to have undergone a 1,2-addition to one of the tert-butyl esters (Scheme 42c). This is 
unexpected as the carbonyl carbon is very hindered and such reactivity has not been observed 
with previous cyclopropyl boronic esters bearing a tert-butyl ester. However, the boron in 139 
is also in the hindered ortho-position which may reduce the rate of borylation. Another 
explanation is that after activation of the carbonyl with magnesium bromide, an intramolecular 
nucleophilic addition of the n-butyl group occurs (Scheme 42d). In this case, the aryl boronate 
complex would be acting as a nucleophilic organometallic reagent which is reported 
reactivity.84,99 
 
Scheme 42. Possible competing reaction mechanisms from cyclopropyl boronate complex 144. 
There is also precedent for the formation of borinic ester 145. Similar reactivity has been 




case, aryl boronate complex 147, which contains a chloride leaving group in the benzylic 
position, was investigated to see if a dearomative 1,2-metallate rearrangement would occur 
upon warming to room temperature to give boronic ester 148. After in situ oxidation, desired 
product 150 was isolated; the boronate complex had indeed undergone the 1,2-metallate 
rearrangement followed by boron elimination/aromatisation, albeit in a low yield. However, 
the major product was diol 151 derived from borinic ester 149, which is formed by the same 
1,4-O-migration mechanism. 
 
Scheme 43. Literature reported example of the occurrence of a similar undesired 1,4-O-migration reaction. 
The various aryl boronate complexes with benzylic leaving groups that have been investigated 
to date in the Aggarwal group are shown in Figure 5.74 It is remarkable that the nature of the 
leaving group has such a large effect on reactivity, to the extent that boronate 152 undergoes a 
completely different reaction mechanism to boronate 153. Effects that could dictate which 
reaction mechanism operates are the steric hindrance at the benzylic position or perhaps the 
favoured conformational geometry adopted by the boronate complex.  
 
Figure 5. Comparison between phenyl boronate complexes with 2-substituted benzylic leaving groups. 
2.3.10. Conclusion and future work 
This chapter has described investigations into the chemistry of activated cyclopropyl boronate 
complexes.82 The Lewis acid facilitated stereospecific 1,2-metallate rearrangement/ring 




been developed (Scheme 44a). This reaction produces γ-carbonyl boronic esters in good to 
excellent yields. A scope of organolithium reagents has been presented with successful 
examples including alkyl, aryl, vinyl and heteroaryl migratory groups. The use of a 
substoichiometric quantity of Lewis acid in the presence of an electrophile enabled concurrent 
functionalisation at the C3 carbon. A γ-carbonyl boronic ester product was shown to 
successfully undergo enantiospecific sp2-sp3 coupling reactions with vinyllithium, furan-2-
yllithium and (3-fluoropyridin-4-yl)lithium. These reactions proceeded with good yields and 
demonstrated that the γ-carbonyl boronic esters can be used as effective chiral molecular 
building blocks. 
 
Scheme 44. Reaction overview, limitation of starting material synthesis and possible future work. 
The 1,2-metallate rearrangement/ring opening sequence was found to only proceed if the 
cyclopropane was substituted with two carboxylate groups. In addition, the driving force of 
strain-release was also found to be necessary for the reaction to occur. 
While the reactivity of cyclopropyl boronate complexes derived from 94 has been established, 
the scope is limited to starting material 94 without further substitution at C1 or C2 (Scheme 
44a). Gevorgan and co-workers reported that the hydroboration of cyclopropene 154 to give 
cyclopropyl boronic ester 155 was unsuccessful due to a competing rearrangement mechanism 




starting materials are not accessible using this method. Still unexplored is the possibility of 
accessing a cyclopropyl boronate complex by the lithiation–borylation of DA cyclopropanes 
such as 157 (Scheme 44c). It would be interesting to see if a hindered base, such as LTMP, is 
able to deprotonate 157 in the benzylic position which would be directed by one of the ester 
carbonyl groups to give 158 and whether such a species is configurationally stable. The 
addition of an enantioenriched alkyl boronic ester to 158 would give boronate complex 159. 
After 1,2-metallate rearrangement/ring opening, boronic ester product 160 would contain two 
contiguous stereocentres.  
The desired transformation from 2-cyclopropylphenyl boronic ester complex 139 has an energy 
barrier associated with the loss of stability due to dearomatisation. In the case of 
2-cyclopropylnaphthyl boronate complex 161 (Scheme 45), the energy cost associated with 
dearomatisation is lower. Therefore, in this system, the 1,2-metallate rearrangement pathway 
may be favoured over the O-migration pathway. However, the second step involving a 
1,3-borotropic shift would have a weaker driving force for rearomatisation.  
 






3. Synthesis of azetidines via azabicyclobutyl boronate 
complexes 
3.1. Azetidines and azabicyclo[1.1.0]butane 
3.1.1. Azetidines in drug molecules 
In 2014, Njardarson and co-workers analysed a database of all U.S. FDA approved drug 
molecules and found that small-molecule drugs on average comprised 2.3 nitrogen atoms per 
drug.101 Two of the most commonly encountered nitrogen containing motifs were the saturated 
heterocycles piperidine and pyrrolidine while the saturated four-membered heterocycle, 
azetidine, was reported to be much less common.101 However, the azetidine motif exhibits 
greater metabolic stability than the larger ring analogues102 and the structural rigidity of the 
strained ring can impart three-dimensionality into potential drug molecules while also 
increasing bioavailability.103–105 
Therefore, new methods that enable the synthesis of functionalised azetidines are desirable due 
to the expected increase in demand for azetidines in drug targets. Indeed, since the report by 
Njardarson and co-workers, azetidine-containing drug molecules cobimetinib46 (melanoma 
with BRAF mutation treatment) and baricitinib47 (rheumatoid arthritis treatment) have both 
been FDA approved (Figure 6).  
 
Figure 6. Recently FDA approved drug molecules containing an azetidine ring. 
3.1.2. Synthesis of azetidines 
 A selection of general methods for the synthesis of substituted azetidines is outlined in Scheme 
46. The reduction of readily available β-lactams106 and the intermolecular cyclisation of 




(Scheme 46a,b). Alternatively, azetidines can be constructed from other ring sizes, for example, 
ring contraction from γ-lactams108 or ring expansion from aziridines (Scheme 46c,d).109  
 
Scheme 46. Methods for the synthesis of substituted azetidines.  
Another approach to substituted azetidines is to functionalise an existing azetidine ring. Therin, 
the coupling of azetidines with other fragments, for example, nucleophilic 1,2-addition to 
3-azetidinones46 or lithiation followed by electrophilic trapping in the 2-position of 
azetidines110 allows for an increase of molecular complexity (Scheme 46e,f). 
As discussed in section 1.2.3, recent developments have demonstrated that the highly strained 
azabicyclo[1.1.0]butane (ABB, 5) is an effective synthon for 1,3-substituted azetidines 
(Scheme 46g).51 The bridgehead carbon of azabicyclo[1.1.0]butane is electrophilic so prone to 
nucleophilic attack which opens the strained bicyclic structure to give the azetidine skeleton. 
ABB is also easily accessible in two steps from cheap and readily available allyl amine (see 
Scheme 7b). 
3.1.3. Lithiation–borylation of azabicyclo[1.1.0]butane 
While ABB has been shown as an effective building block in the synthesis of 1,3-substituted 
azetidines (Scheme 47a), the ability to access 1,3,3-trisubstituted azetidines through a strain-
release strategy is more difficult. The 1,3-functionalisation of azabicyclo[1.1.0]butanes which 
already have a substituent at C3 has been described (Scheme 47b).40,52,111,112 However, unlike 
ABB, to access molecules such as 166 requires lengthy synthetic routes. 
It was proposed by the Aggarwal group that ABB could in fact also act as a synthon for 




the high ring strain of ABB, this methodology takes advantage of the acidity of the bridgehead 
C–H bond to access ABB-lithium (ABB-Li, 167). This is a polarity reversal approach as ABB-
Li is nucleophilic at C3 rather than electrophilic. After nucleophilic addition to introduce a 
substituent at C3, strain-release 1,3-functionalisation can occur to give the desired 
1,3,3-trisubstituted azetidine. 
 
Scheme 47. Strain-release synthetic routes to substituted azetidines. 
It was demonstrated that after the in situ generation of ABB from ammonium salt 33, ABB 
could indeed be lithiated selectively at C3 using sec-butyllithium ligated by 
tetramethylethylenediamine (TMEDA, Scheme 48).113 This gave ABB-Li which could be 
trapped by sulfinate 168 to give sulfoxide 169 in 62% overall yield.  
 
Scheme 48. Lithiation of azabicyclo[1.1.0]butane and trapping as a sulfoxide. 
The use of sulfoxide 169 to access 1,3,3-trisubstituted azetidines was then investigated.113 
Reminiscent of the homologation of boronic esters with BCB-Li, (shown again in Scheme 49a), 
it was proposed that sulfoxide 169 could undergo lithium-sulfoxide exchange to regenerate 
ABB-Li. In the presence of a boronic ester this would lead to the formation of strained boronate 
complex 170 (Scheme 49b). The activation of the nitrogen lone pair of 170 would result in a 
strain-release 1,2-metallate rearrangement to give 1,3,3-trisubstituted azetidine 171 with the 





Scheme 49. Analogous reactions involving the homologation of boronic esters with a four-membered ring. 
As anticipated, the addition of tert-butyllithium to a mixture of sulfoxide 169 and a boronic 
ester resulted in complete boronate formation.113 It was found that the optimum activation 
conditions were the treatment of boronate 170 with 2.0 equivalents of acetic acid. This 
triggered the desired 1,2-metallate rearrangement to give azetidinium salt 172 (Scheme 50). 
The by-product from sulfoxide-lithium exchange (173) was removed by a “silica catch” 
purification, whereby 172 is retained on silica while 173 is eluted with ethyl acetate. The 
azetidinium salt retained on silica was shown to be a versatile intermediate, as the azetidine 
nitrogen could then be further functionalised. For example, with cyclohexyl pinacol boronic 
ester, the azetidine salt could be Boc protected to give azetidine 174 in good yield (Table 4, 
entry 1). Alternatively, subjecting the azetidine salt to amide coupling conditions with benzoic 
acid, amide coupling reagent HATU and N,N-diisopropylethylamine (DIPEA) gave azetidine 
175 (entry 2).  
 
Scheme 50. Lithiation–borylation of azabicyclo[1.1.0]butane to give 1,3,3-trisubstituted azetidines and further 





Table 4. Selected examples of azetidines accessible through the lithiation–borylation of azabicyclo[1.1.0]butane. 
 
An advantage of this method relative to other procedures for the synthesis of azetidines is that 
the azetidine product contains a boronic ester substituent that can be further diversified. For 
example, alcohol 176 could be obtained by the oxidation of boronic ester 174 and was isolated 
in 70% over two steps from cyclohexyl pinacol boronic ester (entry 3). A scope of 27 different 
boronic esters was demonstrated which included primary, secondary, tertiary, vinyl and aryl 
boronic esters.113 A significant example was a piperidine derived boronic ester, giving azetidine 
177 in 54% yield (entry 4). Alkyl groups with α-heteroatoms are known to migrate slowly114 
however, the strain-release of the azabicyclo[1.1.0]butane motif is a sufficiently large driving 
force for 1,2-metallate rearrangement.  
3.2. Project proposal 
3.2.1. Project outline 
The lithiation–borylation of ABB is a rapid, modular approach to the synthesis of 
1,3,3-trisubstituted azetidines. It was proposed that one specific azetidine drug molecule, 
cobimetinib, would be easily accessible by this method from simple building blocks: ABB-Li, 
boronic ester 178 and benzoic acid 179 (Scheme 51).  
The synthesis of cobimetinib using ABB is summarised in this chapter and this work is also 
outlined in the following publication: A. Fawcett, A. Murtaza, C. H. U. Gregson, V. K. 
Aggarwal, J. Am. Chem. Soc., 2019, 141, 4573–4578.113 The contribution of other authors to 





Scheme 51. Proposed synthetic route to cobimetinib. 
3.2.2. Previous syntheses of cobimetinib 
Cobimetinib was first prepared by Rice and co-workers and identified as an effective MEK 
inhibitor.46 MEK inhibitors affect the MAPK/ERK pathway, a protein signalling pathway 
which is overactive in certain cancers.115 Cobimetinib has since been FDA approved for the 
treatment of advanced melanoma with BRAF mutation in combination with vemurafenib, a 
BRAF inhibitor.116 
The synthesis of cobimetinib by Rice and co-workers is outlined in Scheme 52.46 The first step 
is a low yielding 1,2-addition of (N-Boc-piperidin-2-yl)lithium to azetidinone 180 to give 
racemic azetidine 181. The resolution of this species was achieved by esterification with acyl 
chloride 182 to give major diastereomer 183 which was isolated by chromatography and 
hydrolysed to give optically pure (S)-181. Selective deprotection of the azetidine followed by 
amide coupling with acyl fluoride 184 gave azetidine 185, which was Boc deprotected with 
HCl/dioxane to give cobimetinib.  
 




Acyl fluoride 184 was synthesised by the regioselective SNAr reaction between aniline 186 and 
2,3,4-trifluorobenzoic acid (187) to give benzoic acid 188, followed by fluorination with 
cyanuric fluoride (Scheme 53).46 
 
Scheme 53. Synthesis of 3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzoyl fluoride. 
An alternative manufacturing route to cobimetinib has been reported starting from compound 
189, itself derived from the chiral pool (Scheme 54).117,118 As before, the first step is a 
1,2-addition to azetidinone 190 to give 191 in an unspecified dr and yield. The next three steps 
are performed without intermediate purification to access azetidine 193 in 50% yield. 
Specifically, these steps involve a reductive decyanation and C–O bond cleavage, followed by 
Boc deprotection and amide bond formation with 2,3,4-trifluorobenzoyl chloride (192).  
Finally, the SNAr reaction with aniline 186 affords cobimetinib. The advantage of this method 
is the reduced number of purification steps and the use of hemiaminal 189 as the starting 
material for which the manufacturing route is already established.119 
 




3.3. Results and discussion 
3.3.1. Piperidine boronic ester synthesis 
The first objective was to synthesise piperidine boronic ester 178 in enantioenriched form. 
Beak and co-workers reported that while the lithiation of N-Boc-pyrrolidine with 
sec-butyllithium and (–)-sparteine proceeded in good yield with high enantioselectivity, the 
equivalent reaction with N-Boc-piperidine was low yielding and much poorer 
enantioselectivity was achieved (Scheme 55a).120,121  
An improvement was reported by O’Brien and co-workers which is the asymmetric 
deprotonation of N-Boc-piperidine with (+)-sparteine surrogate (Scheme 55b).122 The less 
hindered amine ligand enhances the reactivity of sec-butyllithium, so much faster lithiation of 
N-Boc-piperidine occurred and enantioinduction up to 88:12 er was possible. Fortunately, the 
major enantiomer using (+)-sparteine surrogate has the same stereochemistry as that found in 
cobimetinib. 
 
Scheme 55. Asymmetric deprotonation of N-Boc-piperidine and N-Boc-pyrrolidine. 
This methodology was applied to the synthesis of boronic ester 178. Lithiation of 
N-Boc-piperidine with sec-butyllithium/(+)-sparteine surrogate followed by trapping with 




however, iso-propoxy pinacol borate has been used previously to trap enantioenriched 
organolithium species in high enantioexcess.114 
3.3.2. Synthesis of cobimetinib 
A solution of boronic ester 178 and sulfoxide 169 in THF was treated with tert-butyllithium to 
form boronate complex 194 (Scheme 56). After the addition of acetic acid and “silica catch” 
purification, salt 195 and the top layer of the silica gel plug were then collected and subjected 
to amide coupling conditions with benzoic acid 188, HATU and DIPEA. This gave desired 
boronic ester 196 in 34% yield (Scheme 56).  
The homologation step to give salt 195 is known to achieve 54% yield after Boc protection113 
so it was deduced that the amide coupling was not proceeding in very high yield. Indeed, a 
control amide coupling reaction of azetidine hydrogen chloride with benzoic acid 188 under 
the same conditions gave the product in only 70% yield. When the homologation and amide 
coupling are then telescoped, a moderate yield of 34% is to be expected.  
However, the amide coupling conditions used by Rice and co-workers,46 which utilised acyl 
fluoride 184, gave boronic ester 196 in 52% yield (Scheme 56).  
 
Scheme 56. Reaction of piperidine derived boronic ester and azabicyclobutyl sulfoxide followed by amide 
coupling. 
Up to this point, investigations into the lithiation–borylation of ABB had only been performed 
via sulfoxide 169. The reason for this is that 169 can be purified and is a bench stable solid 




equivalents and potential impurities can be achieved if ABB-Li is generated from sulfoxide 
169. In addition, the synthesis of 169 has been scaled to 1.7 g (8.8 mmol) so if many different 
azetidines are required, the reaction via the sulfoxide is more time efficient.113 
However, if only one particular azetidine is required, the reaction via sulfoxide 169 is less 
efficient, both in terms of time and atom economy. A “one-pot” procedure was established, 
whereby ABB was formed, lithiated and borylated in situ with cyclohexyl pinacol boronic ester 
(Scheme 57). The activation of the boronate complex with acetic acid followed by Boc 
protection afforded desired azetidine product 174 in 67% yield. One advantage of this method 
is that “silica-catch” purification is not required, as no problematic sulfoxide by-products are 
present. 
 
Scheme 57. One pot procedure for the lithiation–borylation of azabicyclo[1.1.0]butane. 
This procedure was applied to the synthesis of cobimetinib (Scheme 58). In this case, starting 
from ammonium salt 33, the synthesis of boronic ester 196 was achieved in an enhanced yield 
of 62%.  
 




Enantiospecific oxidation of the boronic ester with hydrogen peroxide/sodium hydroxide 
proceeded in 89% yield to give alcohol 196’. This is not a high yield for this often-quantitative 
reaction, however, a tertiary boronic ester is a more difficult substrate to oxidise due to steric 
hindrance. The enantiomeric ratio of alcohol 196’ was found to be 88:12 er which is the 
maximum O’Brien and co-workers observed for the asymmetric lithiation of N-Boc 
piperidine.122 Finally, Boc deprotection with trifluoroacetic acid (TFA)/triethyl silane followed 
by neutralisation with sodium hydroxide solution gave cobimetinib (164) in 94% yield.  
This process transforms piperidine boronic ester 178 into cobimetinib in an overall yield of 
52%. This is an improvement on the manufacturing route to cobimetinib with similar step 
economy.117 
3.3.3. Conclusions and future work 
A new route to the anti-cancer drug cobimetinib has been established that employs 
azabicyclo[1.1.0]butane as a synthon for a 1,3,3-trisubstituted azetidine. The synthesis applies 
methodology that was previously investigated within the Aggarwal research group, namely the 
lithiation–borylation of azabicyclo[1.1.0]butane.113 The synthesis of cobimetinib was achieved 
in three steps, one of which is a telescoped process that transforms amine salt 33, piperidine 
boronic ester 178 and acyl fluoride 184 into an advanced intermediate in one pot with a yield 
of 62%.  
While it is unlikely that the synthesis of cobimetinib via ABB will replace the established route, 
due to the requirement for (+)-sparteine surrogate and the moderate enantioselectivity, this 
synthesis has demonstrated the applicability of this methodology to the synthesis of 
biologically active azetidines. In addition, this approach is modular, so by choosing a different 
boronic ester, acyl fluoride or boronic ester transformation, a variety of chemical analogues 
could be synthesised in short succession. Therefore, future work in this area could be the 
synthesis of a library of azetidines that could be analysed for bioactivity (Scheme 59). 
Furthermore, as the procedure is general, the library synthesis could be translated to an 
automated synthesis platform to enhance efficiency.123 
 




4. Strain-release reactions of azabicyclo[1.1.0]butyl carbinols 
4.1. Project proposal 
Following the successful use of ABB-Li as a synthon for 1,3,3-trisubstituted azetidines, 
alternative electrophiles that could also participate in subsequent strain-release chemistry were 
investigated. Due to a diverse and accessible feedstock of ketones and aldehydes, their reaction 
with ABB-Li was explored. 
It was envisioned that a 1,2-addition of ABB-Li at the carbonyl carbon would occur to give an 
alcohol with the ABB group in the β-position (ABB carbinol 197, Scheme 60). Following 
activation of the ABB nitrogen lone pair, 197 could rearrange one of two ways. Firstly, after 
activation, a semipinacol rearrangement could take place with migration of one alcohol 
substituent to give keto azetidine 198 with an all-carbon quaternary centre. Alternatively, the 
oxygen lone pair could engage the strained ABB central bond through a spirocyclisation SN2 
pathway to give spiroepoxy azetidine 199. 
 
Scheme 60. Proposed synthesis of ABB-carbinols and their subsequent reactivity. 
The investigation into these two reaction pathways is summarised in this chapter and this work 
is also outlined in the following publication: C. H. U. Gregson, A. Noble, V. K. Aggarwal, 
Angew. Chem. Int. Ed., 2021, 60, 7360–7365.124 
4.2. The semipinacol rearrangement reaction 
4.2.1. General introduction to the semipinacol rearrangement reaction 
The pinacol rearrangement refers to the acid catalysed reaction of a vicinal diol to give a ketone 
through loss of water and a 1,2-alkyl shift. The primary example is the conversion of pinacol 
to pinacolone (Scheme 61) which was first reported in 1859, although the correct reaction 
product was not elucidated until 1873.125 The reaction involves the acid activation of one of 




methyl groups can migrate to the electrophilic carbon with concomitant stabilisation by the 
other hydroxyl lone pair to give the ketone product.  
 
Scheme 61. Pinacol rearrangement. 
An extension to the pinacol rearrangement reaction is known as the semipinacol rearrangement 
reaction which involves a 1,2-shift to an electrophilic carbon centre, β to a hydroxyl group, 
which has been generated by other means. In the semipinacol rearrangement, the electrophilic 
centre can be generated by the loss of a leaving group (Scheme 62a), electrophilic activation 
of an allylic alcohol (Scheme 62b) or the cleavage of a strained ring among other methods 
(Scheme 62c). The semipinacol rearrangement has been demonstrated as an efficient method 
for the construction of hindered quaternary centres and spirocycles. For this reason, it is often 
used in the total synthesis of complex natural products.126 
 
Scheme 62. Classes of semipinacol rearrangement reactions. 
An example of a leaving group-driven semipinacol rearrangement is the rearrangement of 
bromohydrin 200 (Scheme 63a).127 The addition of silver perchlorate activates the bromide 
which induces a ring expansion semipinacol rearrangement to give cyclohexanone 201. This 
species was used as a precursor to natural product RP 65479 by Hart and co-workers.  
Another commonly used leaving group in the semipinacol rearrangement is N2 from a highly 
reactive 1,2-hydroxyl diazonium intermediate such as 203 (Scheme 63b).128 This process is 
known as the Tiffeneau-Demjanov rearrangement129 and involves the diazotisation of 1,2-
amino alcohols to give rearranged ketone products. For example, amino alcohol 202 was 




the Tiffeneau-Demjanov rearrangement is the direct diazotisation of ketones by the addition of 
a diazoalkane. This generates the α-hydroxy diazonium intermediate which can undergo the 
1,2-rearrangement to give a ketone homologated by one methylene unit.129 
Allylic alcohols can undergo a semipinacol rearrangement if reacted with a suitably 
electrophilic activating agent. For example, a mixture of chloroamide 206 and zinc bromide in 
the presence of allylic alcohol 205 leads to the formation of bromonium intermediate 207 
through the addition of “Br+” across the double bond (Scheme 63c).130 This species undergoes 
a semipinacol rearrangement to give spirocyclic ketone 208. The process is diastereoselective 
as the alkyl migration occurs through an SN2-type mechanism.  
 
Scheme 63. Examples of semipinacol rearrangement reactions: a) halide as a leaving group, b) N2 as a leaving 
group and c) allylic alcohol rearrangement induced by a halonium ion. 
The above-mentioned examples all involve the rearrangement of a symmetric alcohol with no 
choice of migrating group. With asymmetric alcohols, the choice of migrating group is 
governed by a combination of effects: the migratory aptitude of the alcohol substituents and 
the conformation/configuration of the reactive intermediate. While migratory aptitude is 




intermediate is system-specific, as is the extent to which migratory aptitude influences 
selectivity. 
Migratory aptitude in the semipinacol rearrangement generally follows the trend aryl > alkenyl 
> hydride > substituted alkyl > less substituted alkyl.131 This sequence represents the extent to 
which each group is able to stabilize the β-carbocation. The superior migratory aptitude of aryl 
groups is due to the ability of the π system to engage the β-carbocation to form stabilised 
phenonium ion intermediate 209, which facilitates the semipinacol rearrangement (Scheme 
64).  
 
Scheme 64. Semipinacol migration of a phenyl group through a stabilised intermediate. 
Despite secondary alkyl groups having a greater migratory aptitude than primary, the 
Tiffeneau-Demjanov rearrangement is known to generally proceed by the preferential 
migration of the least hindered (least substituted) alkyl group. This is because the Tiffeneau-
Demjanov rearrangement proceeds under steric control and so the favoured conformation of 
the intermediate has the dominating effect on selectivity.  
As the effect of migratory aptitude on selectivity is system-specific, a more detailed look into 
reaction selectivity will be made on systems most similar to the one proposed. Therefore, 
examples of semipinacol rearrangements driven by the cleavage of a strained ring are discussed 
in greater detail below. 
4.2.2. Semipinacol rearrangements triggered by the cleavage of a strained ring 
The proposed rearrangement of ABB-carbinols bears a resemblance to the semipinacol 
rearrangement of α-hydroxy epoxides.132 Marson and co-workers demonstrated that cyclohexyl 
α-hydroxy epoxides such as 210 could undergo a semipinacol rearrangement in the presence 
of tin tetrachloride (Scheme 65).133 The Lewis acid activates the epoxide which triggers a 
1,2-shift to give hydroxy ketone 211. The rearrangement is stereospecific as the epoxide ring 
opening proceeds in an SN2-type manner, which delivers the migrating group to the opposite 





Scheme 65. Semipinacol rearrangement of cyclohexyl α-hydroxy epoxides. 
Marson and co-workers went on to evaluate the selectivity of the migration of different 
substituents when performing their reaction scope (Table 5).133 They showed that while methyl 
does migrate when no other groups are available (entry 1), the selectivity for methyl migration 
is lower than any of the other groups screened. High selectivity for the migration of primary 
alkyl, cyclopropyl, tertiary butyl, vinyl and phenyl groups over methyl were shown to occur 
(entries 2-6). In addition, vinyl and phenyl groups were shown to migrate preferentially over a 
primary benzylic group (entries 7-8). The ring expansion of hydroxy epoxide 212 to give 7-
membered ring containing product 213 was also achieved using this procedure. 
Table 5. Substrate scope for the semipinacol rearrangement of cyclohexyl α-hydroxy epoxides. 
 
The authors show that the migration of an alkynyl group is possible under their reaction 
conditions (Scheme 66).133 This is noteworthy as alkynes are known to be poor migrating 
groups.134 This is due to their sp-hybridisation and thus the high activation energy required to 
form the necessary 3-centre-2-electron transition state during migration.131 In this example, the 
reaction of both diastereomers of 214 led to the formation of the same ketone 215. This 





Scheme 66. Semipinacol rearrangements of diastereomeric alcohols 214 to give the same product. 
Other structural analogues of ABB-carbinols are α-hydroxy aziridines 216 (Scheme 67). These 
species were shown by Tu and co-worders to undergo a strain-release semipinacol 
rearrangement in the presence of zinc bromide to give keto amines such as 217.135  When 
evaluating the reaction scope of asymmetric alcohols (Table 6), the authors saw that the 
reaction of 216 was highly selective over which substituent migrated, affording a single 
reaction product. In stark contrast to the previous example of α-hydroxy epoxides, it was found 
that the configuration of the starting material has the dominating effect on selectivity. The 
selective migration of ethyl over methyl was observed to give a methyl ketone product (entry 
1), however, the opposite selectivity occurred with the other diastereomer of the starting 
material (entry 2). In this case, methyl migrated selectively over ethyl to give an ethyl ketone 
product despite the greater migratory aptitude of the ethyl group. It is reasoned that the Lewis 
acid coordinates to both the nitrogen of the aziridine and the alcohol oxygen, which locks the 
conformation of the starting material. As 1,2-migration happens concurrently with ring 
opening, whichever group is placed antiperiplanar to the cleaved C–N bond is the migrating 
group, regardless of migratory ability. Remarkably, this effect even allowed for the migration 
of the methyl group over phenyl in aziridine 218 to give phenyl ketone 219 in 85% yield 
(entry 4). 
 




Table 6. Substrate scope for the semipinacol rearrangement of cyclic α-hydroxy aziridines. 
 
A similar procedure was reported by Singh and co-workers who showed that α-hydroxy 
aziridine 220 underwent a semipinacol rearrangement when activated by tin triflate to give 
ketone 221 (Scheme 68a).136 This reaction was demonstrated to be enantiospecific as no loss 
of ee was observed, so it must proceed through a stereospecific SN2 inversion at the 
electrophilic carbon centre.  
 
Scheme 68. Rearrangements of β-amino alcohols. 
Interestingly, amino alcohol 222, with a larger ring size, was shown to undergo an entirely 
different mechanism under the same reaction conditions (Scheme 68b). The addition of tin 
triflate led to the formation of 223 as the major reaction product. A plausible mechanism for 
the formation of 223 involves the initial Lewis acid activation of the alcohol lone pair rather 
than the amine lone pair to give carbocation 224, which is stabilised by two phenyl groups. 
This species then undergoes an aza-semipinacol rearrangement with migration of hydride to 
give iminium ion 225 followed by hydrolysis to give ketone 223. 
The remarkable switch in mechanism when changing between substrates 220 and 222 that only 




opening of the aziridine ring in 220 is a much greater driving force than the ring opening of the 
pyrrolidine ring in 222. Therefore, 220 has a better leaving group and a more electrophilic 
β hydroxy carbon than 222. This is evidence that a semipinacol rearrangement mechanism is 
favoured over other pathways when a very labile leaving group is present. Furthermore, the 
strain-release of the C–N bond in 220 is facile as the semipinacol rearrangement is complete 
within 10 minutes at room temperature, whereas the cleavage of the C–N bond in 222 is much 
slower and required up to 10 hours to reach completion.136 
Yokoshima and co-workers have recently reported a semipinacol rearrangement reaction where 
the driving force is the cleavage of a cyclopropane ring (Scheme 69).137 In their report, allylic 
alcohols 226 were first cyclopropanated with bromoform to afford a mixture of separable 
diastereomers of cyclopropyl carbinols 227. Each diastereomer was subjected to a semipinacol 
rearrangement reaction facilitated by the addition of silver perchlorate. Similar to the reaction 
presented in Scheme 63a, the silver salt activates one of the bromide substituents, which 
induces cyclopropane ring opening and a semipinacol rearrangement. This results in the 
formation of β,γ-unsaturated ketone 228. 
 
Scheme 69. Semipinacol rearrangement of cyclopropyl carbinols. 
The authors show that the use of either diastereomer of 227 results in the formation of the same 
reaction product, confirming that configuration has no effect on selectivity in this system 
(Table 7). The migration of an electron rich para-methoxy phenyl group was found to be 
selective over methyl or hydride migration (entries 1 and 2). Whereas, when moving to the 
meta-methoxy substrate, lower reactivity was observed (entry 3). Furthermore, when an 
electron poor para-trifluoromethyl phenyl substrate was employed in the reaction, the 
selectivity was lost, and a complex mixture of products was obtained that could not be 
elucidated (entry 4). However, the ring expansion of cyclobutanol substrate 229 was also 





Table 7. Substrate scope of the semipinacol rearrangement of cyclopropyl carbinols. 
 
The examples discussed above demonstrate that the semipinacol rearrangement does not 
always proceed as expected. This is because relative rates of the desired process over 
competing processes and migratory group selectivity are dependent on a number of steric and 
electronic factors.  
4.3. Spiroepoxy azetidines 
The alternative reaction mechanism proposed leads to the formation of a spiroepoxy azetidine. 
Reported syntheses of such structures are few outside of the patent literature. This is surprising, 
as spirocycles containing the azetidine moiety are garnering increasing interest in medicinal 
chemistry applications.43,138,139 Azetidines themselves are attractive targets due to their rigid, 
hydrophilic skeleton, and this rationale can be extended to spirocyclic azetidines.140 
Spirocycles also have desirable compact structures with well-defined conformations and exit 
vectors, while occupying a region of relatively unexplored chemical space.141,142 Specifically, 
the formation of spiroepoxy azetidines would also be interesting as these structures are 
themselves highly strained and may display further interesting strain-release reactivity.143 
One example of the synthesis and reactivity of a spiroepoxy azetidine was reported by Carriera 
and co-workers (Scheme 70).143 Sulfonium salt 231 was deprotonated with potassium 
bis(trimethylsilyl)amide (KHMDS) to give a sulfur ylide that in the presence of azetidinone 
232, led to the formation of spiroepoxy azetidine 233 via a Corey-Chaykovsky epoxidation 
reaction. This species was shown to undergo a strain-release Meinwald rearrangement144 in the 
presence of lithium iodide to give spiro ketone 234. In this case, the ring expansion of the 




the azetidine. Not only is the cyclopropane ring more strained, but it is also better able to 
stabilise the α-carbocation in intermediate 233’ (see Figure 2). 
 
Scheme 70. Carreira’s synthesis and reactivity of a spiroepoxy azetidine. 
The epoxidation of alkene 235 with meta-chloroperoxybenzoic acid was performed by 
Williams and co-workers to afford spiroepoxy lactam 236 (Scheme 71a).145 Again, the reaction 
with a Lewis acid induced a Meinwald rearrangement, however this time with the ring 
expansion of the β-lactam to give spirocyclic pyrrolidinone 237. Worth noting is the reaction 
of epoxide 238 under the same conditions (Scheme 71b). In this case, after activation of the 
epoxide with boron trifluoride, ring expansion did not occur, as the 5-membered γ-lactam is 
far less strained than the β-lactam. Instead, an elimination occurred to give allyl alcohol 239. 
 
Scheme 71. Williams’ synthesis and reactivity of epoxy lactams. 
4.4. Results and discussion 
4.4.1. Synthesis of azabicyclo[1.1.0]butyl carbinols and initial investigations 
into strain-release reactivity 
To investigate the reaction of ABB-Li with carbonyl compounds, acetophenone was chosen as 
a model substrate. ABB-Li was formed in situ by the sequential reaction of amine salt 33 with 




subsequently reacted with acetophenone at −78 °C to form ABB-carbinol 197a in 77% NMR 
yield (Scheme 72). An alteration to the procedure for the generation of ABB-Li was made: 
before the addition of sec-butyllithium, the reaction was briefly warmed to room temperature 
to ensure complete consumption of amine salt 33 that is sparingly soluble in THF. By 
introducing this warming step, reproducible yields of ABB-carbinol 197a were obtained.  
 
Scheme 72. Synthesis of ABB-carbinols by the reaction of ABB-Li with carbonyl compounds. 
This procedure was successfully applied to a wide range of ketones and aldehydes (Scheme 
72). The ABB-carbinols were found to partially decompose on silica gel and so yields of the 
products were determined by 1H NMR and any subsequent reactions were performed on the 




greater steric hindrance around the carbonyl carbon led to a suppression in reaction yield. For 
example, more hindered cyclohexyl phenyl ketone and 2,2,2-trifluoroacetophenone gave ABB-
carbinols 197q and 197r in moderate yields of 40% and 50% respectively. 
2′,4′,6′-Trimethylacetophenone is even bulkier and, under the reaction conditions, did not yield 
any desired product. It is reasoned that α-deprotonation by ABB-Li acting as a base instead of 
a nucleophile is prevalent when the ketone is more sterically hindered.  Furthermore, 
4-acetylpyridine and 3-acetylpyridine were also unsuccessful substrates. However, by 
introducing a substituent in the ortho position of the pyridyl ketones, ABB-carbinols 197e, 197f 
and 197g were obtained in good yields (59%-67%). It was found that ABB-carbinol 197r was 
completely stable towards silica gel chromatography, which allowed purification to aid 
subsequent separations. 
Having gained access to a range of ABB-carbinols, their reactivity with different activating 
agents was then investigated. Firstly, the addition of benzyl chloroformate (CbzCl) to 197a 
resulted in the formation of chlorohydrin 240 in 83% yield (Scheme 73a). This result is 
consistent with previous reports of the 1,3-functionalisation of ABB with 
chloroformates,146,52,147 and no spiroepoxy azetidine product was observed. On the other hand, 
when trifluoroacetic anhydride (TFAA) was employed as the activating agent, a switch in 
mechanism to the semipinacol rearrangement occurred to form keto azetidine 241a in 71% 
yield (Scheme 73b). As expected, the migration of the phenyl group rather than the low 
migratory aptitude methyl group occurred. 
The divergent reactivity of 197a can be rationalised by the extent of positive charge build-up 
at the electrophilic bridgehead carbon. When TFAA is used as an activator, the trifluoroacetyl 
group, being more electron-withdrawing than the Cbz group, results in a greater build-up of 
positive charge, more resembling a carbocation. It is reasoned that a carbocation α to the 
alcohol would favour the semipinacol reaction pathway. However, it was postulated that the 
different counterions present could also play a role in determining the outcome of the reaction. 
To investigate whether product formation was determined by the nucleophilicity of the 
counterion or by the electron-withdrawing nature of the activating group, the same reactions 
were repeated in the presence of sodium iodide additive (Scheme 73c).148 Once again, with 
CbzCl, the nucleophilic addition pathway dominated to give exclusively iodohydrin 242. With 
TFAA, both nucleophilic addition and semipinacol rearrangement occurred to give 243 and 
241a in 40% and 49% yield, respectively. Finally, when moving to an even more electrophilic 




sulfonamide 244a in 50% yield with no nucleophilic addition observed. Thus, the outcome of 
the reaction is predominantly determined by the electronic nature of the activating group on 
nitrogen: the more electron-withdrawing it is the more the semipinacol pathway is favoured. 
 
Scheme 73. Divergent reactivity of 197a with: a) CbzCl and b) TFAA. c) Investigations into the cause of 
divergence. 
4.4.2. Semipinacol rearrangement of azabicyclo[1.1.0]butyl carbinols 
4.4.2.1. Optimisation of the semipinacol rearrangement 
The semipinacol pathway operating with TFAA and Tf2O presents a novel route to 
1,3,3-substituted azetidines bearing an all-carbon quaternary centre. The choice of TFAA or 
Tf2O for the transformation also introduces the opportunity to select one of two nitrogen 
protecting groups with different properties and lability.149 Therefore, an optimisation study of 





Scheme 74. Semipinacol rearrangement of ABB-carbinol 197a. 
With TFAA, in the absence of sodium iodide, the yield of 241a was improved to 93% by 
changing the solvent to DCM and performing the reaction at –78 °C (Table 8, entry 2). The 
semipinacol rearrangement reaction of 197a with TFAA produces 1 equivalent of trifluoracetic 
acid. It was considered that having a hindered base in solution may improve the reaction yield 
by quenching the acid formed which might otherwise lead to product decomposition. However, 
the use of 2,6-lutidine did not improve the yield of 241a (entry 3).  
 In the case of Tf2O, the yield of sulfonamide 244a was also improved by performing the 
reaction in DCM at –78 °C (entry 5). Further enhancement in efficiency was observed by the 
addition of 2,6-lutidine (entry 6), so the more acidic triflic acid produced does in fact have a 
negative effect on reaction yield.  
Table 8. Optimisation of the semipinacol rearrangement of ABB-carbinol 197a. 
 
4.4.2.2. Ketone scope and investigation into relative migratory aptitude 
The optimised conditions for the semipinacol rearrangement of ABB-carbinols with either 
TFAA (conditions A) or Tf2O (conditions B) were then applied to different ABB-carbinols to 




Firstly, with methyl as the non-migrating group, electron rich and electron poor aryl groups 
migrated smoothly under both conditions to yield azetidines 241b/c and 244b/c in good yields 
(60%-88%). Furthermore, compounds 241d-f and 244d-f were afforded in good to excellent 
yields via the migration of the heteroaryl groups to give indolyl and 3-pyridyl substituted 
azetidines. While the methoxy and bromo substitution in the ortho position of the pyridyl 
substrates were required for the synthesis of the precursor ABB-carbinols, these may also 
deactivate the pyridine nitrogen lone pair towards reacting with the TFAA or Tf2O rather than 
the desired ABB nitrogen lone pair. However, the reaction of ABB-carbinol 197g with a 
4-pyridyl substituent was unsuccessful with TFAA and poorly yielding with Tf2O (23%), 
which suggests that 4-pyridyl is a poor migrating group.  
 
Scheme 75. Reaction scope of the semipinacol rearrangement with aryl and alkyl migrating groups. 
The use of ABB-carbinols derived from cyclic ketones was of interest as the semipinacol 
rearrangement would involve a ring-expansion to give valuable spirocyclic azetidines scaffolds 
(Scheme 75b). Azetidine 241h was obtained following a 4- to 5-membered ring expansion from 




employed which led to the formation of azetidine 241i in 44%. Due to the lower migratory 
aptitude of alkyl groups compared to aryl groups,131 some side products were observed in the 
reaction to produce 241i. The presence of hydroxyl protons in the crude 1H NMR spectrum and 
multiple unknown peaks in the 19F NMR spectrum led to the conclusion that competing 
nucleophilic addition of trifluoroacetate had occured. The yield of this side reaction was 
difficult to quantify due to the facile decomposition of the product during silica gel 
chromatography. This side reaction was more prevalent in the preparation of 241j from ABB-
carbinol 197j following the even less energetically favourable 6- to 7-membered ring 
expansion. Azetidine 241j was therefore obtained in a low yield of 27%. Furthermore, a 7- to 
8-membered ring expansion was attempted to give azetidine 241k in 41% yield; again the 
moderate reaction yield was attributed to competing nucleophilic addition of trifluoroacetate. 
Pleasingly, the relative yields of cyclic azetidines 241h-k (54%, 44%, 27% and 41% 
respectively), formed under TFAA activation, mirror the differences in strain energy (SE) 
between the rings in the products and the starting materials (Table 9). It is worth noting 
however, that the relative SE of unsubstituted cyclic alkanes cannot be assumed to translate to 
the SE of either the cyclic ABB-carbinols or the spirocyclic ketone products, the SE values of 
which are unknown.  
Table 9. Strain energy difference between simple cyclic alkanes. 
 
The equivalent ring-expansion semipinacol reactions with Tf2O as the activator gave good 
yields of sulfonamides 244h-k (87%, 58%, 50% and 71% yield respectively) with no 
competing nucleophilic addition observed. Evidently, the more electron-withdrawing 
activating agent leads to a faster semipinacol rearrangement and so the nucleophilic addition 
pathway competes less effectively. This effect was demonstrated previously in the experiment 
outlined in Scheme 73c. 
Another successful reaction was the semipinacol rearrangement from ABB-alcohol 197l to give 
azetidines 241l and 244l in 48% and 63% yield respecitvely.150 These species comprise an 




example is particularly noteworthy as a Reaxys search identified this motif in > 250 patents 
with > 1300 unique examples where pharmacological data is presented.  
Moving away from ABB-carbinols derived from cyclic alkyl ketones, ABB-carbinol 197m was 
employed, which is derived from acetylcyclohexane. Surprisingly, the migration of the 
cyclohexyl group was slow with TFAA and required warming to 0 °C to consume starting 
material 197m. This resulted in a poor 26% yield of 241m, and the product of nucleophilic 
addition of trifluoroacetate was apparent in the crude 1H NMR spectrum. However, with Tf2O 
as the activator, the semipinacol rearrangement proceeded smoothly and was favoured 
completely, giving sulfonamide 244m in almost quantitative yield. For both reactions, 
exclusive migration of the more substituted alkyl group was observed.133 
An attribute of the semipinacol rearrangement is that there are two possible migrating groups, 
and the selectivity of the reaction is governed by the relative migratory aptitudes of these 
groups. So far, the presence of a poorly migrating methyl group or symmetrical ABB-carbinols 
has ensured the formation of only one semipinacol reaction product. The evaluation of the 
relative migratory aptitude of other groups compared to phenyl was then embarked upon 
(Scheme 76). 
With ABB-alcohol 197n, it was found that the phenyl group migrated exclusively over hydride 
to give aldehyde 241n in 51% yield. The selectivity seen here is typical of reported semipinacol 
rearrangements.137 Aldehyde 244n was also prepared however, to aid purification, was reduced 
with sodium borohydride to give the primary alcohol in 84% yield over two steps. Ethyl and 
alkynyl groups were also shown to be a successful non-migrating group to give azetidines 
241o/p and 244o/p in good to excellent yields (62%-91%).  
Comparing the migratory aptitude of phenyl vs cyclohexyl by employing ABB-carbinol 197q 
resulted in high selectivity for phenyl migration with TFAA to give 241q. With Tf2O on the 
other hand, 244q and 244q’ were formed in a 1:1.5 ratio, now in favour of cyclohexyl 
migration. In both cases, the yield of the ketone was low. In fact, the main component of the 
latter reaction was spirocyclic epoxide 245 formed in 66% NMR yield. 
Trifluoromethyl carbinol 197r was tested and as expected,151 exclusive migration of the phenyl 
group was observed. This substrate was substantially less reactive than the others, requiring 
0 °C to trigger the semipinacol rearrangement. Azetidine 241r was formed in only 25% yield 




was obtained with Tf2O (conditions B), giving azetidine 244r. Both 241r and 244r were 
isolated as a mixture the trifluoromethyl ketone and the corresponding hydrate.152 
 
Scheme 76. Reaction scope of the semipinacol rearrangement with a phenyl migrating group and alternative 
non-migrating groups. 
Azetidines 241s and 244s were obtained from ABB-carbinol 197s derived from benzophenone 
in 42% and 90% yields under conditions A and B, respectively. In the case of 241s, the lower 
yield observed was due to competing nucleophilic addition of trifluoroacetate. Finally, 
comparing phenyl with para-methoxy phenyl, it was found that the more electron-rich aryl 
group migrated preferentially,153 but not exclusively: a 3.2:1 ratio of 241t/241t’ and 1.3:1 ratio 
of 244t/244t’ were obtained under conditions A and B, respectively. 
The commonly observed relative migratory aptitude in semipinacol rearrangements131,137,153 of 
aryl > alkenyl > hydride > substituted alkyl > less substituted alkyl is mirrored here in reactions 
using TFAA. A similar pattern is seen with the more electron withdrawing Tf2O activating 
agent, but the selectivity is lower since it induces a faster and hence less discriminating 
reaction. This difference in reaction rate and selectivity is illustrated well in the reaction of 
ABB-carbinol 197t with only a small electronic difference between the available migrating 
groups. In the case of the especially hindered substrate 197q, containing both phenyl and 




bond rotation at the bridgehead of ABB-carbinol 197q has a higher energy barrier than 1,2-
migration or intramolecular epoxide formation. This would mean that whichever group is 
antiperiplanar to the central C–N upon reaction with Tf2O is the group to react (Scheme 77). 
 
Scheme 77. Conformations of ABB-carbinol 197q activated my Tf2O that lead to each of the three products 
observed. 
4.4.2.3. Attempts to improve yields for poorly migrating substrates 
In response to lower yields observed in the TFAA induced semipinacol rearrangement reaction 
of ABB-carbinols with poor migrating groups, alternative reaction conditions were 
investigated. It was considered that iodohydrin 243, formed from the reaction of ABB-carbinol 
197a with TFAA and sodium iodide (see Scheme 73c), could serve itself as a precursor to a 
semipinacol rearrangement reaction. It was anticipated that the addition of a silver(I) salt to 
243 would result in the formation of a full carbocation at the 3-position of the azetidine which 
would trigger a fast semipinacol rearrangement.127  
To investigate this reaction, ABB carbinol 197j was chosen as a substrate as it performed 
poorly in the semipinacol reaction induced by TFAA (27% yield). On the addition of TFAA to 
197j in the presence of sodium iodide, iodohydrin 246 was formed in 50% yield and the 
semipinacol rearrangement proceeded in only 6% yield (Scheme 78). The remaining mass 
balance was made up of a mixture of two inseparable species the characterisation of which 
proved difficult. The 19F NMR spectrum contained four signals, two characteristic of a 
trifluoroacetamide and two characteristic of a trifluoroacetate. Additionally, the presence of 
hydroxyl signals in the 1H NMR led to assignment that the side products are likely isomers 247 





Scheme 78. Synthesis of iodohydrin 246 other reaction products. 
It was found that upon the addition of silver perchlorate to iodohydrin 246, a mixture of 
products was obtained (Scheme 79a). Once again, the semipinacol rearrangement to keto 
azetidine 241j was not very efficient (21%) and the major product obtained was allyl alcohol 
248 in 59% yield. It was demonstrated previously by Williams145 that spiroepoxy γ-lactam 238 
underwent an acid catalysed rearrangement to allyl alcohol 239 (see Scheme 71b), which 
resembles the product formed here. To establish whether 248 was in fact produced from 
spiroepoxy azetidine 249 (Scheme 79b), the reaction was repeated with the addition of 
2,6-lutidine as a base to quench any perchloric acid produced. Indeed, alcohol 248 was still 
formed under these conditions, but epoxide 249 was also isolated as a reaction product (Scheme 
79a). Nevertheless, it was clear that the semipinacol rearrangement of iodohydrins by the 
addition of silver perchlorate did not present as an improvement over the direct TFAA induced 
semipinacol rearrangement from the parent ABB-carbinol.  
 





4.4.3. Spiroepoxy azetidine formation reaction 
The formation of spiroepoxy azetidines 245 and 249 were intriguing, and it was considered 
whether a general pathway to these interesting motifs could be established. It was reasoned that 
chlorohydrin 240, formed from the reaction of ABB-carbinol 197a with CbzCl (Scheme 73a), 
could potentially serve as an intermediate in the selective synthesis of spiroepoxy azetidines 
by the addition of base (Scheme 80).  
 
Scheme 80. Epoxide ring-closing of halohydrin azetidines 240 and 242a. 
Indeed, addition of potassium carbonate to a solution of 240 in methanol resulted in the 
formation of spiroepoxy azetidine 250a, which after 2.5 hours had reached 57% yield with 7% 
remaining unreacted starting material (Table 10, entry 1). Moving to stronger bases, sodium 
hydride and sodium tert-butoxide improved the yield considerably and the reactions were also 
complete in a shorter amount of time (entries 2 and 3). However, we were eager to avoid the 
use of a strong base as applying this methodology to other more sensitive ABB-carbinols could 
be deleterious to reaction yields. The use of iodohydrin 242a instead of chlorohydrin 240, was 
then considered as the epoxide ring-closure should be more facile with the more labile iodide 
leaving group. Pleasingly, the addition of potassium carbonate to a solution of 242a in 
methanol gave the desired product quantitatively within 15 minutes at room temperature. 
Table 10. Reaction condition screening for the epoxide ring-closing of halohydrin azetidines 240 and 242a. 
 
This method was telescoped to a one-pot procedure from ABB-carbinol 197a, in which a longer 




carbonate in the acetonitrile/methanol solvent mix. Nevertheless, it was possible to monitor the 
reaction by TLC and after 2 hours, 250a was formed in 96% yield over two steps (Scheme 81).  
 
Scheme 81. One-pot spiroepoxy azetidine synthesis from ABB-carbinol 197a. 
This protocol was then extended to produce a range of spiroepoxy azetidines from selected 
ABB-carbinols (Scheme 82). Employing ABB-carbinols with heteroaryl groups (indolyl and 
pyridyl) gave 250d and 250f in good yields of 62% and 66%, respectively. Electron-rich 
indolyl epoxide 250d was found to be unstable on silica gel, which complicated the 
purification. However, it was found that if the intermediate iodohydrin was purified prior to 
base-induced spirocyclization, no further purification of 250d was necessary.  
 
Scheme 82. Scope of the spiroepoxy azetidine formation reaction. 
Dispiro compounds 250j and 250l were obtained from ABB-carbinols 197j and 197l in 
excellent yields of 90% and 91%, respectively. Compound 250l is particularly interesting, as 
the nitrogen protecting groups are orthogonal and serve to desymmetrise the molecule. 
Trisubstituted epoxide 250n was also accessible in 80% yield from benzaldehyde derived 




required 42 hours to reach completion. The sensitive propargylic epoxide 250p was also 
accessible in excellent yield (86%). Due to its instability on silica gel (as with 250d), 
purification of the intermediate iodohydrin was necessary in order to isolate analytically pure 
250p. 
Remarkably, ABB-alcohol 197r was found to be completely unreactive towards CbzCl under 
the reaction conditions, due to inductive deactivation of the nitrogen lone pair by the CF3 group 
(Scheme 83a). In addition, the semipinacol rearrangement of 197r with TFAA was previously 
found to be slow and low yielding. It was found that in the presence of sodium iodide, the 
formation of iodohydrin product 251 is preferential over the semipinacol rearrangement and 
after the addition of potassium carbonate, epoxide 252 was isolated in 49% yield (Scheme 83b).  
 
Scheme 83. Further investigation into the scope of the spiroepoxy azetidine formation reaction with TFAA as 
the activator. 
Having established that the addition of TFAA to 197a in the presence of sodium iodide resulted 
in the formation of iodohydrin 243 and semipinacol rearrangement product 241a (see Scheme 
73c), the addition of potassium carbonate to this mixture led to the formation of epoxide 253 
in 38% yield (Scheme 83c).  
When investigating alternative activating agents, it was found that TsCl behaved similarly to 
CbzCl to give sulfonamide 254 in 87% yield (Scheme 84a). Di-tert-butyl dicarbonate (Boc2O), 




ABB-alcohol 197a. However, under these conditions, cyclisation followed iodohydrin 
formation to give epoxide 255 in 57% yield without the need for the addition of potassium 
carbonate. 
 
Scheme 84. Spiroepoxy azetidine formation reaction with alternative activating agents. 
4.4.4. Investigation into the semipinacol reaction mechanism 
Having established the divergent reactivity of ABB-carbinols, a further examination of reaction 
mechanism was undertaken. We previously observed that the reaction of ABB-carbinol 197a 
with more electron-withdrawing activating agents (TFAA or Tf2O) favoured the semipinacol 
reaction pathway (see Scheme 73c). However, it is known that under certain conditions, 
epoxides can undergo a pinacol-type Meinwald rearrangement to give ketone products (see 
Scheme 68b for an example).  
We cannot yet rule out the possibility that activation of an ABB-carbinol with 1.2 equivalents 
of TFAA or Tf2O leads to the formation of an epoxide that then undergoes a Meinwald 
rearrangement under the reaction conditions (Scheme 85a). This mechanism is unlikely to be 
occurring for a number of reasons. Principally, after activation of the epoxide with either the 
excess anhydride or acid biproduct, there are two possible carbocations that can be formed. In 
most substrates investigated, one of the substituents R1 or R2 is an aryl group that would 
effectively stabilise a benzylic carbocation. This would not give azetidine 198 as the reaction 
product, rather ring expanded pyrrolidine 256. 
To rule out the possibility of a Meinwald rearrangement mechanism rather than a direct 
semipinacol rearrangement, the reaction conditions were simulated by reacting epoxides 245 
and 249 with either 0.2 equivalents of TFAA or 1.0 equivalent of TFA in DCM at −78 °C. In 






Scheme 85. Investigation into whether the spiroepoxy azetidine is a reaction intermediate in the semipinacol 
rearrangement. 
4.4.5. Conclusion 
The lithiation of ABB followed by 1,2-addition to ketones and aldehydes has been achieved to 
yield ABB-carbinols. These species were demonstrated to undergo divergent strain-release 
reactivity when reacted with electrophilic activating agents.  
We found that strongly electrophilic activating reagents (TFAA and Tf2O) induce a 
semipinacol rearrangement in ABB-carbinols to give either amide or sulfonamide azetidine 
products (Scheme 86a). The semipinacol rearrangement proceeds with migration of the group 
best able to stabilize the positive charge, so follows the order aryl > substituted alkyl > less 
substituted alkyl. Even electron-deficient aromatics and heteroaromatics were demonstrated to 
migrate in preference to alkyl groups.  
When two alkyl groups are present, the semipinacol rearrangement is much slower and in the 
case of TFAA as the activator, nucleophilic addition of the counterion begins to compete, 
leading to lower yields. However, employing Tf2O as the activator allows the semipinacol 
rearrangement to dominate, leading to good reaction yields. It was demonstrated that ABB-






Scheme 86. Overview of the divergent reactions of ABB-carbinols. 
Conversely, when ABB-carbinols are treated with less electrophilic activating agents, such as 
CbzCl, no semipinacol rearrangement occurs. Instead, nucleophilic addition of the counterion 
dominates to exclusively form chlorohydrin products. Performing this reaction in the presence 
of sodium iodide leads to the formation of iodohydrins that can be easily converted into 
structurally interesting spiroepoxy azetidines through a base-mediated cyclization (Scheme 
86a). Thus, from a common ABB-carbinol starting material, access to either keto azetidines or 
spiroepoxy azetidines is possible through semipinacol rearrangements and spirocyclisation 
reactions, respectively. 
As the chemistry of ABB generally resembles that of BCBs that bear an electron withdrawing 
group (see sections 1.2.2 and 1.2.3), it was considered whether these novel reactivity modes 
could be extended to bicyclo[1.1.0]butyl carbinols (BCB-carbinols, 257, Scheme 86b). 
However, very recently, the synthesis and reactivity of some BCB-carbinols has in fact been 
reported by Wipf and co-workers (Scheme 87a).154 This investigation took place 
simultaneously and independently of our own studies and provides an interesting comparison. 
Wipf and co-workers deprotonated BCB-sulfone 258 with n-butyllithium to afford 
organolithium 259 that was reacted with cyclobutanone to give BCB-carbinol 260. With the 
addition of catalytic methanesulfonic acid (MsOH), a stereoselective semipinacol 





Scheme 87. a)/b) Wipf and coworkers’ semipinacol rearrangement of BCB-carbinols. c) Comparison to the 
semipinacol rearrangement of ABB-carbinols reported herein. 
The reaction scope presented is limited to BCB-carbinols derived from cyclobutanones with 
one example of a BCB-carbinol derived from 3-oxetanone. Therefore, all semipinacol 
rearrangements were 4- to 5-membered ring expansions which have an additional strain-release 
driving force than just that of the BCB motif. Furthermore, BCB-carbinol 262, derived from 
1-Boc-3-azetidinone, was shown to be inert under the reaction conditions (Scheme 87b), which 
is in direct contrast to our successful synthesis of azetidines 241l and 244l (Scheme 87c). These 
results give insight into the differences in reactivity between BCB and ABB. While their 
thermodynamic strain energy is assumed to be very similar,41,155 ABB is far more kinetically 
activated due to the availability of the nitrogen lone-pair to react with electrophiles. 
4.4.6. Future work 
The reactions of ABB-Li presented in this chapter, and previously in chapter 3, can be 
described as insertion reactions (Scheme 88a-c). Specifically, the reaction of ABB-Li with 
boronic esters followed by 1,2-metallate rearrangement overall represents the homologation of 
a boronic ester with an azetidine. This is essentially the insertion of an azetidine into the C–B 
bond (Scheme 88a). The reactions of this chapter represent the insertion of an azetidine ring 
into the C–O or C–C bond of a ketone or aldehyde (Scheme 88b/c). This analysis can be 
extended to reported reactions of BCB-Li derivatives (Scheme 88d/e).80,81,154 Using this 
thinking, access to spiro[3.3]heptane derivatives, such as 263, would require the insertion of 




88f). Such spirocycles are sought-after motifs in medicinal chemistry,140,141 particularly if they 
contain an oxetane156 or azetidine ring.157  
 
Scheme 88. Reactions of lithiated bicycles and proposed spirocyclisation reaction. 
The nucleophilic ring opening of epoxides and DA cyclopropanes with organometallic reagents 
is known reactivity (Scheme 89). This typically involves the use of a Grignard or organolithium 
reagent and a copper catalyst.158,159 Similarly, the copper-catalysed nucleophilic addition of 
Grignard reagents to both ABB and an electron deficient BCB have been reported (see Scheme 
6 and Scheme 9).39,54 
 
Scheme 89. Nucleophilic ring opening of 3-membered rings by organometallic reagents. 
It would be interesting to investigate whether ABB-Li or an electron deficient BCB-Li could 
undergo nucleophilic addition to epoxides or DA cyclopropanes in the presence of a copper 
catalyst (Scheme 90a). Such a reaction would give strained cuprate 264 that could undergo a 
strain-release intramolecular cyclisation to give spirocyclic compound 265. The addition of an 
electrophile to quench 265 would introduce another opportunity for diversification. If 




of spiro[3.3]heptane derivatives with various heteroatoms and substitution patterns (Scheme 
90b). For example, pairing epoxide 266 with ABB-Li could lead to the formation of 1-oxa-6-
azaspiro[3.3]heptane 267. Alternatively, the combination of DA cyclopropane 73 and BCB-Li 
259 could give all-carbon spiro[3.3]heptane 268. 
 





5. General conclusion 
Investigations into new strain-release-driven transformations were undertaken. This was 
conducted with the aim of establishing efficient, modular routes to diversely decorated 
molecules with interesting molecular scaffolds. The strain-release of the activated C–C bond 
of DA cyclopropanes and the bridge bond of ABB has facilitated the synthesis of a diverse set 
of highly functionalised 3-dimensional molecules (Scheme 91). The main class of reaction 
mechanism explored was strain-release 1,2-migration, namely, the 1,2-metallate rearrangement 
of boronate complexes and the 1,2-semipinacol rearrangement reaction.  
 
Scheme 91. Overview of the reactions investigated in this thesis. 
It was demonstrated that cyclopropyl boronate complexes 109 with two ester substituents 




(Scheme 91a). The 1,2-migration is driven by the cleavage of the strained, activated 
cyclopropyl C–C bond. A scope of migrating groups was presented by the addition of a variety 
of different organolithium reagents to cyclopropyl boronic ester 94. This process was also 
rendered a 3-component reaction by the use of sub-stoichiometric Lewis acid and the addition 
of an electrophile. This enabled the synthesis of enantioenriched γ-carbonyl boronic esters 110. 
In addition, the products were shown to be suitable substrates for further enantiospecific 
transformations of the boronic ester functional group.  
A reactivity study was also undertaken, which indicated that the 1,2-metallate rearrangement 
with C–C cleavage only occurs if the C–C bond is incorporated into a strained cyclopropane 
ring. In addition, the presence of two ester substituents was shown to be necessary for the 
desired reaction to occur. 
The use of the strained bridge bond of ABB was then investigated as a driving force for the 
1,2-metallate rearrangement (Scheme 91b). The addition of ABB-Li (167) to boronic ester 178 
led to the formation of boronate complex 194 that, upon activation with acetic acid, underwent 
the 1,2-metallate rearrangement with cleavage of the strained C–N bridge bond. The product 
of this reaction is azetidine acetic acid salt 195. This species was subjected to amide bond 
coupling conditions, followed by boronic ester oxidation, and finally Boc deprotection to yield 
anti-cancer drug cobimetinib (164). This short reaction sequence demonstrates the utility of 
ABB-Li in the synthesis of valuable complex molecules. 
ABB-Li was then employed in the synthesis of other interesting azetidine-containing molecules 
(Scheme 91c). It was found that ABB-Li reacts smoothly with ketones and aldehydes to yield 
ABB-carbinols 197. These species display divergent strain-release reactivity upon activation 
of the ABB nitrogen lone pair with different activating agents. With strongly electrophilic 
activating agents TFAA and Tf2O, a semipinacol rearrangement occurs with 1,2-migration of 
one of the alcohol substitutents. This leads to the formation of azetidinyl ketones 198 with an 
all-carbon quaternary centre. The relative migratory aptitude of different groups was explored 
by employing a range of ABB-carbinols with varying substituents.  
However, it was shown that the semipinacol rearrangement does not occur when ABB-
carbinols are reacted with less electrophilic activating agents such as CbzCl. In this case, after 
activation of the ABB nitrogen, nucleophilic addition of the counterion to the C3 carbon occurs. 




the formation of iodohydrins, which can be converted into spiroepoxy azetidines 199 simply 
by the addition of potassium carbonate.  
Overall, novel strain-release reactions of DA cyclopropanes and ABB derivatives were 







6.1. General experimental 
6.1.1. Solvents, reagents and glassware 
All solvents were commercially supplied or dried on an Anhydrous Engineering alumina 
column drying system. All reactions were conducted under an inert atmosphere of nitrogen 
using standard Schlenk techniques unless stated otherwise. All glassware was oven dried prior 
to use. All reagents were purchased from commercial sources and used as sold. Exceptions: 
di-tert-butyl malonate and 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (iPrOB(pin)) 
were distilled under reduced pressure using Kugelrohr apparatus; pinacolborane (HBpin), 
benzoyl chloride, benzyl chloroformate, TMEDA, N,N-diisopropylethylamine and 
triethylamine were distilled under an inert atmosphere at standard pressure; all liquid 
ketone/aldehyde reagents and styrene containing starting materials were filtered through 
neutral alumina prior to use. 
6.1.2. Chromatography and spectroscopy 
All reactions were followed by thin-layer chromatography (TLC) when practical, which were 
visualised under UV light or by staining with aqueous potassium permanganate, 
phosphomolybdic acid or p-anisaldehyde solutions. 1H, 13C and 19F NMR spectra were 
recorded using Jeol ECS 400 MHz, Jeol ECz 400 MHz, Bruker 400 MHz and Bruker Avance 
III HD 500 MHz Cryo spectrometers. 11B NMR spectra were recorded using a Jeol 
ECP(Eclipse) 300 MHz and Jeol ECS 400 MHz spectrometers using a quartz NMR tube. 
Chemical shifts (δ) are given in parts per million (ppm) and coupling constants (J) are given in 
Hertz (Hz), rounded to the nearest 0.1 Hz. NMR assignments were made according to spin 
systems, using two-dimensional NMR spectroscopy (COSY, HSQC, HMBC) to assist the 
assignment. NMR yields were determined using tetrachloroethylene or dibromomethane as an 
internal standard. High resolution mass spectra (HRMS) were recorded by Bruker Daltonics 
Apex IV by Electrospray Ionisation (ESI) or Atmospheric pressure chemical ionization 
(APCI). IR spectra were recorded on a Perkin Elmer Spectrum One FT-IR as a thin film. 
Absorption maxima (νmax) are reported in wavenumbers (cm
-1). Melting points were recorded 
in degrees Celsius (°C) using a Stuart SMP30 melting point apparatus. Optical rotations were 




6.2. Synthetic procedures for chapter 2 
6.2.1. Starting material synthesis 
Di-tert-butyl 2-diazomalonate, 102 
 
Following a modified literature procedure:160 
1,8-Diazabicyclo[5.4.0]undec-7-ene (4.91 mL, 32.8 mmol) was added dropwise at 0 °C to a 
stirring solution of di-tert-butyl malonate (5.00 mL, 22.3 mmol, 1.0 equiv) and 
p-acetamidobenzensulfonyl azide (6.44 g, 26.8 mmol, 1.2 equiv) in anhydrous acetonitrile 
(74 mL). The reaction was warmed to room temperature and stirred for 3 days. The solvent 
was removed in vacuo before trituration with 1:1 diethyl ether/petroleum ether and filtration 
through a pad of silica. The mixture was concentrated and purified by flash chromatography 
(100:0 → 90:10 pentane/ethyl acetate) to give di-tert-butyl 2-diazomalonate as a light-yellow 
solid (4.86 g, 90% yield);  
RF 0.41 (90:10 petroleum ether/ethyl acetate); 1H NMR (CDCl3, 400 MHz) δ 1.51 (s, CH3), 
13C NMR (CDCl3, 101 MHz) δ 160.5 (RCO2C(CH3)3), 82.9 (C(CH3)3), 28.4 (CH3) (a signal 
for the diazo carbon was not observed). All characterisation data is consistent with that reported 
in the literature.161 
Di-tert-butyl cycloprop-2-ene-1,1-dicarboxylate, 105 
 
Following a modified literature procedure:86 
A round bottom flask fitted with a condenser and charged with Rh2(OAc)4 (66 mg, 0.15 mmol, 
0.5 mol%) was evacuated and purged with nitrogen. Trimethylsilyl acetylene (72 mL) was 
added and the solution was heated to reflux. A solution of di-tert-butyl 2-diazomalonate 




maintained at reflux for 4 hours. The solvent was then removed in vacuo. At this point, it was 
beneficial to perform flash column chromatography (100:0 → 90:10 hexane/ethyl acetate) to 
separate desired intermediate 103 (RF 0.45 (90:10 petroleum ether/ethyl acetate)) from the 
more polar impurities. Fractions containing 103 and other non-polar compounds were then 
transferred to a round bottom flask and the solvent removed in vacuo before the addition of 
THF (150 mL). A solution of 10% aq. K2CO3 (56 mL) was added dropwise at 0 °C and the 
mixture was stirred at room temperature for 2 hours. The phases were separated, and the 
organic phase was concentrated under reduced pressure. The phases were recombined with the 
addition of water (150 mL) and diethyl ether (90 mL) and the aqueous phase was extracted 
with diethyl ether (3 × 90 mL). Combined organic phases were washed with brine, dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude mixture was purified by 
flash chromatography (100:0 → 80:20 hexane/ethyl acetate) to give 105 as an off-white solid 
(2.40 g, 34% yield);  
RF 0.29 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3143, 3099, 2975, 2936, 
1721, 1700, 1477, 1457, 1392, 1367; HRMS (ESI): Calcd. for C13H20O4Na
+ ([M+Na]+) m/z 
263.1254, found m/z 263.1265; 
1H NMR (CDCl3, 400 MHz) δ 6.88 (s, 2H, HC(R)=C(R)H), 1.47 (s, 18H, OC(CH3)); 13C NMR 
(CDCl3, 101 MHz) δ 171.0 (RCO2C(CH3)3), 103.4 (HC(R)=C(R)H), 81.3 (OC(CH3)), 32.6 




Following a modified literature procedure:86 
A flame dried Schlenk flask was charged with [Rh(COD)Cl]2 (37 mg, 0.075 mmol, 0.03 equiv) 
and (R)-Tol-BINAP (102 mg, 0.150 mmol, 0.06 equiv), evacuated and purged with nitrogen. 
Anhydrous DCM (2.5 mL) was added and the reaction was stirred for 3 minutes at room 
temperature. HBpin (0.43 mL, 3.0 mmol, 1.1 equiv) and 105 (0.60 g, 2.5 mmol, 1.0 equiv) 




filtration through a pad of silica. The crude mixture was concentrated under reduced pressure 
and added to a pre-equilibrated column with pretroleum ether and eluted within 15 minutes of 
contact with silica (98:2 → 70:30 hexane/ethyl acetate) to yield (R)-94 as a white waxy solid 
(0.83 g, 90% yield);  
RF 0.41 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2935, 1725, 1473, 
1450, 1410, 1367, 1332, 1288, 1233, 1167; HRMS (ESI): Calcd. for C19H33O6BNa
+ ([M+Na]+) 
m/z 391.2262, found m/z 391.2282; [𝛂]𝐃
𝟐𝟓 −45.8 (c = 1.95, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 1.47 (s, 9H, OC(CH3)3), 1.44 (s, 9H, OC(CH3)3), 1.36 (d, 
3J = 
9.5, 2H, CH2(R)(R’)), 1.24 (s, 6H, pinacol CH3), 1.23 (s, 6H, pinacol CH3), 0.94 (t, 
3JHH = 9.5, 
1H, pinB-CH(R)(R’)); 13C NMR (CDCl3, 101 MHz) δ 170.0 (RCO2C(CH3)3), 168.2 
(RCO2C(CH3)3), 83.9 (pinacol OC(R)(CH3)2), 81.7 (OC(CH3)3), 81.1 (OC(CH3)3), 36.2 
(C(R)(R’)(CO2R’’)2), 28.2 (OC(CH3)3), 25.1 (pinacol CH3), 24.8 (pinacol CH3), 18.6 
(CH2(R)(R’)); 11B NMR (CDCl3, 128 MHz) δ 30.8.  
To obtain the racemic sample, (±)-BINAP (6 mol%) was substituted for R-Tol-BINAP using 
the same procedure to yield (±)-94 in 91% yield. 
The enantiopurity of (R)-94 was determined using Pirkle’s alcohol ((R)-(-)-1-(9-Anthryl)-
2,2,2-trifluoroethanol) NMR shift reagent (7.0 equiv, rt, CDCl3, 0.1 M).
89 The spectra are 
presented in Figure 4. 
6.2.2. General procedure A for the oxidation of boronic esters 
A round bottom flask containing the boronic ester (0.15 mmol) in THF (1 mL) was cooled to 
0 °C. At 0 °C in air, a solution of 2 M NaOH/30% H2O2(aq) (1.5 mL, 2:1 v/v) was added 
dropwise. The mixture was stirred at 0 °C for 1 hour and then at room temperature for 1 hour. 
After this time, water (5 mL) and ethyl acetate (5 mL) were added and the phases separated. 
The aqueous phase was extracted with ethyl acetate (3 × 5 mL) and the combined organic 
phases were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude mixture was purified by flash column chromatography (100:0 → 70:30 
hexane/ethyl acetate) to give the desired alcohol. 
6.2.3. General procedure B for the conversion of alcohols to benzoate esters 
A round bottom flask was charged with the alcohol (1.0 equiv) and DMAP (0.15 equiv) and 




the solution was cooled to 0 °C before the addition of triethylamine (3 equiv) and benzoyl 
chloride (1.5 equiv). After 20 hours stirring at room temperature (or when TLC analysis 
showed the reaction had reached completion) water and diethyl ether were added and the 
aqueous phase was extracted 3 times with diethyl ether. The combined organic phases were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
mixture was purified by flash chromatography (100:0 → 80:20 hexane/ethyl acetate) to give 
the desired benzoate ester. 
6.2.4. Lewis acid and solvent screen for the 1,2-metallate rearrangement/ring 
opening of the diactivated n-butylcyclopropyl boronate complex 
A flame dried Schlenk flask was charged with 94 (50 mg, 0.14 mmol, 1.0 equiv), evacuated 
and purged with nitrogen before the addition of anhydrous THF (1 mL). The reaction flask was 
cooled to −78 °C before the dropwise addition of n-butyllithium (0.09 mL, 1.6 M solution in 
hexane, 1.1 equiv). The reaction was then stirred at −78 °C for 1 hour. After boronate 
formation, activation conditions were employed, and the reaction was stirred for 16 h. After 
this time, the crude mixture was then oxidised according to general procedure A and a crude 
quantitative 1H NMR spectrum was recorded to determine the NMR yield of the desired 
product. 
6.2.5. General procedure C for the boronate formation and subsequent 1,2-
metallate rearrangement/ring opening reaction of (R)-94 
 
Boronate formation condition i): A flame dried Schlenk flask was charged with (R)-94 (50 mg, 
0.14 mmol, 1.0 equiv), evacuated and purged with nitrogen before the addition of anhydrous 
THF (1 mL). The reaction flask was cooled to −78 °C before the dropwise addition of the 
corresponding organolithium reagent (1.1-1.2 equiv). The reaction was then stirred at −78 °C 
for 1 hour.  
Boronate formation condition ii): The organolithium reagent was formed in a flame dried 
Schlenk flask in anhydrous THF (0.5 mL). (R)-94 (50 mg, 0.14 mmol, 1.0 equiv) was weighed 
into a vial which was evacuated and purged with nitrogen before the addition of anhydrous 




of organolithium reagent cooled to −78 °C. Additional anhydrous THF (2 × 0.2 mL) was used 
to wash residual (R)-94 from the vial into the reaction mixture. The reaction was then stirred 
at −78 °C for 1 hour. 
Boronate formation condition iii): A flame dried Schlenk flask was charged with (R)-94 
(0.050 g, 0.14 mmol, 1.0 equiv) and vinyl/aryl halide (0.163 mmol, 1.2 equiv) then evacuated 
and purged with nitrogen before the addition of anhydrous THF (1 mL). The reaction flask was 
cooled to at −78 °C before the dropwise addition of t-butyllithium (0.20 mL, 1.6 M in pentane, 
2.4 equiv). The reaction was then stirred at −78 °C for 1 hour. 
After boronate formation, MgBr2.Et2O (53 mg, 0.20 mmol, 1.5 equiv) was added as a solid 
under a positive flow of nitrogen at −78 °C and the reaction stirred overnight whilst warming 
slowly to room temperature. Water (10 mL) and diethyl ether (10 mL) were added and the 
phases separated. The aqueous phase was extracted with diethyl ether (3 × 10 mL) and the 
combined organic phases were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. A quantitative 1H NMR spectrum of the crude reaction mixture was 
recorded to determine the NMR yield. The crude reaction mixture was then concentrated and 
added to a pre-equilibrated column (98:2 pentane/ethyl acetate, 10 g Biotage ZIP cartridge) 
with petroleum ether (2 × 0.5 mL) and eluted within 10 minutes of contact with silica (98:2 → 
80:20 pentane/ethyl acetate) to limit the protodeboronation of product boronic esters. 
6.2.6. Reaction scope for the two-component reaction 
Di-tert-butyl (R)-2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexyl)malonate, 110a 
General procedure C, boronate formation condition i): using (R)-94 
(56 mg, 0.15 mmol, 1.0 equiv), n-butyllithium (0.11 mL, 1.6 M 
solution in hexane, 1.1 equiv), MgBr2.Et2O (59 mg, 0.23 mmol, 1.5 
equiv), to yield 110a as a colourless oil (68 mg, 96% yield). 
RF 0.54 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2930, 2873, 1744, 
1726, 1457, 1368, 1316, 1251, 1137; HRMS (ESI): Calcd. for C23H43BO6Na
+ ([M+Na]+) m/z 
449.3045, found m/z 449.3044; [𝛂]𝐃
𝟐𝟓 −13.8 (c = 1.92, 97:3 er); 
 1H NMR (CDCl3, 400 MHz) δ 3.24 (dd, 
3JHH = 8.8, 6.9, CH(CO2R)2), 1.85 (m, 2H, 
CH2CH(CO2R)2)), 1.44 (s, 9H, CO2C(CH3)3), 1.44 (s, 9H, CO2C(CH3)3), 1.41 – 1.34  (m, 2H, 
CH3CH2CH2CH2), 1.31 – 1.25 (m, 4H, CH3CH2CH2), 1.23 (s, 12H, pinacol CH3), 0.94 (m, 1H, 




(RCO2C(CH3)3), 169.2 (RCO2C(CH3)3), 83.1 (pinacol OC(R)(CH3)2), 81.1 (OC(CH3)3), 81.1 
(OC(CH3)3), 53.4 (CH(CO2R)2), 31.2 (CH3CH2CH2CH2), 30.9 (CHCH2CH(Bpin)), 29.9 
(CH2CH(CO2R)2), 28.1 (OC(CH3)3), 25.0 (pinacol CH3), 24.8 (pinacol CH3), 23.0 
(CH2CH2CH3), 21.2 (br, CH(Bpin)), 14.2 (CH2CH2CH3); 11B NMR (CDCl3, 128 MHz) δ 33.2. 
Di-tert-butyl (R)-2-(2-hydroxyhexyl)malonate, 111a 
Oxidation of 110a performed using general procedure A to give 111a 
as a colourless oil. 
RF 0.63 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3449, 2977, 2959, 2931, 
2873, 1725, 1456, 1393, 1368, 1251, 1140; HRMS (ESI): Calcd. for C17H32O5Na
+ ([M+Na]+) 
m/z 339.2142, found m/z 339.2145; [𝛂]𝐃
𝟐𝟓 −6.4 (c = 1.25, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 3.63 (m, 1H, CH(OH)), 3.41 (dd, 
3JHH = 8.0, 6.2, 1H, 
CH(CO2R)2), 2.03 (ddd, 
2JHH = 14.4, 
3JHH = 8.0, 3.0, 1H, CH(OH)CH2CH(CO2R)2), 1.86 (ddd, 
2JHH = 14.4, 
3JHH = 9.2, 6.2, CH(OH)CH2CH(CO2R)2), 1.50 – 1.47 (m, 2H, CH(OH)CH2CH2), 
1.47 (s, 9H, OC(CH3)3)), 1.46 (s, 9H, OC(CH3)3)), 1.37 – 1.31 (m, 4H, CH2CH2CH3), 0.90 (t, 
3JHH = 6.9, 3H, CH2CH3); 13C NMR (CDCl3, 101 MHz) δ 169.6 (RCO2C(CH3)3), 169.3 
(RCO2C(CH3)3), 81.7 (OC(CH3)3), 70.2 (CH(OH)), 51.4 (CH(CO2R)2), 37.7 (CH(OH)CH-
2CH2), 36.2 (CH(OH)CH2CH(CO2R)2), 28.07 (OC(CH3)3), 28.1 (OC(CH3)3), 27.5 
(CH2CH2CH2), 22.8 (CH2CH2CH3), 14.2 (CH2CH3). 
Di-tert-butyl (R)-2-(2-(benzoyloxy)hexyl)malonate, 111a’ 
Esterification of 111a performed using general procedure B to give 
111a’ as a colourless oil (70% yield). 
RF 0.59 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
2962, 2931, 2861, 1721, 1452, 1393, 1368, 1259, 1069; HRMS (ESI): 
Calcd. for C24H36O6Na
+ ([M+Na]+) m/z 443.2404, found m/z 443.2395; [𝛂]𝐃
𝟐𝟓 −12.2 (c = 0.68, 
97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 8.05 (m, 2H, CaH), 7.56 (tt, 
3JHH = 7.8, 
4JHH = 1.4, 1H, CcH), 
7.45 (t, 3JHH = 7.8, 2H, CbH), 5.16 (m, 1H, CH(OBz)), 3.31 (dd, 
3JHH = 9.4, 5.2, 1H, 
CH(CO2R)2), 2.30 – 2.14 (m, 2H, CH(OBz)CH2CH(CO2R)2), 1.62-1.77 (m, 2H, 
CH(OBz)CH2CH2), 1.44 (s, 9H, OC(CH3)3), 1.43 (s, 9H, OC(CH3)3)), 1.38 – 1.35 (m, 4H, 
CH2CH2CH3), 0.89 (t, 




(RCO2C(CH3)3), 168.6 (RCO2C(CH3)3), 166.2 (RO2C(Ph)), 132.9 (CcH), 130.7 (CdH), 129.8 
(CaH), 128.4 (CbH), 81.8 (OC(CH3)3), 72.8 (CH(OBz)), 50.7 (CH(CO2R)2), 34.5 
(CH(OBz)CH2CH2), 33.2 (CH(OBz)CH2CH(CO2R)2), 28.0 (OC(CH3)3), 27.4 (CH2CH2CH3), 
22.7 (CH2CH3), 14.1 (CH2CH3). 
Enantiomeric ratio of 97:3 was determined using chiral HPLC analysis (Chiralpak IA without 






A flame dried Schlenk flask was charged with (R)-94 (74 mg, 0.20 mmol, 
1.0 equiv), evacuated and purged with nitrogen before the addition of 
anhydrous THF (1.5 mL). The reaction flask was cooled to −78 °C before 
the dropwise addition of t-butyllithium (0.15 mL, 1.6 M solution in 
pentane, 1.2 equiv). The reaction was then stirred at −78 °C for 50 minutes and at room 
temperature for 5 minutes. After this time, the solvent was removed in vacuo and replaced with 
anhydrous toluene (1.5 mL). After cooling to −78 °C, MgBr2.Et2O (78 mg, 0.30 mmol, 
1.5 equiv) was added as a solid under a positive flow of nitrogen and the reaction was stirred 
overnight whilst warming slowly to room temperature. Water (10 mL) and diethyl ether 
(10 mL) were added and the phases separated. The aqueous phase was extracted with diethyl 
ether (3 × 10 mL) and the combined organic phases were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure. A quantitative 1H NMR spectrum of the 
crude reaction mixture was recorded to determine the NMR yield. The crude mixture was 
purified by flash column chromatography (100:0 → 80:20 hexane/ethyl acetate) to give 110b 




RF 0.35 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2871, 1744, 1725, 
1474, 1394, 1371, 1313, 1253, 1137; HRMS (ESI): Calcd. for C23H43BO6Na
+ ([M+Na]+) m/z 
449.3045, found m/z 449.3053; [𝛂]𝐃
𝟐𝟓 −34.4 (c = 1.47, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 3.07 (dd, 
3JHH = 11.9, 3.8, 1H, CH(CO2R)2), 1.97 (ddd, 
2JHH = 
12.8, 3JHH = 11.9, 3.3, CH2CH(CO2R)2)), 1.82 (dt, 
2JHH = 12.8, 
3JHH = 12.8, 3.8, 1H, 
CH2CH(CO2R)2)), 1.45 (s, 9H, OC(CH3)3), 1.44 (s, 9H, OC(CH3)3)), 1.25 (s, 12H, pinacol 
CH3), 0.95 (s, 9H, CbH3), 0.78 (dd, 
3JHH = 12.8, 3.3, 1H, CH(Bpin)); 13C NMR (CDCl3, 101 
MHz) δ 169.4 (RCO2C(CH3)3), 169.0 (RCO2C(CH3)3), 83.2 (pinacol OC(R)(CH3)2), 81.1 
(OC(CH3)3), 81.0 (OC(CH3)3), 54.2 (CH(CO2R)2), 33.7 (br., CH(Bpin)), 32.3 
(CH2CH(CO2R)2), 29.6 (Cb), 28.1 (OC(CH3)3), 26.4 (Ca), 25.1 (pinacol CH3), 25.0 (pinacol 
CH3); 11B NMR (CDCl3, 128 MHz) δ 32.4. 
Di-tert-butyl (S)-2-(2-hydroxy-3,3-dimethylbutyl)malonate, 111b 
Oxidation of 110b performed using general procedure A to give 111b as 
a colourless oil. 
RF 0.33 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3485, 
2973, 2867, 1724, 1477, 1395, 1372, 1253, 1143; HRMS (ESI): Calcd. for C17H32O5Na
+ 
([M+Na]+) m/z 339.2142, found m/z 339.2139; [𝛂]𝐃
𝟐𝟓 −25.5 (c = 0.63, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ  3.42 (dd, 
3JHH = 8.6, 35.7, 1H, CH(CO2R)2), 3.22 (ddd, 
3JHH = 
10.9, 6.2, 2.0, 1H, CH(OH)), 2.05 (ddd, 2JHH = 14.3, 
3JHH = 8.6, 2.0, CH2CH(CO2R)2)), 1.84 
(d, 3JHH = 6.2, 1H, CH(OH)), 1.79 (ddd, 
2JHH = 14.3, 
3JHH = 10.9, 5.7, 1H, CH2CH(CO2R)2)), 
1.46 (s, 9H, OC(CH3)3), 1.46 (s, 9H, OC(CH3)3)), 0.91 (s, 9H, CbH3); 13C NMR (CDCl3, 101 
MHz) δ 169.8 (RCO2C(CH3)3), 169.3 (RCO2C(CH3)3), 81.7 (OC(CH3)3), 81.6 (OC(CH3)3), 
77.9 (CH(OH)), 52.1 (CH(CO2R)2), 35.2 (Ca), 30.9 (CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.1 
(OC(CH3)3), 25.7 (Cb). 
Di-tert-butyl (S)-2-(2-(benzoyloxy)-3,3-dimethylbutyl)malonate, 111b’ 
Esterification of 111b performed using general procedure B to give 111b’ 
as a colourless oil (66% yield).  
RF 0.41 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2972, 





+ ([M+Na]+) m/z 443.2404, found m/z 443.2402; [𝛂]𝐃
𝟐𝟓 −16.5 (c = 0.54, 
(96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 8.06 (dd, 
3JHH = 7.6, 
4JHH = 1.1, 2H, CaH), 7.56 (tt, 
3JHH = 7.6, 
4JHH = 1.1, 1H, CcH), 7.45 (t, 
3JHH = 7.6, 2H, CbH), 5.03 (dd, 
3JHH = 11.3, 2.0, 1H, 1H, 
CH(OBz)), 3.18 (dd, 3JHH = 10.2, 4.2, 1H, CH(CO2R)2), 2.31 (ddd, 
2JHH = 14.5, 
3JHH = 10.2, 
2.0, 1H, CH2CH(CO2R)2), 2.07 (ddd, 
2JHH = 14.5, 
3JHH = 11.3, 4.2, 1H, CH2CH(CO2R)2), 1.48 
(s, 9H, OC(CH3)3), 1.36 (s, 9H, OC(CH3)3)), 1.00 (s, 9H, CeH3); 13C NMR (CDCl3, 101 MHz) 
δ  169.0 (RCO2C(CH3)3), 168.4 (RCO2C(CH3)3), 166.2 (RO2C(Ph)), 132.9 (CcH), 130.5 (CdH), 
129.8 (CaH), 128.4 (CbH), 81.7 (OC(CH3)3), 81.7 (OC(CH3)3), 79.0 (CH(OBz)), 51.0 
(CH(CO2R)2), 35.3 (Cf), 29.1 (CH2CH(CO2R)2), 28.0 (OC(CH3)3), 27.9 (OC(CH3)3), 26.0 (Ce). 
Enantiomeric ratio of 96:4 was determined using chiral HPLC (Chiralpak IC with guard, 0.5% 
IPA/hexane, 1.0 mL/min, 25 °C): tR = 7.20 [major, (S)], 8.27 [minor, (R)]. 
  
   
Di-tert-butyl (S)-2-(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)malonate, 110c 
General procedure C, boronate formation condition i), using (R)-94 
(50 mg, 0.14 mmol, 1.0 equiv), phenyllithium (0.08 mL, 1.9 M solution 
in dibutylether, 1.15 equiv), MgBr2·Et2O (53 mg, 0.20 mmol, 
1.5 equiv), to yield 110c as a white solid (47 mg, 78% yield). 
Performed using the same procedure on a 1 mmol scale using (R)-94 (0.402 g, 1.09 mmol, 
1.0 equiv), phenyllithium (0.69 mL, 1.9 M solution in dibutylether, 1.2 equiv), MgBr2·Et2O 
(0.422 g, 1.64 mmol, 1.5 equiv), to yield 110c as a white solid (0.431 g, 88% yield). 
RF 0.41 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2932, 1741(C=O), 
1724, 1453, 1367, 1323, 1254, 1140; HRMS (ESI): Calcd. for C25H39BO6Na
+ ([M+Na]+) m/z 
469.2732, found m/z 469.2730; [𝛂]𝐃




1H NMR (CDCl3, 400 MHz) δ 7.27 – 7.12 (m, 5H, ArCH), 3.06 (m, 1H, CH(CO2R)2), 2.36 – 
2.11 (m, 3H, CH(Ph)(Bpin), CH2CH(CO2R)2), 1.46 (s, 9H, OC(CH3)3), 1.41 (s, 9H, 
OC(CH3)3), 1.20 (s, 6H, pinacol CH3), 1.17 (s, 6H, pinacol CH3); 13C NMR (CDCl3, 101 MHz) 
δ 169.2 (RCO2C(CH3)3), 169.0 (RCO2C(CH3)3), 141.9 (Cd), 128.8 (Ca), 128.6 (Cb), 125.7 (Cc), 
83.6 (pinacol OC(R)(CH3)2), 81.3 (OC(CH3)3), 81.2 (OC(CH3)3), 52.8 (CH(CO2R)2), 31.3 
(CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3), 24.8 (pinacol CH3), 24.7 (pinacol CH3); 
11B NMR (CDCl3, 128 MHz) δ 32.3. 
Di-tert-butyl (S)-2-(2-hydroxy-2-phenylethyl)malonate, 111c 
Oxidation of 110c (0.372 g, 0.835 mmol) performed using general 
procedure A to give 111c as a white solid (0.270 g, 96% yield). 
RF 0.36 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3452 
(O-H), 2978, 2934, 1716, 1456, 1368, 1256, 1142; HRMS (ESI): Calcd. for C19H28O5Na
+ m/z 
359.1829, found m/z 359.1843 [M+Na]+; [𝛂]𝐃
𝟐𝟓 −16.6 (c = 1.38, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.28 – 7.15 (m, 5H, ArCH), 4.67 (br. dt, 
3JHH = 3.9, 6.7, 1H, 
CHOH), 3.28 (t, 3JHH = 7.1, 1H, CH(CO2R)2), 2.34 (br. d, 
3JHH = 3.9, 1H, OH), 2.15 – 2.12 (m, 
2H, CH2CH(CO2R)2), 1.37 (s, 9H, OC(CH3)3), 1.36 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 
MHz) δ 169.2 (RCO2C(CH3)3), 169.1 (RCO2C(CH3)3), 144.1 (Cd), 128.7 (Cb), 127.8 (Cc), 
125.9 (Ca), 81.8 (OC(CH3)3), 72.4 (CHOH), 51.4 (CH(CO2R)2), 38.0 (CH2CH(CO2R)2), 28.1 
(OC(CH3)3), 28.1 (OC(CH3)3).  
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 10% 








General procedure C, boronate formation condition ii), 
4-trifluoromethylphenyllithium was synthesised according to the 
following procedure:  
1-Bromo-4-(trifluoromethyl)benzene (21 µL, 0.15 mmol, 
1.1 equiv) was added to a flame dried Schlenk flask and dissolved in anhydrous THF (0.5 mL) 
then cooled to −78 °C. n-Butyllithium (93 µL, 1.6 M solution in hexane, 1.1 equiv) was added 
and the reaction stirred at −78 °C for 1 hour.  
Using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), 4-trifluoromethylphenyllithium (1.1 equiv), 
MgBr2·Et2O (53 mg, 0.20 mmol, 1.5 equiv), to yield 110d as an amorphous white solid (43 mg, 
62% yield). 
RF 0.38 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2937, 1740 (C=O), 
1718, 1617, 1478, 1444, 1368, 1324, 1247; HRMS (ESI): Calcd. for C26H38BF3O6Na
+ 
([M+Na]+) m/z 537.2606, found m/z 537.2612; [𝛂]𝐃
𝟐𝟓 15.6 (c = 2.11, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.51 (d, 
3JHH = 8.2, 2H, CbH), 7.29 (d, 
3JHH = 8.2, 2H, CaH), 
3.02 (m, 1H, CH(CO2R)2), 2.41 – 2.31 (m, 2H, CH(Ar)(Bpin), CH2CH(CO2R)2), 2.22 – 2.13 
(m, 1H, CH2CH(CO2R)2), 1.46 (s, 9H, OC(CH3)3), 1.41 (s, 9H, OC(CH3)3), 1.20 (s, 6H, pinacol 
CH3), 1.18 (s, 6H, pinacol CH3); 13C NMR (CDCl3, 101 MHz) δ 169.0 (RCO2C(CH3)3), 168.8 
(RCO2C(CH3)3), 146.3 (Cd), 129.0 (Ca), 128.0 (q, 
2JCF = 32, Cc), 125.5 (q, 
3JCF = 4, Cb), 124.3 
(q, 1JCF = 272, CF3), 83.9 (pinacol OC(R)(CH3)2), 81.6 (OC(CH3)3), 81.5 (OC(CH3)3), 52.7 
(CH(CO2R)2), 30.9 (CH2CH(CO2R)2), 29.8 (CH(Bpin)), 28.1 (OC(CH3)3), 28.0 (OC(CH3)3), 
24.7 (pinacol CH3), 24.7 (pinacol CH3); 11B NMR (CDCl3, 128 MHz) δ 31.8; 19F NMR 
(CDCl3, 377 MHz) δ −62.29 (s, CF3). 
Di-tert-butyl (S)-2-(2-hydroxy-2-(4-(trifluoromethyl)phenyl)ethyl)malonate, 111d 
Oxidation of 110d performed using general procedure A to give 
111d as a colourless oil. 
RF 0.39 (80:20 petroleum ether/ethyl acetate); IR (film) 
νmax/cm
-1: 3457, 2979, 2935, 1724, 1394, 1324, 1255, 1161, 1125; HRMS (ESI): Calcd. for 
C20H27F3O5 m/z 427.1703, found m/z 427.1708 [M+Na]
+; [𝛂]𝐃




1H NMR (CDCl3, 400 MHz) δ 7.59 (d, 
3JHH = 8.2, 2H, CbH), 7.48 (d, 
3JHH = 8.2, 2H, CaH), 
4.85 (br. m, 1H, CHOH), 3.37 (dd, 3JHH = 6.3, 7.9, 1H, CH(CO2R)2), 2.75 (br. d, 1H, OH), 2.28 
– 2.14 (m, 2H, CH2CH(CO2R)2), 1.45 (s, 9H, OC(CH3)3), 1.45 (s, 9H, OC(CH3)3); 13C NMR 
(CDCl3, 101 MHz) δ 169.0 (RCO2C(CH3)3), 148.1 (Cd), 169.0 (RCO2C(CH3)3), 129.9 (q, 
2JCF 
= 32, Cc), 126.1 (Ca), 125.5 (q, 
3JCF = 4, Cb), 124.1 (q, 
1JCF = 272, CF3), 82.1 (OC(CH3)3), 82.0 
(OC(CH3)3), 71.7 (CHOH), 51.2 (CH(CO2R)2), 38.0 (CH2CH(CO2R)2), 28.0 (OC(CH3)3), 28.0 
(OC(CH3)3); 19F NMR (CDCl3, 377 MHz) δ −62.39 (s, CF3).  
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 10% 





General procedure C, boronate formation condition ii), 
3-methoxyphenyllithium was synthesised according to the 
following procedure: 
3-Bromoanisole (22 µL, 0.17 mmol, 1.2 equiv) was added to a 
flame dried Schlenk flask and dissolved in anhydrous THF (0.5 mL) then cooled to −78 °C. 
n-Butyllithium (0.11 mL, 1.6 M solution in hexane, 1.2 equiv) was added and the reaction 
stirred at −78 °C for 1 hour.  
Using (R)-94 (53 mg, 0.15 mmol, 1.0 equiv), 3-methoxyphenyllithium (1.2 equiv), MgBr2.Et2O 
(56 mg, 0.22 mmol, 1.5 equiv), to yield 110e as a colourless oil (53 mg, 77% yield). 
RF 0.27 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2932, 1740, 1724, 
1598, 1582, 1486, 1455, 1367, 1323, 1256; HRMS (ESI): Calcd. for C26H41BO7Na
+ ([M+Na]+) 
m/z 499.2838, found m/z 499.2847; [𝛂]𝐃




1H NMR (CDCl3, 400 MHz) δ 7.16 (dd, 
3JHH = 8.0, 7.4, 1H, CdH) 6.77 (dt, 
3JHH = 7.4, 
4JHH 
=1.2, 1H, CeH), 6.73 (t, 
4JHH = 2.0, 1H, CaH), 6.69 (ddd, 
3JHH = 8.0, 
4JHH = 2.6, 0.9, 1H, CcH), 
3.78 (s, 3H, OCH3), 3.08 (m, 1H, CH(CO2R)2), 2.34 – 2.27 (m, 2H, CH(Ar)(Bpin), 
CH2CH(CO2R)2), 2.19 – 2.10 (m, 1H, CH2CH(CO2R)2), 1.46 (s, 9H, OC(CH3)3), 1.42 (s, 9H, 
OC(CH3)3), 1.21 (s, 6H, pinacol CH3), 1.18 (s, 6H, pinacol CH3); 13C NMR (CDCl3, 101 MHz) 
δ 169.2 (RCO2C(CH3)3), 168.9 (RCO2C(CH3)3), 159.8 (Cb), 143.5 (Cf), 129.4 (Cd), 121.3 (Ce), 
114.3 (Ca), 111.5 (Cc), 83.6 (pinacol OC(R)(CH3)2), 81.3 (OC(CH3)3), 81.2 (OC(CH3)3), 55.2 
(OCH3), 52.7 (CH(CO2R)2), 31.3 (CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3), 24.8 
(pinacol CH3), 24.7 (pinacol CH3); 11B NMR (CDCl3, 128 MHz) δ 31.8. 
Di-tert-butyl (S)-2-(2-hydroxy-2-(3-methoxyphenyl)ethyl)malonate, 111e 
Oxidation of 110e performed using general procedure A to give 
111e as a colourless oil. 
RF 0.29 (80:20 petroleum ether/ethyl acetate); IR (film) 
νmax/cm
-1: 3453, 2977, 2931, 1716, 1602, 1457, 1368, 1257, 1141; HRMS (ESI): Calcd. for 
C20H30O6Na
+ m/z 389.1935, found m/z 389.1936 [M+Na]+; [𝛂]𝐃
𝟐𝟓 −12.0 (c = 1.05, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.26 (t, 
3JHH = 8.2, 1H, CdH), 6.77 (ddd, 
3JHH = 7.6, 1.2, 0.9, 
1H, CeH), 6.93 (m, 2H, CaH, CeH), 6.81 (ddd, 
3JHH = 8.2, 
4JHH = 2.5, 1.0, 1H, CcH), 4.75 (t, 
3JHH = 6.6, 1H, OH), 3.81 (s, 3H, OCH3), 3.38 (t, 
3JHH = 7.2, 1H, CH(CO2R)2), 2.44 (br, 1H, 
OH), 2.25 – 2.21 (m, 2H, CH2CH(CO2R)2), 1.47 (s, 9H, OC(CH3)3), 1.46 (s, 9H, OC(CH3)3); 
13C NMR (CDCl3, 101 MHz) δ 169.2 (RCO2C(CH3)3), 169.1 (RCO2C(CH3)3), 160.0 (Cb), 
145.8 (Cf), 129.7 (Cd), 118.1 (Ce), 113.4 (Ca), 111.2 (Cc), 81.8 (OC(CH3)3), 72.3 (CHOH), 55.4 
(OCH3), 51.4 (CH(CO2R)2), 38.0 (CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3). 
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 10% 








General procedure C, boronate formation condition ii), furan-2-
yllithium was synthesised according to the following procedure: 
Furan (12 µL, 0.16 mmol, 1.2 equiv) was added to a flame dried Schlenk 
flask cooled to −78 °C followed by anhydrous THF (0.5 mL). 
n-Butyllithium (0.10 mL, 1.6 M solution in hexane, 1.2 equiv) was added and the reaction 
warmed to room temperature and stirred for 30 minutes.  
Using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), furan-2-yllithium (1.2 equiv), MgBr2·Et2O 
(53 mg, 0.20 mmol, 1.5 equiv), to yield 110f as a colourless oil (43 mg, 73% yield). 
RF 0.32 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2933, 1741, 1725, 
1586, 1504, 1457, 1367, 1330, 1249; HRMS (ESI): Calcd. for C23H37BO7Na
+ ([M+Na]+) m/z 
459.2525, found m/z 459.2541; [𝛂]𝐃
𝟐𝟓 18.0 (c = 1.57, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 7.28 (dd, 
3JHH = 1.9, 
4JHH = 0.8, 1H, CcH), 6.25 (dd, 
3JHH = 3.1, 
1.9, 1H, CbH), 6.01 (dt, 
3JHH = 3.1, 
4JHH = 0.8, 1H, CaH), 3.16 (dd, 
3JHH = 8.5, 6.8, 1H, 
CH(CO2R)2), 2.49 (dd, 
3JHH = 9.4, 7.0, 1H, CH(Bpin)), 2.27 – 2.13 (m, 2H, CH2CH(CO2R)2), 
1.45 (s, 9H, OC(CH3)3), 1.43 (s, 9H, OC(CH3)3), 1.24 (s, 6H, pinacol CH3), 1.23 (s, 6H, pinacol 
CH3); 13C NMR (CDCl3, 101 MHz) δ 169.0 (RCO2C(CH3)3), 168.8 (RCO2C(CH3)3), 155.4 
(Cd), 141.2 (Cc), 110.3 (Cb), 105.7 (Ca), 83.9 (pinacol OC(R)(CH3)2), 81.4 (OC(CH3)3), 81.3 
(OC(CH3)3), 52.9 (CH(CO2R)2), 29.0 (CH2CH(CO2R)), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3), 





Di-tert-butyl (S)-2-(2-(furan-2-yl)-2-hydroxyethyl)malonate, 111f 
Oxidation of 110f performed using general procedure A to give 111f as 
a colourless oil. 
RF 0.30 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
3447, 2778, 2933, 1722, 1368, 1252, 1140; HRMS (ESI): Calcd. for C17H26O6Na
+ m/z 
349.1622, found m/z 349.1624 [M+Na]+; [𝛂]𝐃
𝟐𝟓 −15.4 (c = 0.45, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 7.37 (dd, 
3JHH = 1.8, 
4JHH = 0.7, 1H, CcH), 6.32 (dd, 
3JHH = 3.3, 
1.8, 1H, CbH), 6.26 (dt, 
3JHH = 3.3, 
4JHH = 0.7, 1H, CaH), 4.77 (br. dd, 
3JHH = 12.0, 6.1, 1H, 
CHOH), 3.40 (t, 3JHH = 7.1, 1H, CH(CO2R)2), 2.40 (br. d, 
3JHH = 5.5, 1H, OH), 2.37 – 2.33 (m, 
2H, CH2CH(CO2R)2), 1.46 (s, 9H, OC(CH3)3), 1.46 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 
MHz) δ 169.1 (RCO2C(CH3)3), 169.0 (RCO2C(CH3)3), 156.0 (Cd), 141.3 (Cc), 110.3 (Cb), 
106.2 (Ca), 82.0 (OC(CH3)3), 81.9 (OC(CH3)3), 66.1 (CHOH), 51.0 (CH(CO2R)2), 34.5 
(CH2CH(CO2R)), 28.1 (OC(CH3)3). 
Enantiomeric ratio of 96:4 was determined using chiral HPLC analysis (Chiralpak IA with 






General procedure C, boronate formation condition ii), (N-Boc-
indol-2-yl)lithium was synthesised according to the following 
procedure: 
N-Boc-indole (35 µL, 0.16 mmol, 1.2 equiv) was added to a flame 
dried Schlenk flask and dissolved in anhydrous THF (0.5 mL) then cooled to −78 °C. 
n-Butyllithium (0.10 mL, 1.6 M solution in hexane, 1.2 equiv) was added dropwise and the 




Using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), (N-Boc-indol-2-yl)lithium (1.2 equiv), 
MgBr2·Et2O (53 mg, 0.20 mmol, 1.5 equiv), to yield 110g as a colourless oil (24 mg, 30% 
yield). 
RF 0.25 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2933, 1720, 1454, 
1368, 1332, 1295, 1254, 1156, 1139; HRMS (ESI): Calcd. for C32H48BNO8Na
+ ([M+Na]+) m/z 
608.3365, found m/z 608.3348; [𝛂]𝐃
𝟐𝟓 63.5 (c = 1.09, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.94 (m, 1H, CfH), 7.42 (m, 1H, CcH), 7.17 (m, 2H, CdH/CeH), 
6.34 (s, 1H, CaH), 3.25 (dd, 
3JHH = 8.9, 5.9, 1H, CH(CO2R)2), 2.72 (dd, 
3JHH = 10.1, 5.4, 1H, 
CH(Ar)(Bpin)), 2.43 (ddd, 2JHH = 14.7, 
3JHH = 8.9, 5.4, 1H, CH2CH(CO2R)2), 2.27 (ddd, 
2JHH 
= 14.7, 3JHH = 10.1, 5.9, 1H, CH2CH(CO2R)2), 1.68 (s, 9H, Boc OC(CH3)3), 1.45 (s, 9H, 
OC(CH3)3), 1.37 (s, 9H, OC(CH3)3), 1.24 (s, 6H, pinacol CH3), 1.22 (s, 6H, pinacol CH3); 13C 
NMR (CDCl3, 101 MHz) δ 169.3 (RCO2C(CH3)3), 169.2 (RCO2C(CH3)3), 151.1 
(NCO2C(CH3)3), 142.6 (Ch), 136.2 (Cg), 130.0 (Cb), 123.0 (Cd), 122.6 (Ce), 120.0 (Cc), 115.9 
(Cf), 108.8 (Ca), 84.0 (Boc OC(CH3)3), 83.4 (pinacol OC(R)(CH3)2), 81.2 (OC(CH3)3), 81.1 
(OC(CH3)3), 52.9 (CH(CO2R)2), 28.6 (CH2CH(CO2R)2), 28.5 (Boc OC(CH3)3), 28.1 
(OC(CH3)3), 28.0 (OC(CH3)3), 25.1 (pinacol CH3), 25.0 (pinacol CH3); 11B NMR (CDCl3, 128 
MHz) δ 30.8.  
Di-tert-butyl (S)-2-(2-(1-(tert-butoxycarbonyl)-1H-indol-2-yl)-2-hydroxyethyl)malonate, 
111g 
Oxidation of 110g performed using general procedure A to give 
111g as a colourless oil. 
RF 0.28 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
3495, 2978, 2933, 1729, 1454, 1370, 1331, 1253, 1161; HRMS (ESI): Calcd. for 
C26H37NO7Na
+ ([M+Na]+) m/z 498.2462, found m/z 498.2470; [𝛂]𝐃
𝟐𝟓 −4.0 (c = 0.62, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.97 (m, 1H, CfH), 7.50 (m, 1H, CcH), 7.27 (dt, , 
3JHH = 7.3, 
4JHH = 1.4, 1H, CeH), 7.21 (dt, 
3JHH = 7.6, 
4JHH = 1.2, 1H, CdH), 5.08 (dt, 
3JHH = 8.3, 5.5, 1H, 
CHOH),  6.66 (s, 1H, CaH), 4.26 (br. d, 
3JHH = 5.8, OH), 3.56 (dd, 
3JHH = 7.9, 6.4, 1H, 
CH(CO2R)2), 2.50 (m, 1H, CH2CH(CO2R)2), 1.72 (s, 9H, Boc OC(CH3)3), 1.47 (s, 9H, 
OC(CH3)3), 1.46 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 169.2 (RCO2C(CH3)3), 
169.1 (RCO2C(CH3)3), 151.7 (NCO2C(CH3)3), 142.7 (Ch), 136.5 (Cg), 129.1 (Cb), 124.6 (Cd), 




(OC(CH3)3), 65.6 (CHOH), 51.3 (CH(CO2R)2), 33.8 (CH2CH(CO2R)2), 28.4 (Boc OC(CH3)3), 
28.1 (OC(CH3)3). 
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 20% 
IPA/hexane – iso 50%, 4 mL/min, 125 bar): tR = 10.8 [minor, (R)], 11.3 [major, (S)]. 
 
  
Di-tert-butyl (S)-2-(2-hydroxy-2-(pyridin-3-yl)ethyl)malonate, 111i 
General procedure C, boronate formation condition iii), using (R)-94 
(50 mg, 0.14 mmol, 1.0 equiv), 3-bromopyridine (16 µL, 0.16 mmol, 
1.2 equiv), tert-butyllithium (0.22 mL, 1.6 M solution in pentane, 
2.4 equiv), MgBr2·Et2O (53 mg, 0.20 mmol, 1.5 equiv), oxidation was then performed using 
general procedure A to give 111i as a colourless oil (29 mg, 63% yield). 
RF 0.18 (50:50 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3196, 2978, 2934, 1723, 
1477, 1393, 1368, 1250, 1161, 1138; HRMS (ESI): Calcd. for C18H27NO5Na
+ m/z 360.1781, 
found m/z 360.1768 [M+Na]+; [𝛂]𝐃
𝟐𝟓 −20.4 (c = 1.30, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 8.55 (br s., 1H, CaH), 8.47 (br. d, 
3JHH = 4.1, 1H, CeH), 7.72 
(dt, 3JHH = 7.9, 
4JHH = 1.7, 1H CcH), 7.26 (dd, 
3JHH = 7.9, 4.8, 1H, CdH), 4.81 (dd, 
3JHH = 7.4, 
5.6, 1H, CHOH), 3.50 (br, 1H, OH), 3.40 (t, 3JHH = 7.1, 1H, CH(CO2R)2), 2.26 – 2.18 (m, 2H, 
CH2CH(CO2R)2), 1.45 (s, 9H, OC(CH3)3), 1.45 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 
MHz) δ 169.0 (RCO2C(CH3)3), 168.9 (RCO2C(CH3)3), 148.9 (Ce), 147.7 (Ca), 139.7 (Cb), 
133.7 (Cc), 123.6 (Cd), 82.1 (OC(CH3)3), 82.1 (OC(CH3)3), 70.0 (CHOH), 51.2 (CH(CO2R)2), 
37.9 (CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.0 (OC(CH3)3). 
Enantiomeric ratio of 96:4 was determined using chiral HPLC analysis (Chiralpak IA with 




    
     
 
Di-tert-butyl (S)-2-(2-hydroxy-3-phenylbut-3-en-1-yl)malonate, 111j 
General procedure C, boronate formation condition ii), 
α-Styryllithium was synthesised according to procedure: 
α-Bromostyrene (21 µL, 0.16 mmol, 1.2 equiv) was added to a flame 
dried Schlenk flask and dissolved in anhydrous THF (0.5 mL) then cooled to −78 °C. tert-
Butyllithium (0.21 mL, 1.7 M solution in pentane, 2.5 equiv) was added dropwise and the 
reaction stirred at −78 °C for 1 hour. 
Using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), α-styryllithium (1.2 equiv), MgBr2·Et2O (53 mg, 
0.20 mmol, 1.5 equiv), a quantitative crude NMR yield was recorded of the product boronic 
ester (110j) before oxidation using general procedure A to yield 111j as a white solid (22 mg, 
45% yield). 
RF 0.37 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3443, 2977, 2932, 1721, 
1456, 1368, 1251, 1141; HRMS (ESI): Calcd. for C21H30O5Na
+ ([M+Na]+) m/z 385.1985, 
found m/z 385.1993; [𝛂]𝐃
𝟐𝟓 20.8 (c = 0.86, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.39 – 7.26 (m, 3H, CaH, CbH, CcH), 5.42 (br. t, 
2JHH = 1.3, 
4JHH = 1.3, 1H, C=CH2), 5.35 (br, 1H, C=CH2), 4.72 (br. dt, 
3JHH =  8.0, 3.4, 1H, CHOH), 3.45 
(dd, 3JHH = 8.7, 5.5,  1H, CH(CO2R)2), 2.40 (br. d, 
3JHH = 4.6, 1H, OH), 2.17 (ddd, 
2JHH = 14.4, 
3JHH = 8.7, 3.4, 1H, CH2CH(CO2R)2), 1.95 (ddd, 
2JHH = 14.5, 
3JHH = 8.9, 5.5, 1H, 
CH2CH(CO2R)2), 1.45 (s, 9H, OC(CH3)3), 1.43 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 
MHz) δ 169.4 (RCO2C(CH3)3), 169.2 (RCO2C(CH3)3), 151.3 (C=CH2), 140.0 (Cd), 128.7 (Cb), 
127.9 (Cc), 127.0 (Ca), 113.0 (C=CH2), 81.9 (OC(CH3)3), 81.7 (OC(CH3)3), 71.5 (CHOH), 51.2 




 Enantiomeric ratio of 97:3 was determined using chiral HPLC analysis (Chiralpak IA with 
guard, 1% IPA/hexane, 1 mL/min, 25 °C): tR = 22.5 [major, (S)], 25.6 [minor, (R)]. 
     




General procedure C, boronate formation condition ii), 
(3-methylbuta-1,2-dien-1-yl)lithium was synthesised according to the 
following literature procedure:162 
3-Methylbuta-1,2-diene (16 µL, 0.16 mmol, 1.2 equiv) was added to a flame dried Schlenk 
flask and dissolved in anhydrous THF (0.5 mL) then cooled to −78 °C. tert-Butyllithium (1.7 M 
solution in pentane, 1.2 equiv) was added dropwise and the reaction stirred at −78 °C for 
30 minutes and then warmed to room temperature and stirred for 5 minutes. 
Using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), (3-methylbuta-1,2-dien-1-yl)lithium (1.2 equiv), 
MgBr2·Et2O (53 mg, 0.20 mmol, 1.5 equiv), to yield 110k as a colourless oil (45 mg, 76% 
yield). 
RF 0.41 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2932, 1743, 1726, 
1478, 1455, 1367, 1323, 1257, 1140; HRMS (ESI): Calcd. for C24H41BO6Na
+ ([M+Na]+) m/z 
459.2888, found m/z 459.2877; [𝛂]𝐃
𝟐𝟓 −5.5 (c = 2.00, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 4.94 (dsept, 
3JHH = 7.7, 
5JHH =  2.8, 1H, CaH), 3.34 (dd, 
3JHH = 8.6, 6.5,  1H, CH(CO2R)2), 2.04 (ddd, 
2JHH = 13.8, 
3JHH = 8.6, 6.5, 1H, CH2CH(CO2R)2), 
1.87 (ddd, 2JHH = 13.8, 
3JHH = 9.5, 6.5, 1H, CH2CH(CO2R)2), 1.66 (d, 
5JHH = 2.8, 6H, CcH), 
1.63 (ddd, 3JHH = 9.5, 7.7, 6.5, 1H, CH(Bpin)), 1.44 (s, 9H, OC(CH3)3), 1.44 (s, 9H, OC(CH3)3), 
1.23 (s, 12H, pinacol CH3); 13C NMR (CDCl3, 101 MHz) δ 201.9 (Cb), 169.3 (RCO2C(CH3)3), 
168.8 (RCO2C(CH3)3), 95.9 (Cd), 88.5 (Ca), 83.2 (pinacol OC(R)(CH3)2), 81.0 (OC(CH3)3), 




(OC(CH3)3), 24.7 (Cc), 24.6 (Cc), 22.5 (CH(Bpin)), 20.8 (pinacol CH3), 20.7 (pinacol CH3); 
11B NMR (CDCl3, 128 MHz) δ 31.7. 
Di-tert-butyl (S)-2-(2-hydroxy-5-methylhexa-3,4-dien-1-yl)malonate, 111k 
Oxidation of 110k performed using general procedure A to give 111k 
as a colourless oil. 
RF 0.35 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3444, 2978, 2934, 1725, 
1455, 1393, 1368, 1254, 1140; HRMS (ESI): Calcd. for C18H30O5Na
+ ([M+Na]+) m/z 
359.1985, found m/z 349.1996; [𝛂]𝐃
𝟐𝟓 −4.7 (c = 1.23, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 1.45 (s, 9H, OC(CH3)3), 1.46 (s, 9H, OC(CH3)3),  1.71 (d, 
5JHH 
= 2.1, 3H, CcH), 1.72 (d, 
5JHH = 2.8, 3H, CcH), 1.88 (br. d, 
3JHH = 5.1, 1H, OH), 2.00 (ddd, 
2JHH 
= 14.2, 3JHH = 8.0, 6.5, 1H, CH2CH(CO2R)2), 2.10 (ddd, 
2JHH = 14.2, 
3JHH = 7.7, 4.8, 1H, 
CH2CH(CO2R)2), 3.40 (dd, 
3JHH = 7.7, 6.5,  1H, CH(CO2R)2), 4.15 (br. ddt, 
3JHH = 8.0, 5.0, 
3.1, 1H, CHOH), 5.08 (nonet, 3JHH, 
5JHH =  2.9, 1H, CaH); 13C NMR (CDCl3, 101 MHz) δ 20.7 
(Cc), 20.7 (Cc), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3), 36.3 (CH2CH(CO2R)2), 50.9 (CH(CO2R)2), 
68.2 (CHOH), 81.6 (OC(CH3)3), 81.6 (OC(CH3)3), 93.33 (Ca), 99.5 (Cd), 169.2 
(RCO2C(CH3)3), 169.2 (RCO2C(CH3)3), 199.9 (Cb). 
Di-tert-butyl (S)-2-(2-(benzoyloxy)-5-methylhexa-3,4-dien-1-yl)malonate, 111k’ 
Esterification of 111k performed using general procedure B to give 
111k’ as a colourless oil (87% yield). 
RF 0.46 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
2979, 2935, 2909, 1720, 1451, 1368, 1266, 1138; HRMS (ESI): 
Calcd. for C25H34O6Na
+ ([M+Na]+) m/z 453.2248, found m/z 453.2241; [𝛂]𝐃
𝟐𝟓 −24.9 (c = 1.40, 
97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 8.03 (m, 2H, CfH), 7.54 (tt, 
3JHH = 7.4, 
4JHH = 1.3, 1H, ChH), 
7.42 (m, 2H, CgH), 5.47 (dt, 
3JHH = 7.2, 6.0, 1H, CH(OBz)), 5.12 (nonet, 
3JHH, 
5JHH =  2.8, 1H, 
CaH) 3.37 (t, 
3JHH = 7.3,  1H, CH(CO2R)2), 2.32 (m, 2H, CH2CH(CO2R)2), 2.00 (ddd, 
2JHH = 
14.2, 3JHH = 8.0, 6.5, 1H, CH2CH(CO2R)2), 1.88 (br. d, 
3JHH = 5.1, 1H, OH), 1.68 (d, 
5JHH = 
2.9, 3H, CcH), 1.64 (d, 
5JHH = 2.8, 3H, CcH), 1.44 (s, 9H, OC(CH3)3), 1.43 (s, 9H, OC(CH3)3); 
13C NMR (CDCl3, 101 MHz) δ 202.0 (Cb), 168.4 (RCO2C(CH3)3), 168.4 (RCO2C(CH3)3), 




(Cc), 81.7 (OC(CH3)3), 81.7 (OC(CH3)3), 71.0 (CH(OBz)), 50.6 (CH(CO2R)2), 33.0 
(CH2CH(CO2R)2), 27.9 (OC(CH3)3), 27.9 (OC(CH3)3), 20.2 (Cc). 
Enantiomeric ratio of 97:3 was determined using chiral HPLC analysis (Chiralpak IC with 
guard, 0.5% IPA/hexane, 1 mL/min, 25 °C): tR = 14.4 [major, (S)], 23.8 [minor, (R)]. 
     





General procedure C, boronate formation condition iii), using (R)-94 (50 mg, 0.14 mmol, 
1.0 equiv), vinyl iodide 269 (77 mg, 0.15 mmol, 1.1 equiv), tert-butyllithium (0.19 mL, 1.6 M 
solution in pentane, 2.2 equiv), MgBr2·Et2O (53 mg, 0.20 mmol, 1.5 equiv), to yield 110l as a 
colourless oil (67 mg, 65% yield).  
Notes: (A) vinyl iodide 269 was prepared by previous researcher following a literature 
procedure.163 
RF 0.50 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2975, 2931, 2854, 1744, 
1727, 1462, 1368, 1322, 1251, 1140; HRMS (ESI): Calcd. for C44H75BO7SiNa
+ ([M+Na]+) 
m/z 777.5267, found m/z 777.5298; [𝛂]𝐃
𝟐𝟓 −32.0 (c = 3.04); 
1H NMR (CDCl3, 400 MHz) δ 5.41 (br., 1H, alkene CH), 5.32 (br., 1H, alkene CH), 3.48 (tt, 
3JHH = 10.9, 4.8, 1H, CHOSi(CH2)2R), 3.23 (t, 
3JHH = 7.7, 7.1, 1H, CH(CO2R)2), 2.29 – 2.14 




9H, OC(CH3)3), 1.35 – 1.24 (m, 2H, CH, CH2), 1.21 (s, 6H, pinacol CH3), 1.20 (s, 6H, pinacol 
CH3), 1.02 (s, 3H, CH3), 1.07 – 0.98 (m, 2H, CH, CH2), 0.88 (s, 9H, Si(C(CH3)3), 0.77 (s, 3H, 
CH3), 0.05 (s, 6H, Si(CH3)2); 13C NMR (CDCl3, 101 MHz) δ 169.4 (RCO2C(CH3)3), 169.0 
(RCO2C(CH3)3), 155.3 (alkene C), 142.0 (alkene C), 123.2 (alkene CH), 121.2 (alkene CH), 
83.3 (pinacol OC(R)(CH3)2), 81.2 (OC(CH3)3), 81.1 (OC(CH3)3), 72.8 (CHOSi(CH2)2R)), 57.1 
(CH), 53.3 (CH(CO2R)2), 51.0 (CH), 47.2 (C), 43.0 (CH2), 37.5 (CH2), 37.0 (C), 34.5 (CH2), 
32.3 (CH2), 31.8 (CH2), 31.5 (CH2), 30.8 (CH), 30.5 (CH2), 26.1 (Si(C(CH3)3), 24.9 (pinacol 
CH3), 24.8 (pinacol CH3), 20.9 (CH2), 20.6 (br, CH(Bpin)), 19.5 (CH3), 18.4 (Si(C(CH3)3), 
16.37 (CH3), −4.4 (Si(CH3)2); 11B NMR (CDCl3, 128 MHz) δ  32.4. 
Di-tert-butyl 2-(2-(cyclobut-1-en-1-yl)-2-hydroxyethyl)malonate, 114’ 
 
(±)-94 (50 mg, 0.14 mmol, 1.0 equiv) and sulfoxide 86A (34 mg, 0.18 mmol, 1.3 equiv) were 
added to a flame dried Schlenk tube, evacuated and purged with nitrogen then dissolved in 
anhydrous THF (1.3 mL). At –78 °C, tert-butyllithium (1.7 M solution in pentane, 1.3 equiv) 
was added dropwise and the reaction stirred at –78 °C for 5 minutes. The reaction was then 
warmed to room temperature and stirred for 15 minutes. At –78 °C, MgBr2.Et2O (53 mg, 0.20 
mmol, 1.5 equiv) was added and the reaction was left to warm slowly to room temperature 
overnight. After this time, water (10 mL) and diethyl ether (10 mL) were added and the phases 
separated. The aqueous phase was extracted with diethyl ether (3 × 10 mL) and the combined 
organic phases were washed with brine, dried (MgSO4) and concentrated under reduced 
pressure. The crude reaction mixture was added to a pre-equilibrated column (98:2 
pentane/ethyl acetate, 10 g Biotage ZIP® cartridge) with petroleum ether (3 × 0.5 mL) and 
eluted within 10 minutes of contact with silica (98:2 → 80:20 pentane/ethyl acetate).  
Boronic ester 114 coeluted with an unknown side product so the mixture was oxidised. In a 
round bottom flask, the mixture (28 mg) was dissolved in THF (0.5 mL) and NaBO3·4H2O 
(90 mg, 0.59 mmol, 4.0 equiv) was added at room temperature. The reaction was stirred at 




separated. The aqueous phase was extracted with ethyl acetate (3 × 10 mL) and the combined 
organic phases were washed with brine, dried (MgSO4) and concentrated under reduced 
pressure. The crude mixture was purified by flash column chromatography (100:0 → 70:30 
hexane/ethyl acetate) to give 65h as a colourless oil (9.0 mg, 0.029 mmol, 21% yield). 
Notes: (A) sulfoxide 86 was prepared following a literature procedure.80  
RF 0.34 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3449, 2977, 2925, 1724, 
1456, 1393, 1368, 1255; HRMS (ESI): Calcd. for C17H28O5Na
+ ([M+Na]+) m/z 335.1829, 
found m/z 335.1828; 
 1H NMR (CDCl3, 500 MHz) δ 5.90 (s, 1H, CaH), 4.13 (m, 1H, CH(OH)), 3.40 (dd, 
3JHH = 7.9, 
6.2, 1H, CH(CO2R)2), 2.49 (m, 2H, CcH2), 2.36 (m, 2H, CbH2), 2.15 (ddd, 
2JHH = 14.4, 
3JHH = 7.9, 4.0, 1H, CH2CH(CO2R)2), 1.98 (ddd, 
2JHH = 14.4, 
3JHH = 8.6, 6.2, 1H, 
CH2CH(CO2R)2), 1.45 (s, 9H, OC(CH3)3), 1.45 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 
101 MHz) δ 169.3 (RCO2C(CH3)3), 169.2 (RCO2C(CH3)3), 150.5 (Cd), 128.7 (Ca), 81.8 
(OC(CH3)3), 81.7 (OC(CH3)3), 68.3 (CH(OH)), 50.9 (CH(CO2R)2), 34.0 (CH2CH(CO2R)2), 
28.8 (Cc), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3), 26.5 (Cb). 
6.2.7. Analysis of the necessity for tert-butyl esters 
Diethyl cycloprop-2-ene-1,1-dicarboxylate 
 
Following a modified literature procedure:86 
A round bottom flask fitted with a condenser and charged with Rh2(OAc)4 (0.010 g, 
0.022 mmol, 0.5 mol%) was evacuated and purged with nitrogen. Trimethylsilyl acetylene 
(11 mL) was added and the solution was heated to reflux. A solution of diethyl 
2-diazomalonateA (0.83 g, 4.5 mmol) in trimethylsilyl acetylene (0.7 mL) was added to the 
reaction flask via syringe pump over 16 hours. After complete addition, reflux was maintained 
for a further 5 hours. The reaction mixture was then filtered through a pad of silica and the 
solvent was then removed in vacuo. The crude mixture was then dissolved in THF (23 mL). A 




at room temperature for 1 hour. The phases were separated, and the organic phase was 
concentrated under reduced pressure. The phases were recombined with the addition of water 
(20 mL) and diethyl ether (20 mL) and the aqueous phase was extracted with diethyl ether 
(3 × 20 mL). Combined organic phases were washed with brine, dried dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude mixture was purified by flash 
chromatography (100:0 → 70:30 pentane/ethyl acetate) to give diethyl cycloprop-2-ene-1,1-
dicarboxylate as a brown oil (0.56 g, 68% yield). 
Notes: (A) diethyl 2-diazomalonate was prepared following a literature procedure.160  
RF 0.28 (75:25 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3168, 3118, 2982, 2942, 
1725, 1447, 1367, 1278; HRMS (ESI): Calcd. for C9H13O4
+ ([M+H]+) m/z 185.0808, found 
m/z 185.0804; 
1H NMR (CDCl3, 400 MHz) δ 6.91 (s, 2H, HC(R)=C(R)H), 4.18 (q, 
3JHH = 7.1, 4H, 
OCCH2CH3), 1.26 (t, 
3JHH = 7.1, 6H, OCCH2CH3); 13C NMR (CDCl3, 101 MHz) δ 171.2 





Following a modified literature procedure:86 
A flame dried Schlenk flask was charged with [Rh(COD)Cl]2 (29 mg, 0.058 mmol, 
0.030 equiv) and (±)-BINAP (72 mg, 0.12 mmol, 0.06 eq), evacuated and purged with nitrogen. 
Anhydrous DCM (1.9 mL) was added and the reaction was stirred for 3 minutes at room 
temperature. HBpin (0.34 mL, 2.3 mmol, 1.2 eq) and diethyl cycloprop-2-ene-1,1-
dicarboxylate (349 mg, 1.89 mmol) were added successively. The mixture was stirred at room 
temperature for 40 minutes before filtration through a pad of silica. The crude mixture was 
concentrated under reduced pressure and added to a pre-equilibrated column and eluted within 
15 minutes of contact with silica (98:2 → 60:40 pentane/ethyl acetate) to yield 115 as a yellow 




RF 0.5 (75:25 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2979, 2951, 1732, 1436, 
1413, 1335, 1288, 1233, 1141; HRMS (ESI): Calcd. for C15H26O6B
+ ([M+H]+) m/z 313.1817, 
found m/z 313.1815; 
1H NMR (CDCl3, 400 MHz) δ 4.28 – 4.09 (m, 4H, OCCH2CH3), 1.50 (app. d, 
3JHH = 9.5, 2H, 
CH2(R)(R’)), 1.29 (t, 
3JHH = 7.2, 3H, OCCH2CH3), 1.24 (t, 
3JHH = 7.3, 3H, OCCH2CH3), 1.23 
(s, 6H, pinacol CH3), 1.22 (s, 6H, pinacol CH3), 1.08 (dd, 
3JHH = 10.1, 8.9, 1H, pinB-
CH(R)(R’)); 13C NMR (CDCl3, 101 MHz) δ 170.5 (RCO2Et), 168.9 (RCO2Et), 83.9 (pinacol 
OC(R)(CH3)2), 61.7 (OCH2CH3), 61.5 (OCH2CH3), 34.2 (C(R)(R’)(CO2Et)2), 24.9 (pinacol 
CH3), 24.9 (pinacol CH3), 18.8 (CH2(R)(R’)), 14.1 (OCH2CH3), 11.6 (br., CHBpin); 11B NMR 
(CDCl3, 128 MHz) δ 29.1.  
Two component reaction employing diethyl ester 115 
 
A flame dried Schlenk flask was charged with 115 (42 mg, 0.14 mmol), evacuated and purged 
with nitrogen before the addition of anhydrous THF (1 mL). The reaction flask was cooled to 
at −98 °C (methanol/liquid nitrogen) before the dropwise addition of phenyllithium (0.08 mL, 
1.9 M solution in dibutylether, 1.1 equiv). The reaction was then stirred at −98 °C for 1 hour 
before MgBr2.Et2O (52 mg, 0.20 mmol, 1.5 equiv) was added as a solid under a positive flow 
of nitrogen at −98 °C and the reaction stirred overnight whilst warming slowly to room 
temperature. Water (10 mL) and diethyl ether (10 mL) were added and the phases separated. 
The aqueous phase was extracted with diethyl ether (3 × 10 mL) and the combined organic 
phases were washed with brine, dried (MgSO4), filtered and concentrated. A quantitative 
1H 
NMR spectrum of the crude reaction in the presence of CH2Br2 (1.0 eq) as an internal standard 
showed the ring opened product 116 (35% NMR yield).  
HRMS (ESI): Calcd. for C21H32BO6
+ ([M+H]+) m/z 391.2286, found m/z 391.2285 





6.2.8. General procedure D for the boronate formation and subsequent 1,2-
metallate rearrangement/ring opening then electrophilic trapping of (R)-
94 
 
A flame dried Schlenk flask was charged with (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), evacuated 
and purged with nitrogen before the addition of anhydrous THF (1 mL). The reaction flask was 
cooled to −78 °C before the dropwise addition of phenyllithium (0.09 mL, 1.9 M solution in 
dibutylether, 1.2 equiv). The reaction was stirred at −78 °C for 1 hour. MgBr2.Et2O (7.0 mg, 
0.027 mmol, 0.2 equiv) was weighed into a vial in a nitrogen atmosphere glovebox and the vial 
sealed with a septum before the addition of diethyl ether, (0.2 mL) to the vial. Sequentially, the 
electrophile (2 equiv) and the solution of MgBr2.Et2O were added dropwise to the flask 
containing the boronate complex at −78 °C. The reaction was stirred overnight whilst warming 
slowly to room temperature. Water (10 mL) and diethyl ether (10 mL) were added and the 
phases separated. The aqueous phase was extracted with diethyl ether (3 × 10 mL) and the 
combined organic phases were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. A quantitative 1H NMR spectrum of the crude reaction mixture was 
recorded to determine the NMR yield. The crude reaction mixture was then added to a pre-





ether (2 × 0.5 mL) and eluted within 10 minutes of contact with silica (98:2 → 80:20 
pentane/ethyl acetate) to limit the protodeboronation of product boronic esters. 
6.2.9. Reaction scope for the three-component reaction 
Di-tert-butyl (S)-2-methyl-2-(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)malonate, 117a 
General procedure D using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), 
phenyllithium (0.09 mL, 1.9 M solution in dibutyl ether, 1.2 equiv), 
methyl iodide (17 µL, 0.28 mmol, 2.0 equiv), MgBr2·Et2O (7.0 mg, 
0.028 mmol, 0.2 equiv), to yield 117a as a colourless oil (48 mg, 77% 
yield). 
RF 0.42 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2933, 1725, 1453, 
1368, 1324, 1253, 1141; HRMS (ESI): Calcd. for C26H41BO6Na
+ ([M+Na]+) m/z 483.2888, 
found m/z 483.2904; [𝛂]𝐃
𝟐𝟓 8.4 (c = 1.67, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.21 – 7.18 (m, 4H, CaH, CbH), 7.10 (m, 1H, CcH), 2.51 (dd, 
2JHH = 15.0, 
3JHH = 9.7, 1H, CH2C(Me)(CO2R)2), 2.22 (dd, 
3JHH = 9.7, 4.5, 1H, CH(Ph)(Bpin)), 
2.21 (dd, 2JHH = 15.0, 
3JHH = 4.5, 1H, CH2C(Me)(CO2R)2), 1.43 (s, 9H, OC(CH3)3), 1.37 (s, 
9H, OC(CH3)3), 1.28 (s, 3H, CH3), 1.14 (s, 6H, pinacol CH3), 1.12 (s, 6H, pinacol CH3); 13C 
NMR (CDCl3, 101 MHz) δ 172.0 (RCO2C(CH3)3), 171.5 (RCO2C(CH3)3), 143.8 (Cd), 128.4 
(Cb, Ca), 125.3 (Cc), 83.5 (pinacol OC(R)(CH3)2), 81.0 (OC(CH3)3), 80.9 (OC(CH3)3), 55.7 
(C(Me)(CO2R)2), 37.5 (CH2C(Me)(CO2R)2), 28.0 (OC(CH3)3), 28.0 (OC(CH3)3), 24.7 (pinacol 
CH3), 24.6 (pinacol CH3), 20.0 (CH3); 11B NMR (CDCl3, 128 MHz) δ 31.9. 
Di-tert-butyl (S)-2-(2-hydroxy-2-phenylethyl)-2-methylmalonate, 117a’ 
Oxidation of 117a performed using general procedure A to give 117a’ 
as a white solid. 
RF 0.47 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
3445, 2979, 2935, 1722, 1455, 1394, 1368, 1283, 1249, 1154, 1116; HRMS (ESI): Calcd. for 
C20H30O5Na
+ ([M+Na]+) m/z 373.1985, found m/z 373.1999; [𝛂]𝐃
𝟐𝟓 −20.7 (c = 1.21, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.39 – 7.32 (m, 4H, CaH, CbH), 7.25 (tt, 
3JHH = 7.0, 
4JHH = 1.6, 
1H, CcH), 4.85 (br. dt, 
3JHH = 10.3, 2.8, 1H, CHOH), 3.34 (br. d, 
3JHH = 3.9, 1H, OH), 2.38 (dd, 
2JHH = 15.0, 
3JHH = 10.3, 1H, CH2C(Me)(CO2R)2), 1.99 (dd, 
2JHH = 15.0, 




CH2C(Me)(CO2R)2), 1.51 (s, 3H, CH3), 1.50 (s, 9H, OC(CH3)3), 1.45 (s, 9H, OC(CH3)3); 13C 
NMR (CDCl3, 101 MHz) δ 172.8 (RCO2C(CH3)3), 172.1 (RCO2C(CH3)3), 145.5 (Cd), 128.5 
(Cb), 127.4 (Cc), 125.7 (Ca), 82.0 (OC(CH3)3), 81.8 (OC(CH3)3), 70.9 (CHOH), 54.5 
(C(Me)(CO2R)2), 45.3 (CH2C(Me)(CO2R)2), 28.0 (OC(CH3)3), 28.0 (OC(CH3)3), 20.4 (CH3). 
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 10% 
IPA/hexane – iso 10%, 4 mL/min, 125 bar): tR = 8.0 [major, (S)], 12.0 [minor, (R)]. 
       
       
Di-tert-butyl (S)-2-allyl-2-(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)malonate, 117b 
General procedure D using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), 
phenyllithium (0.09 mL, 1.9 M solution in dibutyl ether, 1.2 equiv), 
allyl iodide (25 µL, 0.27 mmol, 2.0 equiv), MgBr2·Et2O (7.0 mg, 0.028 
mmol, 0.2 equiv), to yield 117b as a colourless oil (58 mg, 88% yield). 
RF 0.44 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3079, 2977, 2933, 1723, 
1640, 1600, 1478, 1453, 1367, 1324, 1251, 1140; HRMS (ESI): Calcd. for C26H43BO6Na
+ 
([M+Na]+) m/z 509.3045, found m/z 509.3042; [𝛂]𝐃
𝟐𝟓 18.4 (c = 2.65, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.21 – 7.18 (m, 4H, CaH, CbH), 7.09 (m, 1H, CcH), 5.67 (dddd, 
3JHH = 17.1, 10.2, 7.7, 6.9, 1H, CgH), 4.91 (m, 1H, ChH2), 4.96 (m, 1H, ChH2), 2.57 (dd, 
2JHH 
= 16.3, 3JHH = 8.4, 1H, CeH2), 2.43-2.53 (m, 2H, CfH2), 2.23 – 2.18 (m, 2H, CH(Ph)(Bpin), 
CeH2,), 1.43 (s, 9H, OC(CH3)3), 1.32 (s, 9H, OC(CH3)3), 1.13 (s, 6H, pinacol CH3), 1.12 (s, 
6H, pinacol CH3); 13C NMR (CDCl3, 101 MHz) δ 170.6 (RCO2C(CH3)3), 170.5 
(RCO2C(CH3)3), 143.6 (Cd), 133.4 (Ch), 128.7 (Ca), 128.4 (Cb), 125.4 (Cc), 118.3 (Ch), 83.5 
(pinacol OC(R)(CH3)2), 81.2 (OC(CH3)3), 81.1 (OC(CH3)3), 59.3 (C(CO2R)2), 36.9 (Cf), 34.1 
(Ce), 28.1 (OC(CH3)3), 28.0 (OC(CH3)3), 24.8 (pinacol CH3), 24.5 (pinacol CH3); 11B NMR 




Di-tert-butyl (S)-2-allyl-2-(2-hydroxy-2-phenylethyl)malonate, 117b’ 
Oxidation of 117b performed using general procedure A to give 117b’ 
as a white solid. 
RF 0.43 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 
3364, 3078, 2977, 2932, 1716 (C=O), 1640 (C=C), 1565, 1455, 1393, 
1368, 1295, 1248, 1223, 1144; HRMS (ESI): Calcd. for C22H32O5Na
+ ([M+Na]+) m/z 
399.2142, found m/z 399.2150; [𝛂]𝐃
𝟐𝟓 −5.1 (c = 1.65, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.37 – 7.31 (m, 4H, CaH, CbH), 7.25 (tt, 
3JHH = 6.7, 
4JHH = 1.9, 
1H, CcH), 5.71 (dddd, 
3JHH = 16.9, 10.1, 7.9, 6.7, 1H, CgH), 5.19 – 5.10 (m, 2H, ChH2), 4.86 
(ddd, 3JHH = 10.3, 3.4, 2.2, 1H, CHOH), 2.87 (br. d, 
3JHH = 3.4, 1H, OH), 2.85 (ddt, 
2JHH = 
14.4, 3JHH = 6.7, 
4JHH = 1.2, 1H, CfH2), 2.69 (ddt, 
2JHH = 14.4, 
3JHH = 7.9, 
4JHH = 0.9, 1H, CfH2), 
2.34 (dd, 2JHH = 15.2, 
3JHH = 10.3, 1H, CeH2,), 2.09 (dd, 
2JHH = 15.2, 
3JHH = 2.2, 1H, CeH2,), 
1.50 (s, 9H, OC(CH3)3), 1.47 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 171.2 
(RCO2C(CH3)3), 171.2 (RCO2C(CH3)3), 145.4 (Cd), 133.0 (Ch), 128.6 (Cb), 127.5 (Cc), 125.7 
(Ca), 119.1 (Ch), 82.0 (OC(CH3)3), 70.8 (CHOH), 57.7 (C(CO2R)2), 42.6 (Ce), 38.3 (Cf), 28.1 
(OC(CH3)3), 28.1 (OC(CH3)3). 
Enantiomeric ratio of 97:3 was determined using chiral SFC analysis (Whelk 01 column, 10% 
IPA/hexane – iso 10%, 4 mL/min, 125 bar): tR = 7.0 [major, (S)], 9.7 [minor, (R)]. 
      
      
Di-tert-butyl (S)-2-((dimethylamino)methyl)-2-(2-hydroxy-2-phenylethyl)malonate, 
117c’ 
General procedure D using (R)-94 (50 mg, 0.14 mmol, 1.0 equiv), 
phenyllithium (0.09 mL, 1.9 M solution in dibutyl ether, 1.2 equiv), 




equiv), MgBr2·Et2O (7.0 mg, 0.028 mmol, 0.2 equiv), a quantitative 
1H NMR yield was 
recorded of the product boronic ester (117c) before oxidation using general procedure A to 
yield 117c’ as a white solid (36 gm, 72% yield). 
RF 0.51 (60:40 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3376, 3170, 2976, 2933, 
2868, 2833, 2785, 1724, 1455, 1393, 1368, 1252, 1164, 1139; HRMS (ESI): Calcd. for 
C22H35NO5H
+ ([M+H]+) m/z 394.2588, found m/z 394.2602; [𝛂]𝐃
𝟐𝟓 −1.4 (c = 1.62, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.39 (br. d, 
3JHH = 7.3, 2H, CaH), 7.32 (br. t, 
3JHH = 7.3, 2H, 
CbH), 7.22 (tt, 
3JHH = 7.3, 
4JHH = 1.3, 1H, CcH), 4.73 (br. d, 
3JHH = 9.6, 1H, CH(OH)(Ph)), 3.39 
(d, 2JHH = 13.5, 1H, CfH2), 2.86 (d, 
2JHH = 13.5, 1H, CfH2), 2.45 (dd, 
2JHH = 15.5, 
3JHH = 0.9, 
1H, CeH2), 2.32 (dd, 
2JHH = 15.5, 
3JHH = 9.6, 1H, CeH2), 2.31 (s, 6H, N(CH3)2), 1.49 (s, 9H, 
OC(CH3)3), 1.44 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 170.6 (RCO2C(CH3)3), 
169.7 (RCO2C(CH3)3), 146.4 (Cd), 128.3 (Cb), 126.9 (Cc), 125.6 (Ca), 82.3 (OC(CH3)3), 82.2 
(OC(CH3)3), 69.8 (CH(OH)(Ph)), 60.2 (Cf), 59.1 (C(CO2R)2), 45.7 (N(CH3)2), 42.8 (Ce), 28.0 
(OC(CH3)3), 27.9 (OC(CH3)3). 
Enantiomeric ratio of 97:3 was determined using chiral HPLC analysis (Chiralpak IA with 
guard, 3% IPA/hexane, 0.5 mL/min, 25 °C): tR = 15.6 [major, (S)], 21.1 [minor, (R)]. 
      
      
6.2.10.  Boronic ester transformations 
Di-tert-butyl (R)-2-(2-phenylbut-3-en-1-yl)malonate, 120 
Following a modified literature procedure:68 
Tetravinyltin (61 µL, 0.34 mmol, 3.4 equiv) was added to a flame dried 
Schlenk flask and n-butyllithium (0.78 mL, 1.6 M solution in hexane, 
13 equiv) was added dropwise at room temperature. The reaction was stirred at room 
temperature for 30 minutes and then the precipitate was left to settle for 30 minutes. The 
supernatant solvent was removed by syringe before the dropwise addition of anhydrous THF 




was charged with (S)-110c (44 mg, 0.099 mmol, 1.0 equiv) and anhydrous THF (0.3 mL) and 
cooled to −78 °C. A quarter of the vinyllithium solution (0.30 mL, 0.31 mmol, 3.2 equiv) was 
added dropwise at −78 °C before the reaction was warmed to room temperature and stirred for 
30 minutes. After this time, the reaction was cooled to −78 °C before the addition of iodine 
(30 mg, 0.12 mmol, 1.2 equiv) in methanol (0.3 mL). After 20 minutes stirring at −78 °C, 
sodium methoxide (16 mg, 0.29 mmol, 3.0 equiv) was added as a suspension in methanol 
(0.1 mL). After 5 minutes, the reaction was warmed to room temperature and stirred for 1 h. 
Saturated aqueous sodium thiosulfate (1 mL) was added and after 5 minutes, water (10 mL) 
and diethyl ether (10 mL) were added and the phases separated. The aqueous phase was 
extracted with diethyl ether (3 × 10 mL) and the combined organic phases were washed with 
brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude mixture was 
purified by flash chromatography (100:0 → 80:20 hexane/ethyl acetate) to give 120 as a 
colourless oil (33 mg, 96% yield). 
RF 0.49 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3062, 2977, 2932, 1741, 
1725, 1637, 1478, 1393, 1368, 1281, 1255, 1163, 1139; HRMS (ESI): Calcd. for C21H30O4Na
+ 
([M+Na]+) m/z 369.2036, found m/z 369.2046; [𝛂]𝐃
𝟐𝟓 −4.4 (c = 1.13, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.33–7.28 (m, 2H, CbH), 7.23–7.19 (m, 3H, CaH, CcH), 5.94 
(ddd, 3JHH = 17.5, 9.9, 7.8, 1H, CeH), 5.11–5.06 (m, 2H, CfH2), 3.30 (br. q, 
3JHH = 7.8, 1H, 
CH(Ph)(Ce)), 3.10 (t, 
3JHH = 7.5, 1H, CH(CO2R)2), 2.27–2.16 (m, 2H, CH2CH(CO2R)2), 1.47 
(s, 9H, OC(CH3)3), 1.44 (s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 169.0 
(RCO2C(CH3)3), 168.9 (RCO2C(CH3)3), 143.2 (Cd), 141.0 (Ce), 128.7 (Cb), 127.8 (Ca), 126.7 
(Cc), 115.3 (Cf), 81.5 (OC(CH3)3), 52.0 (CH(CO2R)2), 47.6 (CH(Ph)(Ce)), 34.4 
(CH2CH(CO2R)2), 28.1 (OC(CH3)3), 28.1 (OC(CH3)3). 
Enantiomers not separable by chiral HPLC but expected enantiomeric ratio is 97:3, based on 
established enantiospecific nature of Zweifel olefination.68 
Di-tert-butyl (S)-2-(2-(furan-2-yl)-2-phenylethyl)malonate, 121 
Following a modified literature procedure:71 
Furan (19.5 µL, 0.27 mmol, 2.4 equiv) was added to a flame dried 
Schlenk flask cooled to −78 °C followed by anhydrous THF (1 mL). 
n-Butyllithium (0.19 mL, 1.6 M solution in hexane, 2.7 equiv) was 




cooled to −78 °C before the addition of (S)-110c (50 mg, 0.11 mmol, 1.0 equiv) as a solution 
in anhydrous THF (0.5 mL). The reaction was stirred at −78 °C for 1 h. After this time, the 
solvent was removed in vacuo at 0 °C and replaced with dry methanol (1 mL) then cooled back 
to −78 °C. N-bromosuccinimide (24 mg, 0.13 mmol, 1.2 equiv) was then added as a solution 
in acetonitrile (1.5 mL) and anhydrous THF (1.5 mL) was also added. The reaction was stirred 
at −78 °C for 1 h. Saturated aqueous sodium thiosulfate (1 mL) was added and the reaction 
warmed to room temperature. Water (10 mL) and diethyl ether (10 mL) were added and the 
phases separated. The aqueous phase was extracted with diethyl ether (3 × 10 mL) and the 
combined organic phases were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude mixture was purified by flash chromatography (100:0 → 
80:20 hexane/ethyl acetate) to give 121 as a colourless oil (26 mg, 61% yield). 
RF 0.40 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2933, 1741, 1724, 
1586, 1478, 1455, 1368, 1257, 1160, 1137; HRMS (ESI): Calcd. for C23H30O5Na
+ ([M+Na]+) 
m/z 409.1985, found m/z 409.1995; [𝛂]𝐃
𝟐𝟓 27.3 (c = 1.20, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.32 (dd, 
3JHH = 1.9, 
4JHH = 0.8, 1H, CgH), 7.29 – 7.31 (m, 2H, 
CbH), 7.25 – 7.23 (m, 3H, CaH, CcH), 6.29 (dd, 
3JHH = 3.2, 1.9, 1H, CfH), 6.11 (dt, 
3JHH = 3.2, 
4JHH = 0.8, 1H, CeH), 4.01 (br. t, 
3JHH = 8.0, 1H, CH(Ph)(Ar)), 3.05 (dd, 
3JHH = 7.8, 7.2, 1H, 
CH(CO2R)2), 2.59 (dt, 
2JHH = 13.9, 
3JHH = 7.8, 1H, CH2CH(CO2R)2), 2.40 (ddd, 
2JHH = 13.9, 
3JHH = 8.4, 7.2, 1H, CH2CH(CO2R)2), 1.47 (s, 9H, OC(CH3)3), 1.44 (s, 9H, OC(CH3)3); 13C 
NMR (CDCl3, 101 MHz) δ 169.0 (RCO2C(CH3)3), 168.7 (RCO2C(CH3)3), 156.7 (Ch), 141.8 
(Cg), 141.6 (Cd), 128.7 (Cb), 128.1 (Ca), 127.0 (Cc), 110.2 (Cf), 106.0 (Ce), 81.7 (OC(CH3)3), 
81.6 (OC(CH3)3), 52.0 (CH(CO2R)2), 43.0 (CH(Ph)(Ar)), 33.8 (CH2CH(CO2R)2), 28.1 
(OC(CH3)3), 28.1 (OC(CH3)3). 
Enantiomeric ratio of 97:3 was determined using chiral HPLC analysis (Chiralpak IB with 
guard + IB without guard, 0.5% IPA/hexane, 0.4 mL/min, 0 °C): tR = 24.2 [minor, (R)], 24.8 
[major, (S)]. 
    




Di-tert-butyl (S)-2-(2-(3-fluoropyridin-4-yl)-2-phenylethyl)malonate, 122 
Following a modified literature procedure:72 
A flame dried Schlenk flask was charged with diisopropylamine 
(39 µL, 0.28 mmol, 2.5 equiv) and anhydrous THF (0.56 mL) and 
cooled to −78 °C. n-Butyllithium (0.19 mL, 1.6 M solution in hexane, 
2.7 equiv) was added and the reaction was stirred at −78 °C for 1 hour. After this time, a 
solution of 3-fluoropyridine (24 µL, 0.28 mmol, 2.5 equiv) in anhydrous THF (0.4 mL) was 
added dropwise and the reaction stirred at −78 °C for 30 minutes. Next, a solution of (S)-110c 
(50 mg, 0.11 mmol, 1.0 equiv) in anhydrous THF (0.5 mL) was added and the reaction stirred 
at −78 °C for 1.5 h. After this time, 2,2,2-trichloroethyl chloroformate (100 µL, 0.73 mmol, 
6.5 equiv) was added dropwise. The reaction was stirred at −78 °C for 2 h then warmed to room 
temperature and stirred for an additional 16 h. Water (10 mL) and diethyl ether (10 mL) were 
added and the phases separated. Saturated aqueous sodium bicarbonate was added to the 
aqueous phase which was then extracted with diethyl ether (3 × 10 mL). The combined organic 
phases were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude mixture was dissolved in THF (1 mL) and cooled to 0 °C. In air, a solution 
of 2 M NaOH/30% H2O2(aq) (1 mL, 1:1 v/v) was added dropwise and the reaction was then 
stirred at room temperature for 18 h. Water (10 mL) and diethyl ether (10 mL) were added and 
the phases separated. Saturated aqueous sodium bicarbonate was added to the aqueous phase 
which was then extracted with diethyl ether (3 × 10 mL). The combined organic phases were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
mixture was purified by flash column chromatography (100:0 → 60:40 hexane/ethyl acetate) 
to give 122 as a colourless oil (23 mg, 50% yield). 
RF 0.49 (60:40 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2932, 1740, 1725 
(C=O), 1600, 1490, 1455, 1369, 1247, 1163, 1139; HRMS (ESI): Calcd. for C24H30FNO4H
+ 
([M+H]+) m/z 416.2232, found m/z 416.2238; [𝛂]𝐃
𝟐𝟓 11.6 (c = 1.00, 96:4 er); 
1H NMR (CDCl3, 400 MHz) δ 8.37 – 8.34 (m, 2H, CfH, CgH), 7.33 – 7.29 (m, 2H, CbH), 7.27 
– 7.22 (m, 4H, CaH, CcH, CeH), 4.31 (t, 
3JHH = 8.1, 1H, CH(Ph)(Ar)), 3.01 (dd, 
3JHH = 8.0, 7.0, 
1H, CH(CO2R)2), 2.63 – 2.49 (m, 2H, CH2CH(CO2R)2), 1.46 (s, 9H, OC(CH3)3),1.44 (s, 9H, 
OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 168.4 (RCO2C(CH3)3), 157.9 (d,
 1JCF = 255.3,
 Ch), 
140.6 (Cd), 146.1 (d, 
4JCF = 5.1,
  Cf), 139.5 (d, 
2JCF = 12.1,
 Ci), 138.3 (d, 
2JCF = 25.1, Cg), 129.0 
(Cb), 128.1 (Ca), 127.4 (Cc), 122.9 (d, 




(CH(CO2R)2), 40.9 (d, 
3JCF = 1.8,
 CH(Ph)(Ar)), 32.9 (CH2CH(CO2R)2), 28.0 (OC(CH3)3), 28.0 
(OC(CH3)3); 19F NMR (CDCl3, 377 MHz) δ −131.4 (br. d, 
3JHF = 6.2, ChF). 
Enantiomeric ratio of 96:4 was determined using chiral SFC analysis (Chiralpak IB, 10% 
IPA/hexane – iso 10%, 4 mL/min, 125 bar): tR = 4.9 [major, (S)], 8.6 [minor, (R)]. 
         
         
(S)-5-phenyldihydrofuran-2(3H)-one, 123 
Following a modified literature procedure:91 
Formic acid (7.9 mL) was added to round bottom flask containing (S)-111c 
(0.27 g, 0.79 mmol) and the reaction was stirred at room temperature until 
complete consumption of the starting material was observed by TLC (5.5 hours). After this 
time, water (10 mL) and diethyl ether (10 mL) were added and the phases separated. The 
aqueous phase was extracted with diethyl ether (3 × 10 mL) and the combined organic phases 
were washed with brine, dried dried (MgSO4), filtered and concentrated under reduced 
pressure. The mixture was dissolved in toluene and heated to reflux for 14 hours. After this 
time, the reaction mixture was concentrated to an approximate volume of 2 mL and then loaded 
directly onto a preequilibrated silica gel column and purified by flash chromatography (100:0 
→ 0:100 pentane/diethyl ether) to give 123 as a colourless oil (96 mg, 75% yield); 
RF 0.20 (80:20 petroleum ether/ethyl acetate); [𝛂]𝐃
𝟐𝟓 −32.7 (c = 3.18, 97:3 er); 
1H NMR (CDCl3, 400 MHz) δ 7.42 – 7.32 (m, 5H, CeH, CfH, CgH), 5.54 – 5.50 (m, 1H, CcH), 
2.71 – 2.62 (m, 3H, CbH2, CaH2), 2.17 – 2.14 (m, 1H, CbH2); 13C NMR (CDCl3, 101 MHz) δ 
177.0 (C=O), 139.5 (Cd), 128.9 (Ce), 128.6 (Cg), 125.4 (Cf), 81.4 (Cc), 31.1 (Ca), 29.1 (Cb). All 




6.2.11.  Starting material synthesis for reactivity study 
tert-Butyl 2-phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopropane-1-
carboxylate, cis-125 and trans-125 
 
Following a modified literature procedure:95 
A flame dried Schlenk flask charged with trans-2-phenyl vinyl boronic acid pinacol ester 
(0.56 g, 2.45 mmol, 1.0 equiv) and Pd(OAc)2 (55 mg, 0.24 mmol, 0.1 equiv) was evacuated 
and purged with nitrogen. Anhydrous THF (20 mL) was added and, with stirring, a solution of 
tert-butyl diazo acetate (1.36 mL, 9.79 mmol, 4.0 equiv) in anhydrous THF (4.5 mL) was added 
over 14 hours by syringe pump at room temperature. After half of the addition, a further portion 
of Pd(OAc)2 (30 mg, 0.13 mmol, 0.05 equiv) was added. The reaction mixture was then stirred 
for a further 2 hours at room temperature. The solvent was removed in vacuo and the crude 
mixture was added to a pre-equilibrated column (98:2 pentane/ethyl acetate, 25 g Biotage 
ULTRA cartridge) with petroleum ether (2 × 0.5 mL) and eluted (98:2 → 80:20 pentane/ethyl 
acetate) to separate the two diastereomers that were assigned as cis/trans using NOE data. 
cis-125 eluted first and was isolated as a white amorphous solid (238 mg, 28% yield). trans-125 
eluted second and was isolated as a white amorphous solid (279 mg, 33% yield). 
RF 0.57 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 
2934, 1709, 1460, 1437, 1381, 1367 (B-O), 1317, 1209; HRMS (ESI): 
Calcd. for C20H29BO4 m/z 344.2159, Neither [M]
+ or [M+Na]+ was 
found, LRMS found m/z 217.1 fragment [M – Bpin]+; 
1H NMR (CDCl3, 500 MHz) δ 7.26 (t, 
3JHH = 7.4, 2H, CbH), 7.17 (tt, 
3JHH = 7.4, 
4JHH = 1.4, 1H, CcH), 7.11 (br. d, 
3JHH = 7.4, 2H, CaH), 2.60 (dd, 
3JHH = 7.9, 4.4, 
1H, CHPh), 2.01 (dd, 3JHH = 9.7, 4.4, 1H, CH(CO2R)), 1.45 (s, 9H, OC(CH3)3), 1.31 (s, 6H, 
pinacol CH3), 1.28 (s, 6H, pinacol CH3), 0.87 (dd, 
3JHH = 9.7, 7.9, 1H, CHBpin); 13C NMR 
(CDCl3, 101 MHz) δ 172.4 (RCO2C(CH3)3), 141.1 (CdH), 128.5 (CbH), 126.3 (CcH), 126.1 
(CaH), 83.8 (pinacol OC(R)(CH3)2), 80.9 (OC(CH3)3), 30.1 CH(CO2R), 28.6 (CHPh), 28.3 




RF 0.42 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2976, 
2935, 1726, 1707, 1437, 1366, 1325, 1289; HRMS (ESI): Calcd. for 
C20H29BO4 m/z 344.2159, Neither [M]
+ or [M+Na]+ was found, LRMS 
found m/z 217.1 fragment [M – Bpin]+; 
1H NMR (CDCl3, 500 MHz) δ 7.30 – 7.23 (m, 4H, CaH, CbH), 7.18 (tt, 
3JHH = 7.3, 
4JHH = 1.5, 1H, CcH), 2.67 (br. t, 
3JHH = 8.5, 1H, CHPh), 2.13 (dd, 
3JHH = 9.2, 6.1, 
1H, CH(CO2R)), 1.31 (dd, 
3JHH = 7.7, 6.1, 1H, CHBpin), 1.26 (s, 12H, pinacol CH3), 1.11 (s, 
9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 169.9 (RCO2C(CH3)3), 137.0 (CdH), 129.6 
(CaH or CbH), 127.9 (CaH or CbH), 126.6 (CcH), 83.8 (pinacol OC(R)(CH3)2), 80.3 
(OC(CH3)3), 30.0 (CHPh), 28.1 (CH(CO2R)), 27.9 (OC(CH3)3), 24.9 (pinacol CH3); 11B NMR 
(CDCl3, 128 MHz) δ 31.8. 
Di-tert-butyl 2-methylmalonate, 130 
Following a modified literature procedure:164 
A flame dried Schlenk flask was charged with sodium hydride (0.105 g, 
60% dispersion in mineral oil, 2.63 mmol), evacuated and flushed with nitrogen. Anhydrous 
THF (5 mL) was added before the dropwise addition of di-tert-butyl malonate (0.56 mL, 
2.50 mmol) with stirring. The reaction was stirred at room temperature for 30 minutes. After 
this time, methyl iodide (0.16 mL, 2.51 mmol) was added dropwise and the reaction stirred 
overnight at room temperature. The reaction was quenched with saturated ammonium chloride 
solution (2 mL). Water (20 mL) and diethyl ether (20 mL) were added and the phases separated. 
The aqueous phase was extracted with diethyl ether (3 × 20 mL) and the combined organic 
phases were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude reaction mixture was purified by flash chromatography (100:0 → 90:10 
pentane/ethyl acetate) to give 130 as a colourless oil (0.366 g, 64% yield).  
RF 0.44 (90:10 petroleum ether/ethyl acetate); 1H NMR (CDCl3, 400 MHz) δ 3.22 (q, 
3JHH = 
7.2, 1H, CH3CH(CO2R)2), 1.46 (s, 18H, OC(CH3)3), 1.32 (d, 
3JHH = 7.2, 3H, CH3CH(CO2R)2); 
13C NMR (CDCl3, 101 MHz) δ 169.8 (C=O), 81.4 (OC(CH3)3), 48.4 (CH3CH(CO2R)2), 28.1 
(OC(CH3)3), 13.6 (CH3CH(CO2R)2). All characterisation data is consistent with that reported 







Following a modified literature procedure:97 
A flame dried Schlenk flask was charged with sodium hydride (20 mg, 60% dispersion in 
mineral oil, 0.50 mmol), evacuated and flushed with nitrogen. Anhydrous THF (1 mL) was 
added and the flask cooled to 0 °C. A solution of di-tert-butyl 2-methylmalonate (90 mg, 0.39 
mmol) in anhydrous THF (1 mL) was then added dropwise with stirring. The reaction was then 
stirred at room temperature for 1 hour. After this time, 2-(bromomethyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (131) (0.14 mL, 0.79 mmol) was added dropwise and the reaction stirred 
overnight at room temperature. The reaction was quenched with saturated ammonium chloride 
solution (2 mL). Water (10 mL) and diethyl ether (10 mL) were added and the phases separated. 
The aqueous phase was extracted with diethyl ether (3 × 20 mL) and the combined organic 
phases were washed with brine, dried (MgSO4), filtered and concentrated under reduced 
pressure. The crude reaction mixture was purified by flash chromatography (100:0 → 90:10 
pentane/ethyl acetate) to give 132 as a colourless oil (22 mg, 15% yield). 
RF 0.33 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2934, 1724, 1479, 
1367, 1325, 1251, 1145; HRMS (ESI): Calcd. for C19H35O6BNa
+ ([M+Na]+)  m/z 393.2419, 
found m/z 393.2438; 
1H NMR (CDCl3, 400 MHz) δ 1.44 (s, 3H, CH3CR(CO2R)2)), 1.43 (s, 18H, OC(CH3)3), 1.23 
(s, 13H, pinacol CH3, CHBpin); 13C NMR (CDCl3, 101 MHz) δ 172.7 (C=O), 83.2 (pinacol 
OC(R)(CH3)2), 80.8 (OC(CH3)3), 53.1 (CH3CR(CO2R)2), 28.0 (OC(CH3)3), 24.9 (pinacol 
CH3), 21.7 (CH3CR(CO2R)2); 11B NMR (CDCl3, 128 MHz) δ 31.7. 
6.2.12.  Conditions for the 11B NMR analysis to study the reactivity of different 
β-carbonyl boronate complexes with MgBr2·Et2O 
A flame dried Schlenk flask was charged with the boronic ester (94, trans-125 or 132, 




(0.15 M). The reaction flask was cooled to at −78 °C before the dropwise addition of 
n-butyllithium (1.1 equiv) and the reaction was then stirred at −78 °C for 1 hour. After this 
time, a 0.3 mL aliquot of the reaction mixture was transferred to a quartz NMR tube under an 
inert atmosphere of nitrogen. The NMR tube was sealed with a septum and a 11B NMR 
spectrum was recorded. The aliquot was transferred back to the original reaction flask before 
the addition of MgBr2.Et2O (1.5 equiv) at −78 °C. The reaction was stirred overnight whilst 
warming slowly to room temperature. After this time another 11B NMR spectrum was recorded 
using the same method. The aliquot was then transferred back to the original reaction flask 
before the addition of water (10 mL) and diethyl ether (10 mL). The phases were separated and 
the aqueous phase was extracted with diethyl ether (3 × 10 mL). The combined organic phases 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. A 
crude 1H NMR spectrum was then recorded. In both reactions with boronic esters trans-125 
and 132, there was no evidence of the 1,2-metallate shift boronic ester product in the crude 1H 
NMR spectrum. Due to instability, borinic esters trans-128 and 2.45 could not be isolated. 
6.2.13. Attempted deraromative 1,2-metallate rearrangement reaction 
4,4,5,5-Tetramethyl-2-(2-vinylphenyl)-1,3,2-dioxaborolane, 143 
 
A flame dried Schlenk tube, evacuated and purged with nitrogen, was charged with 
2-bromostyrene (0.68 mL, 5.46 mmol, 1 eq.). THF (27 mL, 0.2 M) was added and the solution 
was cooled to –78 °C. n-Butyllithium (3.76 mL, 1.6 M solution in hexane, 1.1 eq.), was added 
and the reaction was stirred at –78 °C for 1 hour. After this time, 2-Isopropoxy-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (iPrOBpin) (1.34 mL, 6.56 mmol, 1.2 eq.) was added 
dropwise at –78 °C and the reaction was stirred at –78 °C for 1 hour. After this time, water 
(50 mL) was added and the phases separated. The aqueous phase was extracted with diethyl 
ether (3 × 30 mL) and the combined organic phases were washed with brine, dried (MgSO4) 
and concentrated under reduced pressure. The crude mixture was purified by flash column 





RF 0.59 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3086, 3057, 2981, 2930, 
1626, 1594, 1560, 1482, 1444, 1379, 1341, 1261; HRMS (ESI): Calcd. for C14H19BO2Na
+ 
([M+Na]+) m/z 253.1370, found m/z 253.1371; 
1H NMR (CDCl3, 400 MHz) δ 7.80 (dd, 
3JHH = 7.5, 
4JHH = 1.0, 1H, CaH), 7.63 (br. d, 
3JHH = 
7.5, 1H, CdH), 7.53 (dd, 
3JHH = 17.5, 11.0, 1H, CeH), 7.40 (br. dt, 
3JHH = 7.5, 
4JHH = 1.4, 1H, 
CcH), 7.25 (dt, 
3JHH = 7.5, 
4JHH = 1.1, 1H, CbH), 5.70 (dd, 
3JHH = 17.5, 
2JHH = 1.4, 1H, CfHg), 
5.27 (dd, 3JHH = 11.0, 
2JHH = 1.4, 1H, CfHh), 1.36 (s, 12H, pinacol CH3); 13C NMR (CDCl3, 
101 MHz) δ 143.9 (Ci), 137.7 (Ce), 136.1 (Ca), 131.1 (Cc), 126.9 (Cb), 124.6 (Cd), 114.7 (Cf), 




A flame dried Schlenk tube was charged with Rh2(esp)2 (2 mg, 0.003 mmol, 0.1 mol%), 
evacuated and purged with nitrogen before the addition of DCM (2 mL). DCM (0.8 mL) was 
added to a separate vial containing 143 (0.600 g, 2.61 mmol, 1.0 equiv) and this solution was 
added to the reaction flask. Additional DCM (2 × 0.2 mL) was used to wash residual 143 from 
the vial into the reaction mixture. Di-tert-butyl 2-diazomalonate (102) (0.821 g, 3.39 mmol, 
1.3 equiv) was added at 0 °C as a solution in DCM (2 mL). The reaction was stirred at 0 °C for 
10 minutes then at room temperature for 2 hours. After this time, water (30 mL) was added and 
the phases separated. The aqueous phase was extracted with DCM (3 × 30 mL) and the 
combined organic phases were washed with brine, dried (MgSO4) and concentrated under 
reduced pressure. The crude mixture was purified by flash column chromatography (100:0 → 
90:10 pentane/ethyl acetate) to yield 139 as a white solid (0.837 g, 72% yield). 
RF 0.37 (90:10 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2979, 2932, 1728, 1711, 
1600, 1479, 1444, 1368, 1349, 1332, 1317, 1289, 1258, 1220; HRMS (ESI): Calcd. for 
C25H37BO6Na




1H NMR (CDCl3, 400 MHz) δ 7.77 (dd, 
3JHH = 7.5, 
4JHH = 1.5, 1H, CdH), 7.31 (td, 
3JHH = 7.5, 
4JHH = 1.5, 1H, CbH), 7.19  (td, 
3JHH = 7.5, 
4JHH = 1.1, 1H, CcH), 7.04 (br. d, 
3JHH = 7.5, 1H, 
CaH), 3.78 (dd, 
3JHH = 8.3, 1H, CH(Ar)), 2.10 (dd, 
3JHH = 8.3, 
2JHH = 5.0, 1H, CH2C(CO2R)2), 
1.51 – 1.48 (m, 1H, CH2C(CO2R)2), 1.49 (s, 9H, OC(CH3)3), 1.33 (s, 12H, pinacol CH3), 1.00 
(s, 9H, OC(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 169.3 (RCO2C(CH3)3), 166.3 
(RCO2C(CH3)3), 140.8 (Cf), 135.8 (Cd), 130.7 (Cc), 126.7 (Ca), 126.4 (Cb), 83.7 (pinacol 
OC(R)(CH3)2), 81.2 (OC(CH3)3), 80.6 (OC(CH3)3), 39.7 (C(CO2R)2), 31.1 (CH(Ar)), 28.4 
(OC(CH3)3), 27.5 (OC(CH3)3), 25.1 (pinacol CH3), 24.8 (pinacol CH3), 17.9 (CH2C(CO2R)2); 
11B NMR (CDCl3, 128 MHz) δ 30.6.  
Di-tert-butyl -2-((1-butyl-3,3,4,4-tetramethyl-1,3,4,6-




A flame dried Schlenk flask was charged with 139 (89 mg, 0.20 mmol, 1.0 equiv), evacuated 
and purged with nitrogen before the addition of anhydrous THF (1 mL). The reaction flask was 
cooled to at −78 °C before the dropwise addition of n-butyllithium (0.12 mL, 1.8 M solution 
in hexane, 1.1 equiv.). The reaction was then stirred at −78 °C for 1 hour. MgBr2.Et2O (77 mg, 
0.30 mmol, 1.5 equiv) was added as a solid under a positive flow of nitrogen at −78 °C and the 
reaction stirred at this temperature for 10 minutes then warmed to room temperature for 30 
minutes. After this time, water (10 mL) and ethyl acetate (10 mL) were added and the phases 
separated. The aqueous phase was extracted with ethyl acetate (3 × 10 mL) and the combined 
organic phases were washed with brine, dried (MgSO4), filtered and concentrated under 
reduced pressure. A quantitative 1H NMR spectrum was recorded with dibromomethane as an 




80:20 pentane/ethyl acetate) to yield 145 (16 mg, 16% isolated yield) as a white solid and 146 
(21 mg, 25% isolated yield) as a white solid. 
 RF 0.45 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2976, 
2931, 1703, 1599, 1445, 1368, 1348, 1316, 1280, 1258, 1149; HRMS 
(ESI): Calcd. for C25H37BO5Na
+ ([M+Na]+) m/z 451.2631, found m/z 
451.2647. 
Major diastereomer: 1H NMR (400 MHz, CDCl3) δ 7.76 (dd, 
3JHH = 
7.5, 4JHH = 1.6, 1H, CdH), 7.31 (td, 
3JHH = 7.6,
 4JHH = 1.6, 1H, CbH), 7.19 (td, 
3JHH = 7.4, 
4JHH 
= 1.1, 1H, CcH), 6.91 (d, 
3JHH = 7.4, 1H, CaH), 3.74 (dd, 
3JHH = 8.6, 8.6, 1H, CgH), 2.70 (ddd, 
2JHH = 17.2, 
3JHH = 9.2, 5.7, 1H, CJH2), 2.31 (dd, 
3JHH = 8.3, 4.7, 1H, ChH2), 1.81 (ddd, 
2JHH = 
17.2, 3JHH = 9.3, 5.6, 1H, CjH2), 1.53 – 1.50 (m, 10H, OC(CH3)3, ChH2), 1.36 (s, 6H, pinacol 
CH3), 1.36 (s, 6H, pinacol CH3), 1.23 – 1.11 (m, 1H, CkH2), 0.96 – 0.84 (m, 2H, ClH2), 0.86 – 
0.76 (m, 1H, CkH2), 0.67 (t, 
3JHH = 7.2, 3H, CmH3); 13C NMR (101 MHz, CDCl3) δ 203.6 
(CiC(O)Cj), 169.7 (RCO2C(CH3)3), 140.0 (Cf), 136.1 (Cd), 131.0 (Cb), 126.7 (Ca), 126.5 (Cc), 
83.9 (pinacol OC(R)(CH3)2), 81.7 (OC(CH3)3), 46.0 (Ci), 42.4 (Cj), 33.7 (Cg), 28.4 (OC(CH3)3), 
25.5 (Ck), 25.1 (pinacol CH3), 24.8 (pinacol CH3), 22.2 (Cl), 17.4 (Ch), 13.9 (Cm); 11B NMR 
(CDCl3, 128 MHz) δ 30.4. 
 RF 0.27 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2977, 2937, 
1726, 1457, 1359, 1275, 1239, 1139; HRMS (ESI): Calcd. for 
C29H47BO6Na
+ ([M+Na]+) m/z 525.3363, found m/z 525.3366. 
1H NMR (400 MHz, CDCl3) δ 7.38 – 7.32 (m, 1H, CdH), 7.20 – 7.15 (m, 
2H, CbH, CcH), 7.05 – 7.00 (m, 1H, CaH), 5.31 (dd, 
3JHH = 10.1, 3.5, 1H, 
CgH), 3.41 (dd, 
3JHH = 10.7, 4.0, 1H, CiH), 2.35 (ddd, 
2JHH = 14.4, 
3JHH = 10.7, 3.5, 1H, ChH), 
2.11 (ddd, 2JHH = 14.4, 
3JHH = 10.1, 4.0, 1H, ChH), 1.51 (s, 9H, OC(CH3)3), 1.43 (br. s, 12H, 
OC(CH3)3, CkH3), 1.32 – 1.25 (m, 4H, CoH2, CpH2), 1.24 (s, 3H, CmH3), 1.22 (s, 3H, CkH3), 
0.83 (t, 3JHH = 7.0, 3H, CqH3), 0.77 – 0.67 (m, 5H, CmH3, CnH2); 13C NMR (101 MHz, CDCl3) 
δ 168.5 (RCO2C(CH3)3), 168.4 (RCO2C(CH3)3), 142.7 (Cf), 129.1 (Cd), 127.4 (Cc), 126.3 (Cb), 
121.1 (Ca), 91.5 (Cj), 82.2 (OC(CH3)3), 82.1 (OC(CH3)3), 80.8 (Cg), 79.6 (Cl), 50.9 (Ci), 37.4 
(Ch), 28.1 (OC(CH3)3), 28.0 (OC(CH3)3), 28.0 (Cp), 27.1 (Cm), 26.6 (Co), 25.8 (Cm), 25.3 (Cm), 




6.3. Synthetic procedures for chapter 3 
6.3.1.   One pot formation of azabicyclo[1.1.0]butane and lithiation/borylation 
with cyclohexyl pinacol boronic ester 
 
Phenyllithium (in Bu2O, 0.87 mmol, 3.6 equiv) was added dropwise (at a rate of 
0.02 mL/min) to a suspension of salt 33A (85 mg, 0.29 mmol, 1.2 equiv) in anhydrous THF 
(0.9 mL) at –78 °C (dry ice/acetone). After complete addition, the resulting solution was stirred 
for a further 2 hours at –78 °C. TMEDA (40 μL, 0.29 mmol, 1.2 equiv) and sec-butyllithium 
(in hexane, 0.29 mmol, 1.2 equiv) were then added dropwise, and the resulting solution stirred 
for 1 hour at –78 °C. Cyclohexyl pinacol boronic ester (50 mg, 0.24 mmol, 1.0 equiv) in 
anhydrous THF (0.5 mL) was then added dropwise and the mixture was stirred for 2 hours. 
Acetic acid (30 μL, 0.48 mmol, 2.0 equiv) was then added dropwise and the mixture is stirred 
for 1 hour at ‒78 °C (dry ice/acetone) then warmed to ambient temperature and stirred for a 
further 1 hour. Triethylamine (0.14 mL, 0.96 mmol, 4.0 equiv) and di-tert-butyl dicarbonate 
(0.1 mL, approx. 0.5 mmol, approx. 2.0 equiv) were finally added and the resulting mixture 
was stirred overnight. Et2O (15 mL) and HCl (1 m aqueous solution, 5 mL) were then added. 
The mixture was extracted with Et2O (3× 10 mL) and the combined organic phases were dried 
(MgSO4), filtered, and concentrated under reduced pressure. The crude residue was purified by 
flash column chromatography (90:10 pentane/ethyl acetate) to yield 174 (59 mg, 67% yield) as 
a white solid. 
Notes: (A) Salt 33 was synthesised according to a reported procedure.28  
RF = 0.25 (90:10 pentane/ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 3.91 (d, 
2JHH = 7.8, 
2H, 2 × CaH), 3.63 (br. d, 
2JHH = 7.8, 2H, 2 × CaH), 1.74 – 1.62 (m, 6H, 3 × CH2), 1.50 – 1.41 
(m, 1H, CH), 1.41 (s, 9H, OC(CH3)3), 1.24 (s, 12H, pinacol CH3), 1.21 – 1.08 (m, 2H, CH2), 
1.02 – 0.96 (m, 2H, CH2); 13C NMR (101 MHz, CDCl3) δ 156.6 (C=O), 83.8 (pinacol 
OC(R)(CH3)2), 79.1 (OC(CH3)3), 45.4 (CH), 29.1 (CH2), 28.6 (OC(CH3)3), 26.7 (2 × CH2), 
24.9 (pinacol CH3), signals for N(CH2)2 were not observed. All characterisation data is 








(+)-Sparteine surrogate (250 mg, 1.28 mmol, 1.7 equiv)A was added to a flame dried Schlenk 
flask and dissolved in anhydrous diethyl ether (2.7 mL). The flask was cooled to –78 °C before 
the dropwise addition of sec-butyllithium (in hexane, 1.28 mmol, 1.7 equiv) and, after complete 
addition, the reaction was stirred at –78 °C for 15 minutes. After this time, a solution of 
tert-butyl piperidine-1-carboxylate (139 mg, 0.75 mmol, 1.0 equiv) in diethyl ether (0.54 mL) 
was added dropwise and the reaction maintained at –78 °C for a further 6 hours. Then, 
2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (349 mg, 1.88 mmol, 2.5 equiv) B was 
added dropwise. The reaction mixture was warmed slowly to room temperature and stirred for 
16 hours. The reaction was then diluted with diethyl ether (10 mL) and 1M aqueous HCl (20 
mL) was added. The layers were separated, and the aqueous phase was extracted with diethyl 
ether (3 × 15 mL). The combined organic layers were washed with brine (20 mL), dried 
(MgSO4), filtered and concentrated under reduced pressure. The crude residue was purified by 
flash column column chromatography (85:15 pentane/ethyl acetate) to yield 178 (268 mg, 89% 
yield) as a white solid. 
Notes: (A) (+)-Sparteine Surrogate was prepared following a literature procedure165 and 
purified by Kugelrohr distillation immediately before use and handled under an inert 
atmosphere of nitrogen. (B) isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane was distilled 
prior to use, collecting the second fraction. 
RF 0.18 (80:20 pentane/ethyl acetate); [𝜶]𝐃
𝟐𝟒: +3.0 (88:12 er) (c = 8.2, CHCl3); 1H NMR: (400 
MHz, CDCl3) δ 3.68 (br. d, 
2JHH = 12.4, 1H, N(Boc)CH2), 2.67 (td, 
2JHH = 12.4, 3.2, 1H, 
N(Boc)CH2), 2.28 (dd, 
3JHH = 12.3, 3.2, 1H, N(Boc)CH(Bpin)), 1.77 (m, 1H, CH2), 1.54-1.61 
(m, 2H, CH2, CH2), 1.45 (s, 9H, OC(CH3)3), 1.43 – 1.17 (m, 3H, CH2, CH2, CH2), 1.13 (s, 12H, 
OC(CH3)2); 13C NMR (101 MHz, CDCl3) δ 159.7 (NC(O)OC(CH3)3), 85.7 (OC(CH3)3), 79.9 




25.2 (OC(CH3)2), 24.9 (CH2), 24.5 (CH2). NMR spectra consistent with that reported for the 
racemic synthesis.114 




Phenyllithium (in Bu2O, 0.87 mmol, 3.6 equiv) was added dropwise (at a rate of 0.02 mL/min) 
to a suspension of salt 33 (85 mg, 0.29 mmol, 1.2 equiv) in anhydrous THF (0.9 mL) at –78 °C 
(dry ice/acetone). After complete addition, the resulting solution was stirred for a further 
2 hours at –78 °C. TMEDA (40 μL, 0.29 mmol, 1.2 equiv) and sec-butyllithium (in hexane, 
0.29 mmol, 1.2 equiv) were then added dropwise, and the resulting solution stirred for 1 hour 
at –78 °C. Boronic ester 178 (75 mg, 0.23 mmol, 1.0 equiv) dissolved in anhydrous THF (0.5 
mL) was then added dropwise and the mixture was stirred for 2 h. Acetic acid (30 μL, 0.48 
mmol, 2.0 equiv) was then added dropwise and the mixture stirred for 1 h at ‒78 °C (dry 
ice/acetone) then warmed to ambient temperature and stirred for a further 1 hour. 
Diisopropylethylamine (0.17 mL, 0.96 mmol, 4.0 equiv) and acid fluoride 184A (111 mg, 0.28 
mmol, 1.2 equiv) were finally added and the resulting mixture was stirred overnight. Et2O (15 
mL) and HCl (1 m aqueous solution, 5 mL) were then added. The mixture was extracted with 
Et2O (3× 10 mL) and the combined organic phases were dried (MgSO4), filtered, and 
concentrated under reduced pressure. The crude residue was purified by flash column 
chromatography (90:10 → 60:40 pentane/ethyl acetate) to yield 196 (109 mg, 62% yield) as a 
colourless oil. 
Notes: (A) Acid fluoride 184 was prepared following a literature procedure.46 
RF 0.39 (60:40 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2975, 2935, 2868, 1634, 1601, 1501, 
1444, 1142 and 1045; HRMS (ESI): Calcd. for C32H40BF3IN3NaO5
+ ([M+Na]+) m/z 764.1950, 
found m/z 764.1922; [𝜶]𝐃




NMR spectra showed the presence of two rotamers with some peaks resolved and appearing 
in a 1.85:1 ratio (major/minor) 
1H NMR (400 MHz, CDCl3) δ 8.60 (br. s, 1H, NH (major)), 8.45 (br. s, NH (minor)), 7.37 (dd, 
3JHF = 10.3, 
4JHH = 1.5, 1H, CxH), 7.31 (br. d, 
3JHH = 8.5, 1H, CwH), 7.17 (br. t, J = 6.2, 1H, 
CyH (major)), 7.11 (br. t, J = 6.4, CxH (minor)), 6.78 (m, 1H, CzH), 6.59 (m, 1H, CvH), 4.36 
(d, 2JHH = 8.2, 1H, CaH) (major)), 4.20 (d, 
2JHH = 9.8, 1H, CaH (minor)), 4.16 (d, 
2JHH = 9.1, 
1H, CaH (minor)), 4.08 (d, 
2JHH = 10.2, 1H, CaH (major)), 3.84 (br. m, 2H, CaH, N(Boc)CH2), 
3.70 (d, 2JHH = 10.2, 1H, CaH), 3.40 (br. s, 1H, N(Boc)CH), 2.91 (br. s, 1H, N(Boc)CH2), 1.52-
1.86 (br. m, 4H, 2 × CH2), 1.47 – 1.38 (br. m, 2H, CH2), 1.42 (s, 9H, OC(CH3)3), 1.17 (s, 
OC(CH3)2 (minor)), 1.15 (s, 12H, OC(CH3)2 (major)); 13C NMR (126 MHz, CDCl3) δ 168.8 
(NC(O)Ar, (major)), 168.8 (NC(O)Ar, (minor)), 155.9 ((NC(O)OC(CH3)3), (minor)), 155.8 
((NC(O)OC(CH3)3), (major)), 153.1 (d, 
1JCF = 249.5, CF), 152.4 (dd, 
1JCF = 251.9, 11.6, CF), 
143.5 (dd, 1JCF = 251.1, J = 14.3, CF), 132.8 (d, 
4JCF = 2.5, Cw), 132.2 (br. d, J = 7.3, ArC 
(major)), 132.0 (br. d, J = 7.4, ArC (minor)), 131.1 (d, J = 10.6, ArC), 124.4 (br. m, Cy), 124.1 
(d, J = 21.4, Cx), 120.4 (ArC, (minor)), 120.0 (ArC, (major)), 119.5 (Cv), 109.1 (m, Cz), 81.8 
(br., OC(CH3)2), 81.1 (m, CI), 66.1 (br), 61.0 (Ca (major)), 58.2 (br.), 54.9 (Ca (minor)), 54.0 
(Ca), 47.4 (br.), 28.4 (OC(CH3)3), 28.1 (br.), 26.7 (CH2), 26.2 (CH2), 25.4 (OC(CH3)2 (minor)), 
25.2 (OC(CH3)2 (major)), 24.1 (br., CH2); 19F NMR (377 MHz, CDCl3) δ –127.0 (t, J = 
9.4, CF, (minor)), –127.1 (t, J = 9.4, CF, (major)), –132.4 (br. s, CF), –141.6 (br., CF, (minor)), 




Boronic ester 196 (90 mg, 0.12 mmol, 1.0 equiv) was dissolved in THF (1.3 mL) and cooled 
to 0 °C (ice/water). A solution of 2 M NaOH/30% H2O2(aq) (1.5 mL, 2:1 v/v) was then added 
dropwise to the vigorously stirring reaction mixture, which was subsequently warmed to room 




and the reaction mixture was extracted with ethyl acetate (3 × 5 mL). The combined organic 
fractions were dried (MgSO4), filtered, and concentrated under reduced pressure. The crude 
residue was purified by flash column chromatography (90:10 → 50:50 pentane/ethyl actate) to 
yield alcohol 196’ (68 mg, 89 % yield) as a white foam that solidified under high vacuum. 
NMR spectra showed the presence of two rotamers with some peaks resolved and appearing 
in a 1.22:1 ratio (major/minor) 
RF 0.29 (60:40 pentane/ethyl acetate); IR (thin film) νmax: 3315, 2975, 2936, 2871, 1667, 1636, 
1602, 1504, 1453, 1159 and 1051 cm-1; HRMS (ESI): Calcd for C26H29N3O4F3INa
+ ([M+Na]+) 
m/z 654.1044, found m/z 654.1047; [𝜶]𝐃
𝟐𝟒: too low to be measurable (88:12 er) (c = 4.8, 
CHCl3); 
1H NMR (400 MHz, CDCl3) δ 8.53 (br. s, 1H, NH (major)), 8.41 (br. s, NH (minor)), 7.38 (dd, 
3JHF = 10.3, 
4JHH = 2.0, 1H, CxH), 7.31 (br. d, 
3JHH = 8.5, 1H, CwH), 7.17 (br., 1H, CyH), 6.80 
(br. app. q, J = 8.5, 1H, CzH), 6.59 (app. td, J = 8.6, 5.4, 1H, CvH), 5.60 (br. s, 1H, OH), 4.19 
(d, 2JHH = 10.3, 2H, 2 × CaH (major)), 4.11 (m, 1H, CaH (minor)), 4.00 (br. m, 2H, 2 × CaH), 
3.86 (br. d, 2JHH = 12.6, 1H, N(Boc)CH2), 3.38 (br. s, 1H, N(Boc)CH (major)), 3.29 (br. s, 1H, 
N(Boc)CH (minor)), 2.90 (br. s, 1H, N(Boc) CH2), 1.88 (br. s, 1H, CH2), 1.38 – 1.63 (br. m, 
5H, 3 × CH2), 1.42 (s, 9H, OC(CH3)3); 13C NMR (126 MHz, CDCl3) δ 169.2 (NC(O)Ar), 156.0 
((NC(O)OC(CH3)3), (major)), 155.8 ((NC(O)OC(CH3)3), (minor)), 153.3 (d, 
1JCF = 250.1, CF), 
152.8 (dd, 1JCF = 253.2, J = 11.5, CF), 143.7 (dd, 
1JCF = 250.1, J = 13.6, CF), 133.0 (d, J = 2.9, 
Cw), 132.6 (br., ArC (major)), 132.3 (br., ArC (minor)), 130.9 (d, J = 10.2, ArC), 124.3 (d, J = 
21.4, Cx), 124.3 (br., Cy), 119.9 (br., Cv), 119.7 (ArC, (major)), 119.6 (ArC, (minor)), 109.3 (m, 
Cz), 81.7 (d, J = 7.2, CI), 71.2 (br. COH), 81.0 (OC(CH3)2), 65.0 (Ca), 64.8 (br., N(Boc)CH), 
60.6 (Ca (major)), 60.3 (Ca (minor)), 48.2 (br., N(Boc)CH2), 28.4 (OC(CH3)3), 25.4 (CH2), 25.1 
(CH2 (minor)), 24.9 (CH2 (major)), 24.1 (br., CH2); 19F NMR (377 MHz, CDCl3) δ –127.0 (t, 
J = 9.4, CF, (major)), –127.1 (t, J = 9.4, CF, (minor)), –131.4 (m, CF), –141.4 (br. d, J = 19.1, 
CF); 
Enantiomeric ratio of 88:12 was determined using chiral HPLC analysis (Chiralpak IB with 





   
    
(S)-(3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2- 
yl)azetidin-1-yl)methanone (cobimetinib) (164) 
 
Compound 196’ (60 mg, 0.095 mmol, 1.0 equiv) was dissolved in anhydrous DCM (2.8 mL) 
and cooled to 0 °C (ice/water). Triethylsilane (90 µL, 0.56 mmol, 5.9 equiv) was added 
followed by the dropwise addition of trifluoroacetic acid (0.6 mL). The reaction was stirred at 
0 °C for 3 hours. After this time, toluene (10 mL) was added and the volatiles removed under 
reduced pressure. Then, DCM (5 mL) and water (5 mL) were added and, with stirring, a 
solution of NaOH (2 m aqueous solution, 0.2 mL). The layers were separated, and the aqueous 
layer extracted with DCM (3 × 5 mL). The combined organic layers were washed with brine 
(5 mL), dried (MgSO4), filtered and concentrated under reduced pressure to give cobimetinib 
164 (free base) (50 mg, 94% yield). 
M.p. 161.1−161.6 °C (recrystallised by dissolving in 1:1 Et2O/hexane and letting the solvent 
evaporate slowly). Lit. 171−172 °C 23 (no recrystallization solvent given); IR (film) νmax/cm
-1: 
3297, 3075, 2933, 2855, 1634, 1601, 1503, 1451, 1292, 1123 and 1052; [𝜶]𝐃
𝟐𝟒: too low to be 
measurable (88:12 er) (c = 3.4, CHCl3); 
NMR spectra showed the presence of two rotamers with some peaks resolved and appearing 





1H NMR (500 MHz, CDCl3) δ 8.36 (br., 1H, aniline NH), 7.39 (dd, 
3JHF = 10.3, 
4JHH = 1.9, 
1H, CxH), 7.32 (dt, 
3JHH = 8.5, 
4JHH = 1.4, 1H, CwH), 7.11 (m, 1H, CyH), 6.81 (br. app. q, J = 
7.7, 1H, CzH), 6.59 (app. td, J = 8.6, 5.3, 1H, CvH), 4.13 (br., 3H, 3 × CaH), 4.01 (br., 1H, CaH), 
3.13 (br. d, 2JHH = 11.5, 1H, N(Boc)CH2), 2.73 (br. s, 1H, N(Boc)CH), 2.65 (br. s, 1H, 
N(Boc)CH2), 2.53 (br. s, 1H, OH), 1.78 (br. s, 1H, CH2), 1.61 (br. m, 2H, 2 × CH2), 1.39 – 1.16 
(m, 4H, 3 × CH2, piperidine NH); 13C NMR (101 MHz, CDCl3) δ 169.3 (NC(O)Ar), 153.2 (d, 
1JHF = 251.0, CF), 152.8 (dd, 
1JHF = 252.4, 
2JHF = 11.9, CF), 143.6 (dd, 
1JHF = 251.2, 13.4, CF), 
133.1 (d, J = 3.1, Cw), 132.5 (br., ArC), 130.9 (d, J = 10.7, ArC), 124.5 – 124.2 (m, Cx, Cy), 
119.8 (br., Cv), 109.5 (m, Cz), 81.8 (d, J = 6.5, CI), 71.7 (COH), 65.1 (Ca (major)), 62.5 (Ca 
(major)), 61.4 (N(Boc)CH), 60.3 (Ca (minor)), 58.0 (Ca (minor)), 46.6 (N(Boc)CH2), 25.8 (br. 
CH2), 25.0 (CH2), 23.9 (CH2); 19F NMR (377 MHz, CDCl3) δ –127.1 (m, CF), –131.0 (m, CF), 
–141.2 (br. s, CF). 
13C NMR spectrum consistent with that reported in the literature. The 1H NMR data differs 
slightly due to being taken in a different solvent.46 
6.4. Synthetic procedures for chapter 4 
6.4.1. General procedure E for the synthesis of azabicyclo[1.1.0]butyl alcohols 
 
In a 100 mL Schlenk flask, Phenyllithium (in Bu2O, 6.0 mmol, 3.0 equiv) was added dropwise 
(at a rate of 0.11 mL/min) to a suspension of salt 33A (590 mg, 2.0 mmol, 1.0 equiv) in 
anhydrous THF (6.4 mL) at –78 °C (dry ice/acetone). After complete addition, the resulting 
solution was stirred for a further 2 hours at –78 °C. After this time, the reaction mixture was 
removed from the cooling bath and warmed to room temperature over 10 minutes with stirring 
(the reaction mixture should be homogeneous once at room temperature). After cooling back 
down to –78 °C, TMEDA (0.36 mL, 2.4 mmol, 1.2 equiv) was then added followed by sec-
butyllithium (in cyclohexane, 2.4 mmol, 1.2 equiv) dropwise (at a rate of 0.11 mL/min), and 
the resulting solution stirred for 1 hour at –78 °C. After this time, the ketone/aldehyde 
(0.26 mmol, 1.3 equiv) was added dropwise, either neat or as a solution in anhydrous THF. 




and water (20 mL) were then added, and the reaction mixture transferred to a separating funnel. 
The phases were separated, and the aqueous phase was extracted with diethyl ether or ethyl 
acetate (3 × 30 mL) and the combined organic phases were washed with brine, dried (MgSO4), 
filtered and concentrated under reduced pressure.  
The crude NMR yield of the product was then determined by quantitative 1H NMR. The crude 
mixture was dissolved in deuterated chloroform and dibromomethane (42 μL, 0.60 mmol, 
0.3 equiv) was added as an internal standard. After the yield was determined by 1H NMR, the 
crude product was transferred to a volumetric flask, the concentration calculated and the 
volume corresponding to 0.25 mmol was removed by syringe and transferred to a round bottom 
flask and evacuated for any further reaction. The crude azabicyclo[1.1.0]butyl carbinols (197) 
can be stored for extended periods (weeks) in a freezer under inert atmosphere without 
degradation.   
Notes: (A) Salt 33 was synthesised according to a reported procedure.28 
6.4.2. Synthesis of azabicyclo[1.1.0]butyl carbinols 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol, 197a 
Prepared using general procedure E on a 4.0 mmol scale. Acetophenone (0.60 mL, 
5.2 mmol, 1.3 equiv) was added neat to the reaction. 1H NMR yield: 80%. 
HRMS (ESI): Calcd. for C11H13NONa













Crude 1H NMR (CDCl3, 400 MHz) of 197a  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-(4-methoxyphenyl)ethan-1-ol, 197b 
Prepared using general procedure E. 4′-Methoxyacetophenone (0.390 g, 
2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated and 
backfilled with nitrogen. Anhydrous THF (1.5 mL) was added and this solution 
was added dropwise to the reaction. 1H NMR yield: 70%. 
HRMS (ESI): Calcd. for C12H15NO2Na
+ ([M+Na]+) m/z 228.0995, found m/z 228.1006. 









Prepared using general procedure E. 4′-(Trifluoromethyl)acetophenone 
(0.490 g, 2.6 mmol, 1.3 equiv) was weighed into a vial, which was evacuated 
and backfilled with nitrogen. Anhydrous THF (1.5 mL) was added, and this 
solution was added dropwise to the reaction. 1H NMR yield: 70%.  
HRMS (ESI): Calcd. for C12H13F3NO
+ ([M+Na]+) m/z 244.0944, found m/z 244.0944. 




Prepared using general procedure E. tert-Butyl 3-acetyl-1H-indole-1-
carboxylateA (674 mg, 2.6 mmol, 1.3 equiv) was weighed into a vial which 
was evacuated and backfilled with nitrogen. Anhydrous THF (5 mL) was 
added and this solution was added dropwise to the reaction mixture over 
3 minutes. 1H NMR yield: 69%. 
HRMS (ESI): Calcd. for C18H22N2O3Na





Crude 1H NMR (CDCl3, 400 MHz) of 197d  
  
Notes: (A) Prepared according to a literature procedure.166 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-(6-methoxypyridin-3-yl)ethan-1-ol, 197e 
Prepared using general procedure E. 1-(6-methoxypyridin-3-yl)ethan-1-one 
(393 mg, 2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated 
and backfilled with nitrogen. Anhydrous THF (1.5 mL) was added and this 
solution was added dropwise to the reaction mixture. 1H NMR yield: 66%. 
HRMS (ESI): Calcd. for C11H15N2O2
+ ([M+H]+) m/z 207.1128, found m/z 207.1132. 








Prepared using general procedure E. 1-(6-Bromopyridin-3-yl)ethan-1-one 
(520 mg, 2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated 
and backfilled with nitrogen. Anhydrous THF (5 mL) was added and this 
solution was added dropwise to the reaction mixture over 3 minutes. 1H NMR 
yield: 59%. 
HRMS (ESI): Calcd. for C10H11BrN2ONa
+ ([M+Na]+) m/z 276.9947, found m/z 276.9954. 
Crude 1H NMR (CDCl3, 400 MHz) of 197f 
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-(2-chloropyridin-4-yl)ethan-1-ol, 197g 
Prepared using general procedure E. 1-(2-Chloropyridin-4-yl)ethan-1-one 
(405 mg, 2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated 
and backfilled with nitrogen. Anhydrous THF (1.5 mL) was added and this 
solution was added dropwise to the reaction mixture over 3 minutes. 1H NMR yield: 62%.  
HRMS (ESI): Calcd. for C10H12ClN2O






Crude 1H NMR (CDCl3, 400 MHz) of 197g  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)cyclobutan-1-ol, 197h 
 Prepared using general procedure E. Cyclobutanone (0.19 mL, 2.6 mmol, 
1.3 equiv) was added neat to the reaction dropwise over 10 minutes. 1H NMR 
yield: 55%. 
HRMS (ESI): Calcd. for C7H12NO
+ ([M+H]+) m/z 126.0913, found m/z 126.0918. 









Prepared using general procedure E on a 1.0 mmol scale. Cyclopentanone 
(0.11 mL, 1.3 mmol, 1.3 equiv) was added neat to the reaction. 1H NMR yield: 
61%. 
HRMS (APCI): Calcd. for C8H13NO
+ ([M+Na]+) m/z 140.1070, found m/z 140.1071. 
Crude 1H NMR (CDCl3, 400 MHz) of 197i  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)cyclohexan-1-ol, 197j 
Prepared using general procedure E on a 4.0 mmol scale. Cyclohexanone 
(0.62 mL, 5.2 mmol, 1.3 equiv) was added neat to the reaction. 1H NMR yield: 
88%.  
HRMS (ESI): Calcd. for C9H15NONa






Crude 1H NMR (CDCl3, 400 MHz) of 197j 
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)cycloheptan-1-ol, 197k 
Prepared using general procedure E. Cycloheptanone (0.31 mL, 2.6 mmol, 
1.3 equiv) was added neat to the reaction. 1H NMR yield: 75%.  
HRMS (APCI): Calcd. for C10H17NO
+ ([M+H]+) m/z 168.1383, found 
m/z 168.1385. 
Crude 1H NMR (CDCl3, 400 MHz) of 197k  
 
tert-Butyl 3-(1-azabicyclo[1.1.0]butan-3-yl)-3-hydroxyazetidine-1-carboxylate, 197l 
Prepared using general procedure E on a 4 mmol scale. tert-Butyl 
3-oxoazetidine-1-carboxylate (0.890 g, 5.2 mmol, 1.3 equiv) was weighed into 








(3.0 mL) was added and this solution was added dropwise to the reaction mixture slowly over 
10 minutes. 1H NMR yield: 51%.  
 HRMS (ESI): Calcd. for C11H18N2O3Na
+ ([M+Na]+) m/z 249.1210, found m/z 249.1200. 
Crude 1H NMR (CDCl3, 400 MHz) of 197l  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-cyclohexylethan-1-ol, 197m 
Prepared using general procedure E. 1-Cyclohexylethan-1-one (0.36 mL, 
2.6 mmol, 1.3 equiv) was added neat to the reaction. 1H NMR yield: 71%.  
HRMS (ESI): Calcd. for C11H19NONa
+ ([M+Na]+) m/z 204.1359, found m/z 
204.1353. 








Prepared using general procedure E. Benzaldehyde (0.26 mL, 2.6 mmol, 
1.3 equiv) was added neat to the reaction. 1H NMR yield: 71%.  
HRMS (ESI): Calcd. for C10H11NONa
+ ([M+Na]+) m/z 184.0733, found m/z 184.0736. 
Crude 1H NMR (CDCl3, 400 MHz) of 197n  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-1-phenylpropan-1-ol, 197o 
 Prepared using general procedure E. Propiophenone (0.30 mL, 2.6 mmol, 
1.3 equiv) was added neat to the reaction. 1H NMR yield: 78%.  
HRMS (APCI): Calcd. for C12H15NO
+ ([M+H]+) m/z 190.1226, found m/z 190.1227. 









Prepared using general procedure E. 1,3-Diphenylprop-2-yn-1-one 
(536 mg, 2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated 
and backfilled with nitrogen. Anhydrous THF (1.5 mL) was added and this solution was added 
dropwise to the reaction mixture. 1H NMR yield: 79%.  
HRMS (ESI): Calcd. for C18H15NONa
+ ([M+Na]+) m/z 284.1046, found m/z 284.1043. 
Crude 1H NMR (CDCl3, 400 MHz) of 197p  
 
(1-Azabicyclo[1.1.0]butan-3-yl)(cyclohexyl)(phenyl)methanol, 197q 
Prepared using general procedure E. Cyclohexyl(phenyl)methanone (308 mg, 2.6 
mmol, 1.3 equiv) was weighed into a vial which was evacuated and backfilled 
with nitrogen. Anhydrous THF (1.5 mL) was added and this solution was added 
dropwise to the reaction mixture. 1H NMR yield: 40%. 
HRMS (APCI): Calcd. for C16H21NO





Crude 1H NMR (CDCl3, 400 MHz) of 197q  
 
1-(1-Azabicyclo[1.1.0]butan-3-yl)-2,2,2-trifluoro-1-phenylethan-1-ol, 197r 
Prepared using general procedure E. 2,2,2-Trifluoro-1-phenylethan-1-one 
(0.37 mL, 2.6 mmol, 1.3 equiv) was added neat to the reaction. The crude 
reaction mixture was purified by flash column chromatography 
(90:10 pentane/ethyl acetate) to give 197r (231 mg, 50% yield) as a white solid.  
RF 0.46 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 3161, 1453, 1390, 1282, 
1247, 1151; HRMS (ESI): Calcd. for C11H10F3NONa
+ ([M+Na]+) m/z 252.0607, found 
m/z 252.0612; 
1H NMR (CDCl3, 400 MHz) δ 7.80 – 7.63 (m, 2H, 2 × CfH), 7.47 – 7.35 (m, 3H, CgH, 2 × CfH), 
4.66 (s, 1H, OH), 2.91 (ddd, 2JHH = 6.7, 
4JHH = 2.4, 1.2, 1H, CaH), 2.32 (dd, 
4JHH = 6.7, 2.5, 
1H, CaH), 1.70 (d, 
4JHH = 2.4, 1H, CaH), 1.37 (d, 
4JHH = 2.5, 1H, CaH); 13C NMR (CDCl3, 
101 MHz) δ 136.1 (Cd), 129.1 (Cg), 128.3 (Ce), 127.3 (Cf), 124.8 (d, 
1JCF = 286.7, CF3), 74.4 
(q, 2JCF = 28.9, Cc), 56.4 (Ca), 52.8 (Ca), 34.4 (Cb); 19F NMR (CDCl3, 377 MHz) δ –77.43.  
Azabicyclo[1.1.0]butan-3-yl)diphenylmethanol, 197s 
Prepared using general procedure E. Benzophenone (0.474 g, 2.6 mmol, 
1.3 equiv) was weighed into a vial which was evacuated and backfilled with 
nitrogen. Anhydrous THF (1.0 mL) was added, and this solution was added dropwise to the 
reaction and a further portion of anhydrous THF (0.5 mL) was used to wash the residual reagent 
from the vial into the reaction mixture. 1H NMR yield: 73%.  
HRMS (ESI): Calcd. for C16H15NONa






Crude 1H NMR (CDCl3, 400 MHz) of 197s  
 
(1-Azabicyclo[1.1.0]butan-3-yl)(4-methoxyphenyl)(phenyl)methanol, 197t 
 Prepared using general procedure E. 4-Methoxybenzophenone (0.552 g, 
2.6 mmol, 1.3 equiv) was weighed into a vial which was evacuated and 
backfilled with nitrogen. Anhydrous THF (1.0 mL) was added and this solution 
was added dropwise to the reaction and a further portion of anhydrous THF 
(0.5 mL) was used to wash the residual reagent from the vial into the reaction mixture. 1H NMR 
yield: 70%.  
HRMS (ESI): Calcd. for C17H17NO2Na
+ ([M+Na]+) m/z 290.1151, found m/z 290.1153. 








6.4.3. Initial reaction investigations 
Benzyl 3-chloro-3-(1-hydroxy-1-phenylethyl)azetidine-1-carboxylate, 240 
 
To a round bottom flask containing the 1-(1-azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol 
(197a, 0.25 mmol, 1.0 equiv) under an inert atmosphere was added anhydrous DCM (2.5 mL). 
The flask was cooled to –78 °C and benzyl chloroformate (40 μL, 0.30 mmol, 1.2 equiv) was 
added with stirring. After 1 hour at –78 °C, diethyl ether (10 mL) and saturated aqueous sodium 
bicarbonate solution (10 mL) were added and the reaction mixture transferred to a separating 
funnel. The phases were separated, and the aqueous phase was extracted with diethyl ether 
(3 × 20 mL) and the combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography (95:5 → 80:20 pentane/acetone) to give 240 (64 mg, 74% yield) as a 
colourless oil. 
Reaction repeated on a 0.1 mmol scale in anhydrous acetonitrile and 0 °C for 15 minutes. An 
NMR yield of 83% was achieved.  
RF 0.32 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 3400, 2948, 1694, 1446, 1424, 1356, 
1213, 1130, 1058, 1033; HRMS (ESI): Calcd. for C19H20ClNO3Na
+ ([M+Na]+) m/z 368.1024, 
found m/z 368.1021; 
1H NMR (CDCl3, 400 MHz) δ 7.57 – 7.49 (m, 2H, ArCH), 7.39 – 7.28 (m, 8H, ArCH), 5.05 
(s, 2H, ROCH2Ph), 4.69 (dd, 
2JHH = 9.8, 
4JHH = 1.2, 2H, 2 × CaH), 4.19 (d, 
2JHH = 9.6, 1H, 
CaH), 3.94 (dd, 
2JHH = 9.8, 
4JHH = 1.2, 1H, CaH), 2.79 (br. s, 1H, OH), 1.71 (s, 3H, CH3); 13C 
NMR (CDCl3, 101 MHz) δ 156.4 (R2NC(O)OR), 142.2 (ArC), 136.4 (ArC), 128.6, 128.3 
(ArCH), 128.2 (ArCH), 128.1 (ArCH), 128.1 (ArCH), 126.6 (ArCH), 75.8 (Cc), 69.1 (Cb), 67.1 
(ROCH2Ph), 61.6 – 60.2 (br., 2 × Ca), 24.5 (CH3).   





To a round bottom flask containing the 1-(1-azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol 
(197a, 0.25 mmol, 1.0 equiv) and sodium iodide (75 mg, 2.0 equiv) under an inert atmosphere 
was added anhydrous acetonitrile (2.5 mL). The flask was cooled to 0 °C and benzyl 
chloroformate (40 μL, 0.30 mmol, 1.2 equiv) was added with stirring. After 15 minutes at 0 °C, 
diethyl ether (10 mL) and saturated aqueous sodium bicarbonate solution (5 mL) were added 
and the reaction mixture transferred to a separating funnel. The phases were separated, and the 
aqueous phase was extracted with diethyl ether (3 × 20 mL) and the combined organic phases 
were washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude reaction mixture was purified by flash column chromatography (95:5 → 
85:15 pentane/acetone) to give 242a (100 mg, 91% yield) as a colourless oil. 
RF 0.33 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 3433, 2969, 1693, 1446, 1422, 1356, 
1194, 1129, 1059, 1033; HRMS (ESI): Calcd. for C19H20INO3Na
+ ([M+Na]+) m/z 460.0380, 
found m/z 460.0382; 
1H NMR (CDCl3, 400 MHz) δ 7.49 – 7.43 (m, 2H, ArCH), 7.36 – 7.25 (m, 8H, ArCH), 5.02 
(s, 2H, ROCH2Ph), 4.97 (d, 
2JHH = 10.3, 1H, CaH), 4.89 (d, 
2JHH = 9.9, 1H, CaH), 4.48 (d, 
2JHH = 9.9, 1H, CaH), 4.31 (dd, 
2JHH = 10.3, 1.3, 1H, CaH), 2.65 (br. s, 1H, OH), 1.77 (s, 3H, 
CH3); 13C NMR (CDCl3, 101 MHz) δ (R2NC(O)OR), 143.6 (br. ArC), 136.4 (ArC), 128.7 
(ArCH), 128.3 (ArCH), 128.3 (ArCH), 128.1 (ArCH), 126.6 (ArCH), 76.7 (Cc), 67.2 
(ROCH2Ph), 65.0 (br., 2 × Ca), 45.3 (Cb), 26.0 (CH3).   
2,2,2-Trifluoro-1-(3-(1-hydroxy-1-phenylethyl)-3-iodoazetidin-1-yl)ethan-1-one, 243 
 
To a round bottom flask containing the 1-(1-azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol 
(197a, 0.25 mmol, 1.0 equiv) and sodium iodide (75 mg, 2.0 equiv) under an inert atmosphere 
was added anhydrous acetonitrile (2.5 mL). The flask was cooled to 0 °C and trifluoroacetic 
anhydride (40 μL, 0.30 mmol, 1.2 equiv) was added with stirring. After 15 minutes at 0 °C, 
diethyl ether (10 mL) and saturated aqueous sodium bicarbonate solution (5 mL) were added 
and the reaction mixture transferred to a separating funnel. The phases were separated, and the 




were washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The 
crude reaction mixture was purified by flash column chromatography (50:50 DCM/pentane → 
DCM → 98:2 DCM/ethyl acetate). These column conditions were repeated on the mixed 
fractions. Mixed fractions were observed again and discarded. The combined clean fractions 
gave 243 (27 mg, 27% yield) as a colourless oil. 
RF 0.39 (95:5 DCM/ethyl acetate); IR (film) νmax/cm
-1: 3432, 2970, 2922, 2852, 1684, 1455, 
1253, 1206, 1148; HRMS (ESI): Calcd. for C13H13F3INO2Na
+ ([M+Na]+) m/z 421.9835, found 
m/z 421.9832; 
Rotamers observed. 
1H NMR (CDCl3, 400 MHz) δ 7.52 (ddd, 
3JHH = 7.8, 6.3, 
4JHH = 1.5, 2H, 2 × CfH), 7.43 – 7.30 
(m, 3H, ArCH), 5.35 (d, 2JHH = 11.0, 1H, CaH), 5.24 (d, 
2JHH = 10.7, 1H, CaH), 5.08 (d, 
2JHH = 11.7, 1H, CaH), 5.01 (d, 
2JHH = 11.7, 1H, CaH), 4.79 (dt, 
2JHH = 10.7, 
4JHH = 1.5, 1H, 
CaH), 4.57 (d, 
2JHH = 10.7, 2H, 2 × CaH), 4.35 (dd, 
2JHH = 11.9, 
4JHH = 1.8, 1H, CaH), 2.39 (br. 
s, 1H, OH), 2.37 (br. s, 1H, OH), 1.85 (s, 3H, CH3), 1.84 (s, 3H, CH3); 13C NMR (CDCl3, 101 
MHz) δ 156.4 (q, 2JCF = 37.9, CF3C(O)NR2), 156.3 (q, 
2JCF = 37.9, CF3C(O)NR2), 142.6 (Cd), 
141.8 (Cd), 128.6 (Cg), 128.5 (Cg), 128.4 (2 × Ce), 128.4 (2 × Ce), 126.7 (2 × Cf), 126.6 (2 × 
Cf), 116.0 (q, 
1JCF = 288.1, CF3), 116.0 (q, 
1JCF = 288.1, CF3), 76.4 (Cc), 76.4 (Cc), 67.3 (q, 
3JCF 
= 2.38, Ca), 66.4 (q, 
3JCF = 2.38, Ca), 64.6 (Ca), 63.7 (Ca), 42.4 (Cb), 26.9 (CH3), 26.3 (CH3); 
19F NMR (CDCl3, 377 MHz) δ –72.5, –72.6. 
6.4.4. Optimisation of the semipinacol rearrangement reaction 
To a round bottom flask containing 197a (0.10 mmol, 1.0 equiv) under an inert atmosphere 
was added anhydrous solvent (2.5 mL). The flask was cooled to 0 °C or –78 °C and 
trifluoroacetic anhydride (16 μL, 0.12 mmol, 1.2 equiv) or trifluoromethanesulfonic anhydride 
(0.02 mL, 0.12 mmol, 1.2 equiv) was added with stirring. After the reaction time, diethyl ether 
or ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate solution (10 mL) were 
added, and the reaction mixture transferred to a separating funnel. The phases were separated, 
and the aqueous phase was extracted with diethyl ether or ethyl acetate (3 × 20 mL) and the 
combined organic phases were washed with brine, dried (MgSO4), filtered and concentrated 





6.4.5. General procedure F for the synthesis of keto azetidines 
 
To a round bottom flask containing the azabicyclo[1.1.0]butyl carbinol (0.25 mmol, 
1.0 equiv) under an inert atmosphere was added anhydrous DCM (2.5 mL). The flask was 
cooled to –78 °C and trifluoroacetic anhydride (40 μL, 0.30 mmol, 1.2 equiv) was added with 
stirring. After 1 hour at –78 °C, diethyl ether or ethyl acetate (10 mL) and saturated aqueous 
sodium bicarbonate solution (10 mL) were added and the reaction mixture transferred to a 
separating funnel. The phases were separated, and the aqueous phase was extracted with diethyl 
ether or ethyl acetate (3 × 20 mL) and the combined organic phases were washed with brine, 
dried (MgSO4), filtered and concentrated under reduced pressure. 
6.4.6. General procedure G for the synthesis of keto azetidines 
 
To a round bottom flask containing the azabicyclo[1.1.0]butyl carbinol (0.25 mmol, 
1.0 equiv) under an inert atmosphere was added anhydrous DCM (2.5 mL). The flask was 
cooled to –78 °C and 2,6-lutidine (34 μL, 0.30 mmol, 1.2 equiv) followed by 
trifluoromethanesulfonic anhydride (50 μL, 0.30 mmol, 1.2 equiv) was added with stirring. 
After 1 hour at –78 °C, diethyl ether or ethyl acetate (10 mL) and saturated aqueous sodium 
bicarbonate solution (10 mL) were added and the reaction mixture transferred to a separating 
funnel. The phases were separated, and the aqueous phase was extracted with diethyl ether or 
ethyl acetate (3 × 20 mL) and the combined organic phases were washed with brine, dried 





6.4.7. Scope of the semipinacol rearrangement reaction 
1-(3-Acetyl-3-phenylazetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241a 
Prepared following general procedure F using the crude 
1-(1-azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol, 197a (0.25 mmol). 
The crude reaction mixture was purified by flash column chromatography 
(95:5 → 75:25 pentane/ethyl acetate) to give 241a (63 mg, 93% yield) as 
a white solid. 
RF 0.23 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2956, 2922, 1695, 1468, 
1221, 1205, 1150; HRMS (ESI): Calcd. for C13H13F3NO2
+ ([M+H]+) m/z 272.0893, found 
m/z 272.0891; 
1H NMR (CDCl3, 400 MHz) δ 7.56 – 7.41 (m, 2H, CcH), 7.41 – 7.34 (m, 1H, CdH), 7.24 – 
7.18 (m, 2H, CbH), 5.10 (dt, 
2JHH = 9.5, 
4JHH = 1.3, 1H, CaH), 4.66 (d, 
2JHH = 10.5, 1H, CaH), 
4.61 – 4.51 (m, 2H, CaH), 2.05 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 203.7 
(CH3C(O)Cf), 156.4 (q, 
2JCF = 38.5, CF3C(O)NR2), 137.8 (Ce), 129.6 (2 × Cc), 128.6 (Cd), 126.2 
(2 × Cb), 116.1 (q, 
1JCF = 288.2, CF3), 58.8 (q, 
4JCF = 2.5, Ca), 55.7 (Ca), 54.4 (Cf), 24.7 (CH3); 
19F NMR (CDCl3, 377 MHz) δ –72.54. 
1-(3-Phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 244a 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol, 197a (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(98:2 → 80:20 pentane/ethyl acetate) to give 244a (60 mg, 79% yield) as 
a white solid. 
RF 0.39 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2965, 2918, 1714, 1383, 
1225, 1193; HRMS (ESI): Calcd. for C12H12F3NO3SNa
+ ([M+Na]+) m/z 330.0382, found 
m/z 330.0376; 
1H NMR (CDCl3, 400 MHz) δ 7.49 – 7.41 (m, 2H, CcH), 7.41 – 7.35 (m, 1H, CdH), 7.20 – 7.12 
(m, 2H, CbH), 4.80 (d, 
2JHH = 7.9, 2H, 2 × CaH), 4.53 (d, 
2JHH = 7.9, 2H, 2 × CaH), 2.05 (CH3). 
13C NMR (CDCl3, 101 MHz) δ 203.0 (CH3C(O)Cf), 137.3 (Ce), 129.7 (2 × Cc), 128.7 (Cd), 
126.0 (2 × Cb), 119.9 (q, 
1JCF = 322.3, CF3), 58.8 (2 × Ca), 53.3 (Cf), 24.6 (CH3); 19F NMR 





Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(4-methoxyphenyl)ethan-1-ol, 197b 
(0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (95:5 → 65:35 pentane/ethyl acetate) to 
give 241b (66 mg, 88% yield) as an off-white solid. 
RF 0.38 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2870, 1698, 1514, 
1251, 1145; HRMS (ESI): Calcd. for C14H15F3NO3
+ ([M+H]+) m/z 302.0999, found 
m/z 302.1000; 
1H NMR (CDCl3, 400 MHz) δ 7.12 (m, 2H, 2 × CbH), 6.95 (m, 2H, 2 × CcH), 5.07 (d, 
2JHH = 9.5, 1H, CaH), 4.63 (d, 
2JHH = 10.6, 1H, CaH), 4.53 (d, 
2JHH = 9.5, 1H, CaH), 4.49 (d, 
2JHH = 10.6, 1H, CaH), 3.82 (s, 3H, OCH3), 2.04 (s, 3H, C(O)CH3); 13C NMR (CDCl3, 101 
MHz) δ 204.0 (CH3C(O)Cf), 159.7 (Ce), 156.4 (q, 
2JCF = 37.7), 129.6 (Cd), 127.4 (2 × Cb), 
116.0 (q, 1JCF = 285.86, CF3), 115.0 (2 × Cc), 58.8 (q, 
4JCF = 2.4, Ca), 55.7 (Ca), 55.5 (OCH3), 
53.7 (Cf), 24.5 (C(O)CH3); 19F NMR (CDCl3, 377 MHz) δ –72.6.   
 1-(3-(4-Methoxyphenyl)-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 244b  
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(4-methoxyphenyl)ethan-1-ol, 
197b (0.25 mmol). The crude reaction mixture was purified by 
flash column chromatography (95:5 → 65:35 pentane/ethyl 
acetate) to give 244b (60 mg, 71% yield) as a white solid. 
RF 0.51 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2982, 1869, 1707, 1514, 
1384, 1375, 1224, 1190; HRMS (ESI): Calcd. for C13H14F3NO4SNa
+ ([M+Na]+) m/z 360.0488, 
found m/z 360.0489; 
1H NMR (CDCl3, 400 MHz) δ 7.08 (m, 2H, 2 × CbH), 6.94 (m, 2H, 2 × CcH), 4.76 (d, 
2JHH = 8.1, 2H, 2 × CaH), 4.46 (d, 
2JHH = 8.1, 2H, 2 × CaH), 3.80 (s, 3H, OCH3), 2.02 (s, 3H, 
C(O)CH3); 13C NMR (CDCl3, 101 MHz) δ 203.3 (CH3C(O)Cf), 159.8 (Ce), 129.1 (Cd), 127.3 
(2 × Cb), 119.9 (q, 
1JCF = 322.4), 115.0 (2 × Cc), 58.8 (Ca), 55.5 (OCH3), 52.6 (Cf), 24.4 




1-(3-Acetyl-3-(4-(trifluoromethyl)phenyl)azetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241c  
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(4-(trifluoromethyl)phenyl)ethan-1-
ol, 197c (0.25 mmol). The crude reaction mixture was purified by 
flash column chromatography (95:5 → 70:30 pentane/ethyl acetate) 
to give 241c (74 mg, 87% yield) as a white solid. 
RF 0.25 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2870, 1705, 1332, 
1146, 1130; HRMS (ESI): Calcd. for C14H11F6NO2Na
+ ([M+Na]+) m/z 362.0586, found 
m/z 362.0582; 
1H NMR (CDCl3, 400 MHz) δ 7.71 (d, 
3JHH = 8.2, 2H, 2 × CcH), 7.36 (d, 
3JHH = 8.2, 2H, 
2 × CbH), 5.12 (d, 
2JHH = 9.6, 1H, CaH), 4.69 (d, 
2JHH = 10.7, 1H, CaH), 4.58 (d, 
2JHH = 9.6, 
1H, CaH), 4.54 (d, 
2JHH = 10.7, 1H, CaH), 2.07 (s, 1H, CH3); 13C NMR (CDCl3, 101 MHz) δ 
202.7 (CH3C(O)Cf), 156.4 (q, 
2JCF = 37.9, CF3C(O)NR2), 141.7 (Cd), 131.0 (q, 
2JCF = 33.1, Ce), 
126.8 (2 × Cb), 126.7 (q, 
3JCF = 3.7, 2 × Cc), 123.8 (q, 
1JCF = 272.4, ArCF3), 116.0 (q, 
1JCF = 
288.1, C(O)CF3), 58.8 (q, 
4JCF = 2.4, Ca), 55.7 (Ca), 54.4 (Cf), 24.8 (CH3); 19F NMR (CDCl3, 
377 MHz) δ -62.89, –72.72.   
1-(3-(4-(Trifluoromethyl)phenyl)-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 
244c 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(4-(trifluoromethyl)phenyl)ethan-1-
ol, 197c (0.25 mmol). The crude reaction mixture was purified by 
flash column chromatography (95:5 → 70:30 pentane/ethyl acetate) to give 244c (56 mg, 60% 
yield) as a white solid. 
RF 0.20 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2870, 1711, 1377, 
1332, 1200, 1161, 1120; HRMS (ESI): Calcd. for C13H11F6NO3SNa
+ ([M+Na]+) m/z 398.0256, 
found m/z 398.0256; 
1H NMR (CDCl3, 400 MHz) δ 7.73 (d, 
3JHH = 8.2, 2H, 2 × CcH), 7.33 (d, 
3JHH = 8.2, 2H, 
2 × CbH), 4.83 (d, 
2JHH = 8.1, 1H, 2 × CaH), 4.53 (d, 
2JHH = 8.1, 2H, 2 × CaH), 2.08 (s, 3H, 
CH3); 13C NMR (CDCl3, 101 MHz) δ 202.0 (CH3C(O)Cf), 141.2 (Cd), 131.2 (q, 
2JCF = 33.0, 
Ce), 126.8 (q, 
3JCF = 3.7, 2 × Cc), 126.6 (2 × Cb), 123.7 (q, 




1JCF = 322.1, SO2CF3), 58.7 (Ca), 53.3 (Cf), 24.8 (CH3); 19F NMR (CDCl3, 377 MHz) δ –62.89, 
–75.33.   
tert-Butyl 3-(3-acetyl-1-(2,2,2-trifluoroacetyl)azetidin-3-yl)-1H-indole-1-carboxylate, 
241d 
Prepared following general procedure F using the crude tert-butyl 3-
(1-(1-azabicyclo[1.1.0]butan-3-yl)-1-hydroxyethyl)-1H-indole-1-
carboxylate, 197d (0.25 mmol). The crude reaction mixture was 
purified by flash column chromatography (98:2 → 80:20 
pentane/ethyl acetate) to give 241d (96 mg, 94% yield) as a white 
solid. 
RF 0.10 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2871, 1697, 1452, 1372, 1245, 
1227, 1147; HRMS (ESI): Calcd. for C20H21F3N2O4Na
+ ([M+Na]+) m/z 433.1346, found 
m/z 433.1360; 
1H NMR (CDCl3, 400 MHz) δ 8.17 (br. d, 
3JHH = 8.3, 1H, ChH), 7.70 (s, 1H, CdH), 7.37 (ddd, 
3JHH = 8.3, 7.1, 
4JHH = 1.3, 1H, CjH), 7.23 (ddd, 
3JHH = 8.0, 7.1, 
4JHH = 1.0, 1H, CiH), 7.15 (dt, 
3JHH = 8.0, 
4JHH = 1.0, 1H, CgH), 5.19 (d, 
2JHH = 9.2, 1H), 4.67 (d, 
2JHH = 10.3, 1H), 4.53 (d, 
2JHH = 10.3, 2H), 4.50 (d, 
2JHH = 9.2, 1H), 2.08 (s, 3H, C(O)OCH3), 1.71 (s, 9H, C(CH3)3); 13C 
NMR (CDCl3, 101 MHz) δ 203.9 (CH3C(O)Cb), 156.8 (q, 
2JHH = 37.9, CF3C(O)NR2), 149.5 
(R2NC(O)OR), 136.2 (Cf), 127.6 (Ce), 125.8 (Cj), 123.8 (Cd), 123.6 (Ci), 119.2 (Cg), 118.0 (Cb), 
116.1 (q, 1JHH = 287.7, CF3), 116.0 (Ch), 85.0 (R2NC(O)OC(CH3)3), 58.2 (q, 
3JHH = 2.3, Ca), 
55.3 (Ca), 48.7 (Cb), 28.4 ((CH3)3), 24.8 (C(O)OCH3); 19F NMR (CDCl3, 377 MHz) δ –72.62.   
tert-Butyl 3-(3-acetyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)-1H-indole-1-
carboxylate, 244d 
 Prepared following general procedure G using the crude tert-butyl 
3-(1-(1-azabicyclo[1.1.0]butan-3-yl)-1-hydroxyethyl)-1H-indole-1-
carboxylate, 197d (0.25 mmol). The crude reaction mixture was 
purified by flash column chromatography (DCM) to give 244d 
(96 mg, 86% yield) as a white solid. 
RF 0.46 (DCM); IR (film) νmax/cm
-1: 2981, 2870, 1718, 1453, 1373, 1152; HRMS (ESI): 
Calcd. for C19H21F3N2O5SNa




1H NMR (CDCl3, 400 MHz) δ 8.17 (br. d, 
3JHH = 8.4, 1H, ChH), 7.69 (s, 1H, CdH), 7.38 (ddd, 
3JHH = 8.4, 7.2, 
4JHH = 1.1, 1H, CjH), 7.23 (ddd, 
3JHH = 7.9, 7.2, 
4JHH = 1.0, 1H, CiH), 7.13 (dt, 
3JHH = 7.9, 
4JHH = 1.1, 1H, CgH), 4.87 (d, 
2JHH = 7.9, 2H, 2 × CaH), 4.49 (d, 
2JHH = 7.9, 2H, 
2 × CaH), 2.08 (s, 3H, C(O)CH3), 1.72 (s, 9H, C(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 203.1 
(CH3C(O)Cb), 149.4 (R2NC(O)C(CH3)3), 136.0 (Cf), 127.3 (Ce), 125.7 (Cj), 123.6 (Cj), 123.6 
(Ci), 119.9 (q, 
1JCF = 322.7, CF3), 119.1 (Cg), 117.4 (Cb), 116.0 (Ch), 85.0 (R2NC(O)OC(CH3)3), 
58.2 (2 × Ca), 47.6 (Cb), 28.3 ((CH3)3), 24.6 (C(O)OC(CH3)3); 19F NMR (CDCl3, 377 MHz) δ 
–75.21.   
1-(3-Acetyl-3-(6-methoxypyridin-3-yl)azetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241e 
Prepared following general procedure F using the crude 1-
(1-azabicyclo[1.1.0]butan-3-yl)-1-(6-methoxypyridin-3-yl)ethan-1-
ol, 197e (0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (98:2 → 80:20 pentane/acetone) to give 241e 
(53 mg, 70% yield) as a colourless oil. 
RF 0.09 (90:10 pentane/acetone); IR (film) νmax/cm
-1: 2952, 2925, 1698, 1606, 1497, 1380, 
1294, 1257,1206, 1151; HRMS (ESI): Calcd. for C13H13F3N2O3Na
+ ([M+Na]+) m/z 325.0770, 
found m/z 325.0786; 
1H NMR (CDCl3, 400 MHz) δ 8.07 (dd, 
4JHH = 2.7, 
5JHH = 0.8, 1H, CdH), 7.37 (dd, 
3JHH = 8.7,
 
4JHH = 2.7, 1H, CeH), 6.80 (dd, 
3JHH = 8.7, 
5JHH = 0.8, 1H, CfH), 5.07 (dt, 
2JHH = 9.6, 
4JHH = 1.3, 
1H, CaH), 4.65 (d,
 2JHH = 10.6, 1H, CaH), 4.52 (dt, 
2JHH = 9.9, 
4JHH = 1.3, 1H, CaH), 4.48 (d,
 
2JHH = 10.6, 1H, CaH), 3.93 (s, 3H, OCH3), 2.08 (s, 3H, RC(O)CH3); 13C NMR (CDCl3, 
101 MHz) δ 203.4 (CH3C(O)Cb), 164.2 (Cg), 156.5 (q, 
2JCF = 37.8, R2NC(O)CF3), 144.9 (Cd), 
136.5 (Ce), 126.1 (Cc), 116.0 (q, 
1JCF = 288.1, CF3), 112.1 (Cf), 58.7 (q, 
1JCF = 2.4, Ca), 55.6 
(Ca), 53.9 (OCH3), 52.1 (Cb), 24.6 (RC(O)CH3); 19F NMR (CDCl3, 377 MHz) δ –72.68.   
1-(3-(6-Methoxypyridin-3-yl)-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 
244e 
Prepared following general procedure G using the crude 1-
(1-azabicyclo[1.1.0]butan-3-yl)-1-(6-methoxypyridin-3-yl)ethan-1-
ol, 197e (0.25 mmol). The crude reaction mixture was purified by 




further purified by flash column chromatography (100:0 → 95:5 DCM/ethyl acetate) to give 
244e (57 mg, 67% yield) as a white solid. 
RF 0.46 (95:5 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2988, 2852, 1709, 1612, 1497, 1380, 
1297, 1227, 1195; HRMS (ESI): Calcd. for C12H13F3N2O4SNa
+ ([M+Na]+) m/z 361.0440, 
found m/z 361.0458 
1H NMR (CDCl3, 400 MHz) δ 8.05 (dd, 
4JHH = 2.7, 
5JHH = 0.8, 1H, CdH), 7.35 (dd, 
3JHH = 8.7,
 
4JHH = 2.7, 1H, CeH), 6.81 (dd, 
3JHH = 8.7, 
5JHH = 0.8, 1H, CfH), 4.79 (d, 
2JHH = 8.1, 2H, 
2 × CaH), 4.46 (d, 
2JHH = 8.1, 2H, 2 × CaH), 3.95 (s, 3H, OCH3), 2.08 (s, 3H, RC(O)CH3); 13C 
NMR (CDCl3, 101 MHz) δ 202.7 (CH3C(O)Cb), 164.3 (Cg), 144.7 (Cd), 136.3 (Ce), 125.6 (Cc), 
119.8 (q, 1JCF = 322.2, CF3), 112.2 (Cf), 58.6 (2 × Ca), 53.9 (OCH3), 50.9 (Cb), 24.6 
(RC(O)CH3); 19F NMR (CDCl3, 377 MHz) δ –75.15.   
1-(3-Acetyl-3-(6-bromopyridin-3-yl)azetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241f 
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(6-bromopyridin-3-yl)ethan-1-ol, 197f 
(0.25 mmol). The crude reaction mixture was purified by flash column 
chromatography (95:5 DCM/ethyl acetate) then further purified by flash 
column chromatography (95:5 → 80:20 pentane/acetone) to give 241f (51 mg, 58% yield) as a 
colourless oil. 
RF 0.25 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2956, 1693, 1456, 1366, 1205, 1148; 
HRMS (ESI): Calcd. for C12H10BrF3N2O2Na
+ ([M+Na]+) m/z 372.9770, found m/z 372.9792. 
1H NMR (CDCl3, 400 MHz) δ 8.30 (dd, 
4JHH = 2.8, 
5JHH = 0.8, 1H, CdH), 7.57 (dd, 
3JHH = 8.3, 
5JHH = 0.8, 1H, CfH), 7.40 (dd, 
3JHH = 8.3,
 4JHH = 2.7, 1H, CeH), 5.10 (dt, 
2JHH = 9.9, 
4JHH = 1.0, 
1H, CaH), 4.69 (dd, 
2JHH = 10.6, 
4JHH =1.0, 1H, CaH), 4.56 (d, 
2JHH = 9.9, 1H, CaH), 4.50 (d,
 
2JHH = 10.6, 1H, CaH), 2.11 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 202.2 (CH3C(O)Cb), 
156.4 (q, 2JCF = 38.0, R2NC(O)CF3), 148.1 (Cd), 142.6 (Cc), 136.5 (Ce), 132.9 (Cg), 128.9 (Cf), 
115.9 (q, 1JCF = 288.1, CF3), 58.6 (q, 
1JCF = 2.7, Ca), 55.5 (Ca), 52.3 (Cb), 24.9 (CH3); 19F NMR 





Prepared following general procedure G using the crude 1-
(1-azabicyclo[1.1.0]butan-3-yl)-1-(6-bromopyridin-3-yl)ethan-1-ol, 
197f (0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (98:2 → 85:15 pentane/acetone) then further 
purified by flash column chromatography (95:5 DCM/ethyl acetate) to 
give 244f (52 mg, 54% yield) as a white solid. 
RF 0.39 (95:5 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2872, 1715, 1580, 1557, 1459, 
1379, 1230, 1196; HRMS (ESI): Calcd. for C11H10BrF3N2O3SNa
+ ([M+Na]+) m/z 408.9440, 
found m/z 408.9452. 
1H NMR (CDCl3, 400 MHz) δ 8.28 (d, 
4JHH = 2.7, 1H, CdH), 7.59 (dd, 
3JHH = 8.4, 
5JHH = 0.8, 
1H, CfH), 7.37 (dd, 
3JHH = 8.4,
 4JHH = 2.7, 1H, CeH), 4.82 (d, 
2JHH = 8.3, 2H, 2 × CaH), 4.49 (d, 
2JHH = 8.2, 2H, 2 × CaH), 2.12 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 201.6 
(CH3C(O)Cb), 147.9 (Cd), 142.8 (Cc), 136.3 (Ce), 132.5 (Cg), 129.1 (Cf), 119.7 (q, 
1JCF = 322.0, 
CF3), 58.5 (2 × Ca), 51.2 (Cb), 24.9 (CH3); 19F NMR (CDCl3, 377 MHz) δ –75.23.   
1-(3-(2-Chloropyridin-4-yl)-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 244g  
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(2-chloropyridin-4-yl)ethan-1-ol, 
197g (0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (95:5 → 75:25 pentane/acetone) to give 244g 
(20 mg, 23% yield) as a white solid. 
RF 0.38 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2967, 2944, 1720, 1591, 1543, 1466, 
1380, 1225, 1194; HRMS (ESI): Calcd. for C11H10F3ClN2O3SNa
+ ([M+Na]+) m/z 343.0126, 
found m/z 343.0120; 
1H NMR (CDCl3, 400 MHz) δ 8.49 (dd, 
3JHH = 5.2,
 5JHH = 0.7, 1H, CfH), 7.19 (dd, 
4JHH = 1.7, 
5JHH = 0.7, 1H, CdH), 7.06 (dd, 
3JHH = 5.2, 
4JHH = 1.7, 1H), 4.79 (d, 
2JHH = 8.30, 2H, 2 × CaH), 
4.47 (d, 2JHH = 8.30, 2H, 2 × CaH), 2.12 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 200.7 
(CH3C(O)Cb), 153.3 (Cg), 151.1 (Cf), 149.1 (Cc), 121.8 (Cd), 119.7 (q, 
1JCF = 322.2, CF3), 119.7 





Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclobutan-1-ol, 197h (0.25 mmol). The crude 
reaction mixture was purified by flash column chromatography (95:5 → 
30:70 pentane/ethyl acetate) to give 241h (30 mg, 54% yield) as a colourless oil. 
RF 0.18 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2872, 1741, 1694, 
1464, 1253, 1199, 1143; HRMS (ESI): Calcd. for C9H11F3NO2
+ ([M+H]+) m/z 222.0736, found 
m/z 222.0731; 
1H NMR (CDCl3, 400 MHz) δ 4.47 (d, 
2JHH = 9.3, 1H, CaH), 4.18 (d, 
2JHH = 10.2, 1H, CaH), 
4.14 (d, 2JHH = 9.3, 1H, CaH), 3.89 (d, 
2JHH = 10.2, 1H, CaH), 2.36 – 2.18 (m, 4H, CbH2, CdH2), 
1.96 – 1.88 (m, 2H, CcH2); 13C NMR (CDCl3, 101 MHz) δ 216.7 (CbC(O)Ce), 156.4 (q, 
2JCF = 
37.9, CF2C(O)NR2), 116.1 (q, 
1JCF = 289.0, CF3), 59.0 (q, 
4JCF = 2.2, Ca),  56.7 (Ca), 45.6 (Ce), 
36.9 (Cb), 34.9 (Cd), 19.3 (Cc); 19F NMR (CDCl3, 377 MHz) δ –72.56.   
2-((Trifluoromethyl)sulfonyl)-2-azaspiro[3.4]octan-5-one, 244h 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclobutan-1-ol, 197h (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography (95:5 
→ 50:50 pentane/ethyl acetate) to give 244h (56 mg, 87% yield) as a white solid. 
RF 0.20 (70:30 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2978, 2873, 1734, 1380, 
1218, 1193, 1155, 1178, 1088; HRMS (ESI): Calcd. for C8H10F3NO3SNa
+ ([M+Na]+) 
m/z 280.0226, found m/z 280.0216; 
1H NMR (CDCl3, 400 MHz) δ 4.30 (d, 
2JHH = 7.5, 2H, 2 × CaH), 3.95 (d, 
2JHH = 7.5, 2H, 
2 × CaH), 2.29 (t, 
3JHH = 7.8, 2H, CbH2), 2.27 (t, 
3JHH = 6.8, 2H, CdH2), 1.91 (m, 2H, CcH2); 
13C NMR (CDCl3, 126 MHz) δ 215.7 (CbC(O)Ce), 120.0 (q, 
1JCF = 325.4, CF3), 59.5 (2 × Ca), 
44.5 (Ce), 36.8 (Cb), 34.8 (Cd), 19.2 (Cc).; 19F NMR (CDCl3, 377 MHz) δ –74.98.   
2-(2,2,2-Trifluoroacetyl)-2-azaspiro[3.5]nonan-5-one, 241i 
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclopentan-1-ol, 197i (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography (95:5 




RF 0.14 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: redo, 2944, 2863, 1695, 
1465, 1448, 1250, 1200, 1145; HRMS (ESI): Calcd. for C10H13F3NO2
+ ([M+H]+) 
m/z 236.0893, found m/z 236.0891; 
1H NMR (CDCl3, 400 MHz) δ 4.72 (d, 
2JHH = 9.5, 1H, CaH), 4.30 (d, 
2JHH = 10.4, 1H, CaH), 
3.97 (d, 2JHH = 9.5, 1H, CaH), 3.85 (d, 
2JHH = 10.4, 1H, CaH), 2.39 (t, J = 6.6, 2H, CbH2), 
2.22 – 2.10 (m, 1H, CeH), 2.04 (ddd, 
2JHH = 13.4, 
3JHH = 8.2, 4.6, 1H, CeH), 1.98 – 1.89 (m, 
1H, CcH), 1.89 – 1.71 (m, 3H, CcH, CdH2); 13C NMR (CDCl3, 101 MHz) δ 207.6 (CbC(O)Cf), 
156.8 (q, 2JCF = 37.5, CF3C(O)NR2), 116.1 (q, 
1JCF = 288.1, CF3), 57.5 (q, 
4JCF = 2.3, Ca), 
55.6 (Ca), 47.0 (Cf), 38.7 (Cb), 37.4 (Ce), 26.7 (Cc), 21.9 (Cd); 19F NMR (CDCl3, 377 MHz) δ 
–72.68.   
2-((Trifluoromethyl)sulfonyl)-2-azaspiro[3.5]nonan-5-one, 244i 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclopentan-1-ol, 197i (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(98:2 → 80:20 pentane/ethyl acetate) to give 244i (39 mg, 58% yield) as a white solid. 
RF 0.24 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2924, 2861, 1714, 1384, 
1187, 1220; HRMS (ESI): Calcd. for C9H12F3NO3SNa
+ ([M+Na]+) m/z 294.0382, found 
m/z 294.0390; 
1H NMR (CDCl3, 400 MHz) δ 4.48 (d, 
2JHH = 7.6, 2H, 2 × CaH), 3.87 (d, 
2JHH = 7.8, 2H, 
2 × CaH), 2.39 (t, 
3JHH = 6.8, 2H, CbH2), 2.15 – 2.08 (m, 2H, CeH2), 1.87 (qd, 
3JHH = 6.8, 3.1, 
2H, CcH2), 1.79 – 1.65 (m, 2H, CdH2); 13C NMR (CDCl3, 126 MHz) δ 206.9 (CbC(O)Cf), 120.1 
(q, 1JCF = 322.7, CF3), 58.2 (2 × Ca), 46.0 (Cf), 38.9 (Cb), 37.3 (Ce), 26.8 (Cc), 22.0 (Cd); 19F 
NMR (CDCl3, 377 MHz) δ –74.85.   
2-(2,2,2-Trifluoroacetyl)-2-azaspiro[3.6]decan-5-one, 241j 
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclohexan-1-ol, 197j (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(95:5 → 60:40 pentane/ethyl acetate) to give 244j (17 mg, 27% yield) as a colourless oil. 
RF 0.16 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2933, 2869, 1698, 1463, 
1255, 1202, 1144; HRMS (ESI): Calcd. for C11H15F3NO2





1H NMR (CDCl3, 400 MHz) δ 4.64 (dt, 
2JHH = 9.3, 
4JHH = 1.3, 1H, CaH), 4.27 (d, 
2JHH = 10.3, 
1H, CaH), 4.02 (dt, 
2JHH = 9.3, 
4JHH = 1.3, 1H, CaH), 3.87 (d, 
2JHH = 10.3, 1H, CaH), 2.70 – 2.51 
(m, 2H, CbH2), 2.15 – 1.99 (m, 2H, CfH2), 1.74 – 1.54 (m, 6H, CcH2, CdH2, CeH2); 13C NMR 
(CDCl3, 101 MHz) δ 211.6 (CbC(O)Cg), 156.7 (q, 
2JCF = 37.2, CF3C(O)NR2), 116.2 (q, 
1JCF = 
287.4, CF3), 59.8 (q, 
4JCF = 2.2, Ca), 56.6 (Ca), 49.0 (Cg), 41.8 (Cb), 35.6 (Cf), 29.2 (Cc), 25.5 
(Ce), 24.5 (Cd); 19F NMR (CDCl3, 377 MHz) δ –72.53.   
2-((Trifluoromethyl)sulfonyl)-2-azaspiro[3.6]decan-5-one, 244j 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclohexan-1-ol, 197j (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(95:5 → 60:40 pentane/ethyl acetate) to give 244j (35 mg, 50% yield) as a white solid. 
RF 0.31 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2932, 2860, 1701, 1453, 
1385, 1208; HRMS (ESI): Calcd. for C10H15F3NO3S
+ ([M+H]+) m/z 286.0719, found 
m/z 286.0720; 
1H NMR (CDCl3, 400 MHz) δ 4.43 (d, 
2JHH = 7.7, 2H, 2 × CaH), 3.89 (d, 
2JHH = 7.7, 2H, 
2 × CaH), 2.60 (m, 2H, CbH2), 2.09 (m, 2H, CfH2), 1.66 – 1.58 (m, 6H, CcH2, CdH2, CeH2); 13C 
NMR (CDCl3, 101 MHz) δ 210.84 (CbC(O)Cg), 120.05 (q, 
1JCF = 322.3, CF3), 59.69 (2 × Ca), 
47.97 (Cg), 41.69 (Cb), 35.27 (Cf), 29.04 (Cc), 25.42 (Ce), 24.43 (Cd); 19F NMR (CDCl3, 
377 MHz) δ -74.87.   
2-(2,2,2-Trifluoroacetyl)-2-azaspiro[3.7]undecan-5-one, 241k 
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cycloheptan-1-ol, 197k (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(95:5 → 70:30 pentane/ethyl acetate) to give 241k (27 mg, 41% yield) as a white solid. 
RF 0.20 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2930, 2860, 1696, 1467, 
1253, 1201, 1147; HRMS (ESI): Calcd. for C12H16F3NO2Na
+ ([M+Na]+) m/z 286.1025, found 
m/z 286.1029; 
1H NMR (CDCl3, 400 MHz) δ 4.64 (d, 
2JHH = 9.4, 1H, CaH), 4.24 (d, 
2JHH = 10.4, 1H, CaH), 
4.04 (d, 2JHH = 9.4, 1H, CaH), 3.85 (d, 
2JHH = 10.4, 1H, CaH), 2.54 (ddd, 
2JHH = 12.4, 
3JHH = 8.9, 
4.4, 1H, CbH), 2.45 (ddd, 
2JHH = 12.4, 
3JHH = 7.9, 4.4, 1H, CbH), 2.33 (dt, 
2JHH = 14.7, 
3JHH = 6.1, 1H, CgH), 2.23 (dt, 
2JHH = 14.7,




1.59 – 1.48 (m, 4H, CfH2, CdH2), 1.44 – 1.35 (m, 1H, CeH), 1.26 – 1.15 (m, 1H CeH); 13C NMR 
(CDCl3, 126 MHz) δ 213.4 (CbC(O)Ch), 156.8 (q, 
2JCF = 37.5, CF3C(O)NR2), 116.1 (q, 
1JCF = 
288.1, CF3), 57.4 (q, 
4JCF = 2.3, Ca), 55.3 (Ca), 49.7 (Ch), 38.0 (Cb), 34.5 (Cg), 27.8 (Cc), 25.8 
(Cd), 24.3 (Ce), 23.2 (Cf); 19F NMR (CDCl3, 377 MHz) δ –72.63.   
2-((Trifluoromethyl)sulfonyl)-2-azaspiro[3.7]undecan-5-one, 244k 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cycloheptan-1-ol, 197k (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography 
(100:0 → 90:10 pentane/acetone) to give 244k (54 mg, 71% yield) as a white solid. 
RF 0.35 (80:20 petroleum ether/acetone); IR (film) νmax/cm
-1: 2948, 2864, 1698, 1381, 1224, 
1194; HRMS (ESI): Calcd. for C11H16F3NO3SNa
+ ([M+Na]+) m/z 3220695, found 
m/z 322.0714; 
1H NMR (400 MHz, Chloroform-d) δ 4.41 (dd, 2JHH = 7.9, 
4JHH = 1.0, 2H, 2 × CaH), 3.90 (dd, 
2JHH = 7.8, 
4JHH = 1.0, 2H, 2 × CaH), 2.48 (m, 2H, CbH2), 2.29 (m, 2H, CgH2), 1.80 (m, 2H, 
CcH2), 1.55 (m, 4H, CfH2, CdH2), 1.29 (m, 2H, CeH2); 13C NMR (CDCl3, 101 MHz) δ 212.7 
(CbC(O)Ch), 120.0 (q, 
1JCF = 322.7, CF3), 58.0 (Ca), 47.6 (Ch), 38.1 (Cb), 34.5 (Cg), 27.5 (Cc), 
25.9 (Cd), 24.3 (Ce), 22.9 (Cf); 19F NMR (CDCl3, 377 MHz) δ –74.92.   
tert-Butyl 8-oxo-2-(2,2,2-trifluoroacetyl)-2,6-diazaspiro[3.4]octane-6-carboxylate, 241l 
Prepared following general procedure F using the crude tert-butyl 3-(1-
azabicyclo[1.1.0]butan-3-yl)-3-hydroxyazetidine-1-carboxylate, 197l 
(0.25 mmol). The crude reaction mixture was purified by flash column 
chromatography (100:0 → 85:15 DCM/ethyl acetate) to give 241l 
(38 mg, 48% yield) as a white solid. 
RF 0.23 (90:10 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2972, 1764, 1589, 1458, 1402, 1262, 
1201, 1147; HRMS (APCI): Calcd. for C13H17N2O4F3Na
+ ([M+H]+) m/z 345.1033, found 
m/z 345.1042. 
1H NMR (CDCl3, 400 MHz) δ 4.56 (d, 
2JHH = 9.5, 1H, CaH), 4.30 (d, 
2JHH = 10.4, 2H, 2 × CaH), 
4.05 (d, 2JHH = 10.8, 1H, CaH), 4.01 – 3.97 (m, CdH2), 3.90 (d, 
2JHH = 20.2, CcH), 3.85 (d, 
2JHH = 20.2, CcH), 1.47 (s, 9H, 3 × CH3); 13C NMR (CDCl3, 126 MHz) δ 209.1 (br., CcC(O)Cb), 
156.3 (q, 1JCF = 37.8, R2NC(O)R), 115.9 (q, 
1JCF = 288.5, CF3), 81.4 (Ce), 58.6 (q, 




Ca), 56.2 (Ca), 52.9 (br., Cc), 52.1 (br., Cd), 45.0 (br., Cb), 28.4 (C(CH3)3); 19F NMR (CDCl3, 
377 MHz) δ –72.70.   
tert-Butyl 8-oxo-2-((trifluoromethyl)sulfonyl)-2,6-diazaspiro[3.4]octane-6-carboxylate, 
244l 
Prepared following general procedure G using the crude tert-butyl 
3-(1-azabicyclo[1.1.0]butan-3-yl)-3-hydroxyazetidine-1-
carboxylate, 197l (0.25 mmol). The crude reaction mixture was 
purified by flash column chromatography (98:2 → 85:15 
pentane/acetone) and then further purified by flash column chromatography (100:0 → 90:10 
DCM/ethyl acetate) to give 244l (56 mg, 63% yield) as a white solid. 
RF 0.50 (90:10 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2974, 1766, 1696, 1682, 1415, 1384, 
1194; HRMS (ESI): Calcd. for C12H17F3N2O5SNa
+ ([M+Na]+) m/z 381.0702, found 
m/z 381.0709. 
1H NMR (CDCl3, 400 MHz) δ 4.39 (d, 
2JHH = 8.0, 2H, 2 × CaH), 4.10 (d, 
2JHH = 8.0, 2H, 
2 × CaH), 3.99 (s, 2H, CcH2), 3.86 (s, 2H, CdH2), 1.47 (s, 9H, 3 × CH3); 13C NMR (CDCl3, 
101 MHz) δ 208.3 (br., CcC(O)Cb), 154.0 (R2NC(O)R) , 119.8 (q, 1JCF = 322.2, CF3), 81.5 (Ce), 
58.8 (2 × Ca), 53.0 (br., Cc), 52.0 (br., Cd), 43.9 (br., Cb), 28.4 (C(CH3)3); 19F NMR (CDCl3, 
377 MHz) δ –75.07.   
1-(3-Acetyl-3-cyclohexylazetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241m 
Prepared following general procedure F using the crude 
1-(1-azabicyclo[1.1.0]butan-3-yl)-1-cyclohexylethan-1-ol, 197m 
(0.25 mmol) with the following alteration: the reaction was stirred for 
15 minutes at –78 °C then 30 minutes at 0 °C. The crude reaction mixture 
was purified by flash column chromatography (100:0 → 80:20 pentane/acetone) to give 241m 
(18 mg, 26% yield) as a colourless oil. 
RF 0.13 (90:10 pentane/acetone); IR (film) νmax/cm
-1: 2929, 2856, 1697, 1469, 1359, 1248, 
1202, 1149; HRMS (ESI): Calcd. for C13H18NO2F3Na
+ ([M+Na]+) m/z 300.1182, found 
m/z 300.1194; 
1H NMR (400 MHz, Chloroform-d) δ 4.46 (d, 2JHH = 9.8, 1H, CaH), 4.14 (d, 
2JHH = 9.9, 1.2, 
1H, CaH), 4.11 (d, 
2JHH = 11.5, 1H, CaH), 4.00 (d, 




1.84 – 1.70 (m, 3H, CcH, 2 × CeH), 1.72 – 1.61 (m, 2H, CfH, CdH), 1.55 (m, 1H, CdH), 
1.28 – 1.04 (m, 3H, 2 × CeH, CfH), 0.94 (app. dqd, 
2JHH = 20.9, 
3JHH = 12.6, 3.5, 2H, 2 × CdH); 
13C NMR (CDCl3, 126 MHz) δ 207.1 (CH3C(O)Cb), 156.5 (q, 
2JCF = 37.8, CF3C(O)NR2), 116.1 
(q, 1JCF = 288.5, CF3), 54.6 (q, 
4JCF = 2.5, Ca), 52.3 (Ca), 41.4 (Cc), 27.4 (Cd), 27.1 (Cd), 26.3 
(Ce), 26.2 (Ce), 26.0 (Cf), 25.8 (CH3).   
1-(3-Cyclohexyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 244m 
Prepared following general procedure G using the crude 
1-(1-azabicyclo[1.1.0]butan-3-yl)-1-cyclohexylethan-1-ol, 197m 
(0.25 mmol) with the following alteration: the reaction was stirred for 
15 minutes at –78 °C then 30 minutes at 0 °C. The crude reaction mixture 
was purified by flash column chromatography (100:0 → 98:2 DCM/ethyl acetate) to give 244m 
(76 mg, 97% yield) as a white solid. 
RF 0.72 (98:2 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2933. 2857, 1702, 1379, 1209, 1197, 
1177; HRMS (ESI): Calcd. for C12H18F3NO3SNa
+ ([M+Na]+) m/z 336.0852, found 
m/z 336.0867; 
1H NMR (CDCl3, 400 MHz) δ 4.31 (d, 
2JHH = 8.3, 2H, 2 × CaH), 4.08 (d, 
2JHH = 8.3, 2H, 
2 × CaH), 2.15 (s, 3H, CH3), 1.91 – 1.77 (m, 3H, CcH, 2 × CeH), 1.77 – 1.63 (m, 3H, CfH, 
2 × CdH), 1.27 (app.  qt,
 2JHH = 12.5, 
3JHH = 12.5, 3.2, 2H, 2 × CeH), 1.16 (app. tt, 
3JHH = 12.9, 
3.1, 1H, CfH), 1.02 (app. qd,
 2JHH = 12.5, 
3JHH = 12.5, 3.4, 2H, 2 × CdH); 13C NMR (CDCl3, 
101 MHz) δ 206.43 (CH3C(O)Cb), 119.90 (q, 
1JCF = 322.3, CF3), 55.12 (2 × Ca), 52.77 (Cb), 
41.28 (Cc), 27.18 (2 × Cd), 26.23 (2 × Ce), 25.97 (Cf), 25.71 (CH3); 19F NMR (CDCl3, 
377 MHz) δ –75.47.   
3-Phenyl-1-(2,2,2-trifluoroacetyl)azetidine-3-carbaldehyde, 241n 
Prepared following general procedure F using the crude 
(1-azabicyclo[1.1.0]butan-3-yl)(phenyl)methanol, 197n (0.25 mmol). The 
crude reaction mixture was purified by flash column chromatography with 
florisil (30 – 60 mesh) as the stationary phase (95:5 → 70:30 pentane/ethyl 
acetate) to give 241n (33 mg, 51% yield) as a colourless oil. 
RF 0.33 (70:30 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2969, 2922, 1736, 1365, 1228, 1216, 
1206; HRMS (APCI): Calcd. for C12H10F3NO2




1H NMR (CDCl3, 400 MHz) δ 9.61 (s, 1H, RC(O)H), 7.52 – 7.44 (m, 2H, 2 × CcH), 7.44 – 7.37 
(m, 1H, CdH), 7.20 – 7.14 (m, 2H, 2 × CbH), 5.04 (dt, 
2JHH = 9.5, 
4JHH = 1.2, 1H, CaH), 4.69 
(dd, 2JHH = 10.5, 
4JHH = 1.2, 1H, CaH), 4.62 (d, 
2JHH = 9.5, 1H, CaH), 4.45 (d, 
2JHH = 10.5, 1H, 
CaH); 13C NMR (CDCl3, 101 MHz)  δ 194.8 (HC(O)Cf), 156.5 (q, 
2JCF = 37.9, CF3C(O)NR2), 
135.2 (Ce), 129.8 (2 × Cc), 128.9 (Cd), 126.5 (2 × Cb), 116.0 (q, 
1JCF = 288.1, CF3), 56.9 (q, 
3JCF = 2.5, Ca), 54.4 (Ca), 52.7 (Cf); 19F NMR (CDCl3, 377 MHz) δ –72.64.   
(3-Phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)methanol, 244n  
Prepared following general procedure G using the crude 
(1-azabicyclo[1.1.0]butan-3-yl)(phenyl)methanol, 197n (0.25 mmol). 
Due to instability of the aldehyde on silica, the crude reaction mixture 
was oxidised prior to purification. The crude mixture was dissolved in anhydrous methanol 
(2.5 mL) under an inert atmosphere and cooled to 0 °C before the addition of sodium 
borohydride (19 mg, 0.5 mmol, 2.0 equiv). The reaction was stirred for 1 hour at 0 °C and a 
further 45 minutes at room temperature before the addition of water (10 mL) and ethyl acetate 
(10 mL). The phases were separated, and the aqueous phase was extracted with diethyl ether 
(3 × 10 mL) and the combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography (95:5 → 60:40 pentane/ethyl acetate) to give 244n (62 mg, 82% yield) 
as a colourless oil. 
RF 0.35 (70:30 pentane/ethyl acetate); IR (film) νmax/cm
-1: 3391, 2969, 2871, 1382, 1219, 1193; 
HRMS (ESI): Calcd. for C11H12F3NO3SNa
+ ([M+Na]+) m/z 318.0382, found m/z 318.0395; 
1H NMR (CDCl3, 400 MHz) δ 7.42 (ddd, 
3JHH = 7.8, 6.3, 
4JHH = 1.4, 2H, 2 × CcH), 7.37 – 7.31 
(m, 1H, CdH), 7.13 – 7.08 (m, 2H, 2 × CbH), 4.47 (d, 
2JHH = 8.1, 2H, 2 × CaH), 4.42 (d, 
2JHH = 7.7, 2H, 2 × CaH), 3.87 (s, 2H, RCH2OH), 1.82 (br. s, 1H, OH); 13C NMR (CDCl3, 
101 MHz) δ 140.7 (Ce), 129.8 (2 × Cc), 127.9 (Cd), 126.0 (2 × Cb), 120.0 (q, 
1JCF = 322.4, CF3) 
68.8 (RCH2OH), 59.4 (2 × Ca), 43.6 (Cf); 19F NMR (CDCl3, 377 MHz) δ –75.26. 
1-(3-Phenyl-1-(2,2,2-trifluoroacetyl)azetidin-3-yl)propan-1-one, 241o 
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-phenylpropan-1-ol, 197o (0.25 mmol). 




(95:5 → 80:20 pentane/ethyl acetate) to give 241o (63 mg, 88% yield) as a colourless oil. 
RF 0.12 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2870, 1697, 1467, 1203, 1145; 
HRMS (ESI): Calcd. for C14H14F3NO2Na
+ ([M+Na]+) m/z 308.0869, found m/z 308.0870; 
1H NMR (CDCl3, 400 MHz) δ 7.45 – 7.39 (m, 2H, 2 × CcH), 7.38 – 7.32 (m, 1H, CdH), 
7.22 – 7.17 (m, 2H, 2 × CbH), 5.11 (d, 
2JHH = 9.5, 1H, CaH), 4.65 (d, 
2JHH = 10.6, 1H, CaH), 
4.58 (d, 2JHH = 9.6, 1H, CaH), 4.54 (d, 
2JHH = 10.6, 1H, CaH), 2.44 – 2.20 (m, 2H, CH2CH3), 
0.96 (t, 3JHH = 7.2, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 206.9 (EtC(O)Cf), 156.4 (q, 
2JCF 
= 37.8, CF3C(O)NR2), 138.1 (Ce), 129.5 (2 × Cc), 128.4 (Cd), 126.2 (2 × Cb), 116.0 (q, 
1JCF = 
288.4, CF3), 59.0 (q, 
4JCF = 2.6, Ca), 55.8 (Ca), 53.8 (Cf), 30.3 (CH3), 8.10 (CH2CH3); 19F NMR 
(CDCl3, 377 MHz) δ –72.56.   
1-(3-Phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)propan-1-one, 244o 
Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-phenylpropan-1-ol, 197o (0.25 mmol). 
The crude reaction mixture was purified by flash column 
chromatography (100:0 → 85:15 pentane/ethyl acetate) to give 244o 
(50 mg, 62% yield) as a colourless oil. 
RF 0.28 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2870, 1716, 1387, 1192, 1225, 
1142; HRMS (ESI): Calcd. for C13H14F3NO3SNa
+ ([M+Na]+) m/z 344.0539, found 
m/z 344.0537; 
1H NMR (CDCl3, 400 MHz) δ 7.48 – 7.41 (m, 2H, 2 × CcH), 7.40 – 7.34 (m, 1H, CdH), 
7.20 – 7.14 (m, 2H, 2 × CbH), 4.81 (d, 
2JHH = 8.0, 2H, 2 × CaH), 4.53 (d, 
2JHH = 8.0, 2H, 
2 × CaH), 2.32 (q, 
3JHH = 7.3, 2H, CH2CH3), 0.98 (t, J = 7.2, 3H, CH3); 13C NMR (CDCl3, 
101 MHz) δ 206.3 (EtC(O)Cf), 137.7 (Ce), 129.7 (2 × Cc), 128.6 (Cd), 126.0 (2 × Cb), 119.9 (q, 
1JCF = 322.4, CF3), 59.0 (Ca), 52.8 (Cf), 30.4 (CH2CH3), 8.2 (CH3); 19F NMR (CDCl3, 377 
MHz) δ –75.14.   
3-Phenyl-1-(3-phenyl-1-(2,2,2-trifluoroacetyl)azetidin-3-yl)prop-2-yn-1-one, 241p  
Prepared following general procedure F using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1,3-diphenylprop-2-yn-1-ol, 197p 
(0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (100:0 → 80:20 pentane/ethyl acetate) to 




RF 0.55 (80:20 pentane/ethyl acetate); IR (film) νmax/cm
-1: 3062, 2955, 2884, 2194, 1698, 1668, 
1466, 1264, 1244; HRMS (ESI): Calcd. for C20H15F3NO2
+ ([M+H]+) m/z 380.0869, found 
m/z 380.0878; 
1H NMR (CDCl3, 400 MHz) δ 7.51 – 7.43 (m, 5H, ArCH), 7.42 – 7.36 (m, 3H, ArCH), 
7.33 – 7.29 (m, 2H, ArCH), 5.21 (dt, 2JHH = 9.7, 
4JHH = 1.3, 1H, CaH), 4.92 (dd, 
2JHH = 10.7, 
4JHH = 1.1, 1H, CaH), 4.75 (dq, 
2JHH = 9.8, 
4JHH = 1.0, 1H, CaH), 4.61 (d, 
2JHH = 10.7, 1H, CaH); 
13C NMR (CDCl3, 101 MHz) δ 184.0 (CcC(O)Cb), 156.5 (q, 
2JCF = 37.8, CF3C(O)NR2), 137.2 
(ArC), 133.4 (ArCH), 131.7 (ArCH), 129.5 (ArCH), 129.0 (ArCH), 128.8 (ArCH), 127.0 
(ArCH), 119.2 (ArC), 116.2 (q, 1JCF = 288.0, CF3), 97.3 (Cd), 84.9 (Cc), 59.2 (q, 
1JCF = 2.0, 
Ca), 56.6 (Ca), 54.8 (Cb); 19F NMR (CDCl3, 377 MHz) δ –72.59.   
3-Phenyl-1-(3-phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)prop-2-yn-1-one, 244p 
 Prepared following general procedure G using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1,3-diphenylprop-2-yn-1-ol, 197p 
(0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (100:0 → 80:20 pentane/ethyl acetate) 
to give 244p (88 mg, 89% yield) as a yellow solid. 
RF 0.40 (90:10 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2965, 2870, 2199, 1668, 1383, 1229, 
1198; HRMS (ESI): Calcd. for C19H14F3NO3SNa
+ ([M+Na]+) m/z 416.0539, found 
m/z 416.0527; 
1H NMR (CDCl3, 400 MHz) δ 7.52 – 7.43 (m, 5H, ArCH)), 7.43 – 7.35 (m, 3H, ArCH)), 
7.31 – 7.25 (m, 2H, ArCH)), 4.98 (d, 2JHH = 8.1, 2H, 2 × CaH), 4.65 (d, 
2JHH = 8.1, 2H, 
2 × CaH); 13C NMR (CDCl3, 101 MHz) δ 183.2 (CcC(O)Cb), 136.6 (ArC), 133.3 (ArCH), 
131.7 (ArCH), 129.5 (ArCH), 128.9 (ArCH), 128.9 (ArCH), 126.7 (ArCH), 119.9 (q, 1JCF = 
322.2, CF3), 119.1 (ArC), 97.3 (Cd), 84.7 (Cc), 59.3 (2 × Ca), 53.6 (Cb); 19F NMR (CDCl3, 
377 MHz) δ –75.29.   
1-(3-(Cyclohexanecarbonyl)-3-phenylazetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241q 
Prepared following general procedure F using the crude (1-
azabicyclo[1.1.0]butan-3-yl)(cyclohexyl)(phenyl)methanol, 197q 
(0.25 mmol). The crude reaction mixture was purified by flash column 
chromatography (98:2 → 80:20 DCM/ethyl acetate) to give 241q 




RF 0.42 (90:10 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2933, 2858, 1698, 1467, 1449, 1238, 
1203, 1146; HRMS (ESI): Calcd. for C18H20F3NO2Na
+ ([M+Na]+) m/z 362.1338, found 
m/z 362.1349; 
1H NMR (CDCl3, 400 MHz) δ 7.47 – 7.39 (m, 2H, 2 × CjH), 7.39 – 7.33 (m, 1H, CkH), 
7.24 – 7.19 (m, 2H, CiH), 5.13 (dt, 
2JHH = 9.5, 
4JHH = 1.3, 1H, CaH), 4.66 (d, 
2JHH = 10.7, 1H, 
CaH), 4.55 (dt, 
2JHH = 9.4, 
4JHH = 1.2, 2H, CaH), 2.46 (tt, 
3JHH = 10.1, 
3JHH = 3.3, 1H, CdH), 
1.73 – 1.63 (m, 2H, 2 × CfH), 1.63 – 1.52 (m, 2H, 2 × CfH), 1.39 (m, 2H, 2 × CeH), 1.30 – 1.20 
(m, 1H, CeH), 1.09 (m, 3H, CeH, CgH2); 13C NMR (CDCl3, 101 MHz) δ 209.0 (Cc), 156.5 (d, 
2JCF = 37.6, R2NC(O)CF3), 137.4 (Ch), 129.5 (2 × Ci), 128.5 (Ck), 126.4 (2 × Cj), 116.1 (d, 
1JCF 
= 288.1, CF3), 58.8 (Ca), 55.3 (Ca), 54.2 (Cb), 46.7 (Cd), 30.3 (Ce), 30.2 (Ce), 25.5 (2 × Cf, Cg); 
19F NMR (CDCl3, 377 MHz) δ –72.52.   
Semipinacol rearrangement of 197q with Tf2O 
 
Following general procedure G using the crude (1-azabicyclo[1.1.0]butan-3-
yl)(cyclohexyl)(phenyl)methanol, 197q (0.25 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 → 90:10 DCM/ethyl acetate), mixed fractions were 
further purified by flash column chromatography (99:1 → 60:40 pentane/DCM). 
2-Cyclohexyl-2-phenyl-5-((trifluoromethyl)sulfonyl)-1-oxa-5-azaspiro[2.3]hexane, 245 
Mixed fractions were discarded and 245 was isolated as a white solid 
(30 mg, 32% yield). 
RF 0.51 (50:50 pentane/DCM); IR (film) νmax/cm
-1: 2930, 2855, 
1446, 1377, 1226, 1195; HRMS (ESI): Calcd. for 
C17H20F3NO3SNa




1H NMR (CDCl3, 400 MHz) δ 7.39 – 7.29 (m, 3H, CiH, CkH), 7.27 – 7.21 (m, 2H, CjH), 4.66 
(d, 2JHH = 10.0, 1H, CaH), 4.56 (d, 
2JHH = 10.0, 1H, CaH), 4.14 (d, 
2JHH = 10.2, 1H, CaH), 4.08 
(d, 2JHH = 10.2, 1H, CaH), 1.91 – 1.67 (m, 4H, 2 × CeH, CfH, CgH), 1.67 – 1.53 (m, 1H, CgH), 
1.33 – 1.10 (m, 4H, CeH, 2 × CfH, CdH), 1.00 – 1.69 (m, CeH, CfH); 13C NMR (CDCl3, 
101 MHz) δ 134.4 (Ch), 128.4 (Ck), 128.3 (2 × Ci), 127.5 (2 × Cj), 120.0 (d, 
1JHH = 322.6), 69.7 
(Cc), 63.5 (Cb), 59.6 (Ca), 59.3 (Ca), 43.6 (Cd), 29.4 (Ce), 27.8 (Ce), 26.2 (Cf), 25.9 (Cf), 25.7 
(Cg); 19F NMR (CDCl3, 377 MHz) δ –74.82.   
Cyclohexyl(3-phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)methanone, 244q and (3-
cyclohexyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)(phenyl)methanone, 244q’  
Compounds 244q and 244q’ were isolated as a mixture in a 1:1.5 ratio 
(22 mg, 23% yield). 
RF 0.33 and 0.29 (95:5 DCM/ethyl acetate); IR (film) νmax/cm
-1: 2932, 
2855, 1710, 1678, 1448, 1385, 1223, 1192; HRMS (ESI): Calcd. for 
C17H20F3NO3SNa
+ ([M+Na]+) m/z 398.1021, found m/z 398.1008; 
1H NMR (CDCl3, 400 MHz) δ 7.73 – 7.67 (m, ArCH), 7.64 – 7.58 (m, 
ArCH), 7.53 – 7.46 (m, ArCH), 7.46 – 7.40 (m, ArCH), 7.40 – 7.34 
(m, ArCH), 7.20 – 7.13 (m, ArCH), 4.83 (d, 2JHH = 8.0, 2H, 2 × CaH), 4.62 (d, 
2JHH = 8.2, 2H, 
2 × Ca’H), 4.52 (d, 
2JHH = 8.0, 2H, 2 × CaH), 4.35 (d, 
2JHH = 8.3, 2H, 2 × Ca’H), 2.44 (tt, 
3JHH = 11.4, 3.6, 1H, CdH), 2.15 – 2.02 (m, 1H, Cd’H), 1.92 – 1.53 (m, CalkylH), 1.41 – 0.98 (m, 
CalkylH); 13C NMR (CDCl3, 101 MHz) δ 208.3 (Cc), 198.7 (Cc’), 136.9 (Ce), 134.0 (ArC), 132.8 
(ArC), 129.6 (ArC), 129.2 (ArC), 129.1 (ArC), 128.6 (ArC), 126.1 (ArC), 119.9 (q, 1JCF = 
322.6, CF3), 119.8 (q, 
1JCF = 321.9, CF3), 58.6 (2 ×Ca), 55.7 (2 ×Ca’), 53.2 (Cb), 51.5 (Cb’), 46.7 
(Cd), 41.7 (Cd’), 30.3 (Calkyl), 26.9 (Calkyl), 26.1 (Calkyl), 25.9 (Calkyl), 25.5 (Calkyl), 25.4 (Calkyl); 





Prepared following general procedure F using the purified 1-(1-
azabicyclo[1.1.0]butan-3-yl)-2,2,2-trifluoro-1-phenylethan-1-ol, 197r 
(0.25 mmol) with the following alteration: the reaction was stirred for 
15 minutes at –78 °C then 30 minutes at 0 °C. The crude reaction mixture 
was purified by flash column chromatography (95:5 → 60:40 
pentane/ethyl acetate) to give 241r (20 mg, 25% yield) as a white solid. In 
solution it exists as a mixture of the ketone and the hydrate. 
RF 0.24 (70:30 pentane/ethyl acetate); IR (film) νmax/cm
-1: 3380, 2963, 1754, 1697, 1458, 1260, 
1204, 1151; HRMS (APCI): Calcd. for C13H9F6NO2
+ ([M+H]+) m/z 326.0610, found m/z 
326.0600; Calcd. for C13H11F6NO3
+ (hydrate [M+H]+) m/z 344.0716, found m/z 344.0701; 
1H NMR (CDCl3, 400 MHz) δ 7.52 – 7.37 (m, 3H, 2 × CdH, CfH), 7.31 – 7.26 (m, 2H, 2 × CeH), 
5.18 (d, 2JHH = 10.1, 1H, CaH), 5.08 (d, 
2JHH =  9.9, 1H, Ca’H), 4.84 (d, 
2JHH = 11.2, 1H, CaH), 
4.78 (d, 2JHH = 10.1, 1H, CaH), 4.70 (d, 
2JHH = 9.9, 1H, Ca’H), 4.67 (d, 
2JHH = 11.2, 1H, CaH), 
4.41 (d, 2JHH = 10.7, 1H, CaH), 4.08 (s, 2H, 2 × OH); 13C NMR (CD2Cl2, 126 MHz) δ 188.5 
(q, 2JCF = 33.7, Cg), 156.5 (q, 
2JCF = 37.9, Ci), 156.1 (q, 
2JCF = 36.8, Ci’), 138.4 (Cc’), 133.9 
(Cc), 130.1 (2 × Cd), 129.8 (Cf), 128.9 (2 × Ce’), 128.6 (2 × Cd’), 128.4 (Cf), 127.1 (2 × Ce), 
125.8 (q, 1JCF = 268.9, Ch’), 116.6 (q, 
1JCF = 287.7, Cj’), 116.3 (q, 
1JCF = 290.0, Ch), 116.1 (q, 
1JCF = 293.7, Cj), 95.4 (q, 
2JCF = 30.5, Cg’), 59.7 (Ca’), 58.9 (Ca), 57.0 (Ca’), 55.5 (Ca), 51.6 
(Cb), 48.1 (Cb’).   
2,2,2-Trifluoro-1-(3-phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)ethan-1-one, 244r 
Prepared following general procedure G using the purified 1-(1-
azabicyclo[1.1.0]butan-3-yl)-2,2,2-trifluoro-1-phenylethan-1-ol, 197r 
(0.25 mmol) with the following alteration: the reaction was stirred for 
15 minutes at –78 °C then 30 minutes at 0 °C. The crude reaction mixture 
was purified by flash column chromatography (100:0 → 70:30 pentane/acetone) to give 244r 
(65 mg, 72% yield) as a white solid. In solution it exists as a mixture of the ketone and the 
hydrate. 
RF 0.22 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2982, 1750, 1382, 1229, 1190, 1160; 
HRMS (APCI): Calcd. for C12H9F6NO3S




1H NMR (CDCl3, 400 MHz) δ 7.53 – 7.41 (m, 3H, 2 × CcH, CdH), 7.25 – 7.19 (m, 2H, CbH), 
4.91 (d, 2JHH = 8.7, 2H, 2 × CaH), 4.66 (d, 
2JHH = 8.7, 1H, 2 × CaH); 13C NMR (CDCl3, 
101 MHz) δ 187.8 (q, 2JHH = 34.2, CF3C(O)Cf), 133.3 (Ce), 130.1 (2 × Cc), 129.8 (Cd), 126.6 
(2 × Cb), 119.9 (d, 
1JCF = 321.8, RSO2CF3), 115.8 (d, 
1JCF = 293.6, RC(O)CF3), 58.4 (d, 
3JCF = 
1.7, Ca), 50.4 (Cf); 19F NMR (CDCl3, 377 MHz) δ –71.33, –75.43.   
1-(3-benzoyl-3-phenylazetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241s 
Prepared following general procedure F using the crude (1-
azabicyclo[1.1.0]butan-3-yl)diphenylmethanol, 197s (0.25 mmol). 
The crude reaction mixture was purified by flash column 
chromatography (100:0 → 90:10 toluene/acetone) to give 241s (35 mg, 
42% yield) as a colourless oil. 
RF 0.53 (90:10 toluene/acetone); IR (film) νmax/cm
-1: 2969, 2870, 1696, 1681, 1448, 1469, 
1255, 1229, 1204, 1145; HRMS (ESI): Calcd. for C18H15F3NO2
+ ([M+H]+) m/z 334.1049, 
found m/z 334.1050; 
1H NMR (CDCl3, 400 MHz) δ 7.67 (dd, 
3JHH = 8.5, 
4JHH =1.3, 2H, CdH), 7.51 (tt, 
3JHH = 7.4, 
4JHH =1.3, 1H, CeH), 7.44 – 7.30 (m, 7H, ArCH), 5.22 (d, 
2JHH = 9.9, 1H, CaH), 4.81 (d, 
2JHH = 11.1, 1H, CaH), 4.70 (d, 
2JHH = 11.1, 1H, CaH), 4.64 (dt, 
2JHH = 9.9, 1.2, 1H, CaH); 13C 
NMR (CDCl3, 101 MHz) δ 197.0 (ArC(O)Cb), 156.6 (q, 
2JCF = 37.8, CF3C(O)NR2), 139.2 (Cc), 
133.9 (ArCH), 132.7 (Cf), 129.8 (ArCH), 129.8 (ArCH), 129.0 (ArCH), 128.4 (ArCH), 125.6 
(ArCH), 116.1 (q, 1JCF = 288.0, CF3), 61.0 (Ca), 57.3 (Ca), 52.1 (Cb); 19F NMR (CDCl3, 377 
MHz) δ –72.51.   
Phenyl(3-phenyl-1-((trifluoromethyl)sulfonyl)azetidin-3-yl)methanone, 244s 
Prepared following general procedure G using the crude (1-
azabicyclo[1.1.0]butan-3-yl)diphenylmethanol, 197s (0.25 mmol). 
The crude reaction mixture was purified by flash column 
chromatography (100:0 → 90:10 toluene/acetone) to give 244s 
(83 mg, 90% yield) as a white solid. 
RF 0.41 (80:20 petroleum ether/ethyl acetate); IR (film) νmax/cm
-1: 2981, 2869, 1673, 1384, 
1227, 1197; HRMS (ESI): Calcd. for C17H14F3NO3SNa





1H NMR (400 MHz, Chloroform-d) δ 7.61 – 7.51 (m, 2H, CdH), 7.47 – 7.38 (m, 1H, CdH), 
7.37 – 7.23 (m, 7H, ArCH), 4.88 (d, 2JHH = 8.2, 2H, 2 × CaH), 4.49 (d, 
2JHH = 8.2, 2H, 2 × CaH); 
13C NMR (101 MHz, CDCl3) δ 196.5 (ArC(O)Cb), 138.8 (Cc), 134.0 (ArCH), 132.6 (Cf), 129.9 
(ArCH), 129.7 (ArCH), 129.0 (ArCH), 128.6 (ArCH), 125.5 (ArCH), 119.9 (q, 1JCF = 322.6, 
CF3) 60.6 (2 × Ca), 50.9 (Cb); 19F NMR (CDCl3, 377 MHz) δ –75.21.   
1-(3-Benzoyl-3-(4-methoxyphenyl)azetidin-1-yl)-2,2,2-trifluoroethan-1-one, 241t and 
2,2,2-trifluoro-1-(3-(4-methoxybenzoyl)-3-phenylazetidin-1-yl)ethan-1-one, 241t’ 
 
Prepared following general procedure F using the crude (1-azabicyclo[1.1.0]butan-3-yl)(4-
methoxyphenyl)(phenyl)methanol, 197t (0.25 mmol). The crude reaction mixture was purified 
by flash column chromatography (100:0 → 90:10 pentane/acetone) and further purified by 
flash column chromatography (90:10 DCM/ethyl actetate) to give a mixture of 241t and 241t’ 
in a 1:0.3 ratio respectively (36 mg, 42% yield). 
RF 0.38 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2981, 2870, 1698, 1682, 1514, 1467, 
1251, 1146; HRMS (ESI): Calcd. for C19H17F3NO3
+ ([M+H]+) m/z 364.1155, found 
m/z 364.1161; 
1H NMR (CDCl3, 500 MHz) δ 7.67 (dd, 
3JHH = 8.4, 
4JHH = 1.2, 2H, 2 × ArCH), 7.64 (d, 
3JHH = 9.0, 2H, 2 × ArCH’), 7.51 (tt, 
3JHH = 7.0, 
4JHH = 1.2, 1H, CeH), 7.38 (m, 2H, 2 × ArCH), 
7.29 (d, 3JHH = 8.9, 2H, 2 × ArCH), 6.92 (d, 
3JHH = 8.9, 2H, 2 × ArCH), 6.84 (d, 
3JHH = 9.0, 
2H, 2 × ArCH’), 5.22 (d, 2JHH = 9.8, 1H, Ca’H), 5.20 (d, J = 9.9, 1H, CaH), 4.80 (d, 
2JHH = 11.1, 
1H, Ca’H), 4.78 (d, 
2JHH = 11.0, 1H, CaH), 4.68 (d, 
2JHH = 11.1, 1H, Ca’H), 4.65 (d, 
2JHH = 10.9, 
1H, CaH), 4.60 (d, 
2JHH = 9.8, 1H, Ca’H), 4.59 (d, 
2JHH = 9.9, 1H, CaH), 3.82 (OCH3’), 3.79 (s, 
3H, OCH3); 13C NMR (CDCl3, 101 MHz) δ 197.1 (Cc), 195.5 (Cc’), 163.9 (Cf’), 159.5 (Cf), 
156.6 (q, 2JCF = 37.7, Ch), 156.6 (q, 
2JCF = 37.8, Ch’), 139.6 (Cg’), 133.7 (Ce), 132.7 (Cd), 132.1 
(ArCH’), 131.0 (Cg), 129.7 (ArCH), 129.7 (ArCH’), 128.9 (ArCH), 128.2 (Ce’), 126.8 (ArCH), 
125.5 (ArCH’), 115.7 (q, 1JCF = 289.0, CF3) 115.1 (ArCH), 114.2 (ArCH’), 61.1 (q, 
4JCF = 2.2, 
Ca), 61.1 (Ca’), 57.4 (Ca), 57.4 (Ca’), 55.6 (OCH3’), 55.4 (OCH3), 51.8 (Cb’), 51.6 (Cb); 19F 







Prepared following general 
procedure G using the crude (1-
azabicyclo[1.1.0]butan-3-yl)(4-
methoxyphenyl)(phenyl)methanol, 
197t (0.25 mmol). The crude 
reaction mixture was purified by flash column chromatography (100:0 → 90:10 
pentane/acetone) and further purified by flash column chromatography (90:10 DCM/ethyl 
actetate) to give a mixture of 244t and 244t’ in a 1:0.8 ratio respectively (88 mg, 80% yield). 
RF 0.15 (90:10 pentane/acetone); IR (film) νmax/cm
-1: 2968, 2906, 1676, 1599, 1513, 1386, 
1257, 1224, 1203; HRMS (ESI): Calcd. for C18H17F3NO4S
+ ([M+H]+) m/z 400.0825, found 
m/z 400.0840; 
1H NMR (CDCl3, 400 MHz) δ 7.63 (dd, 
3JHH = 8.3,
 4JHH = 1.4, 2H, ArCH), 7.59 (d, 
3JHH = 8.9, 
2H, ArCH), 7.51 (t, 3JHH = 7.6, 1H, CeH), 7.43 – 7.24 (m, 9H, ArCH), 6.93 (d, 
3JHH = 8.9, 2H, 
ArCH), 6.83 (dd, 3JHH = 9.0, 
4JHH = 2.4, 2H, ArCH), 4.94 (m, 4H, CaH, CaH’), 4.53 (m, 4H, 
CaH, CaH’), 3.82 (s, 3H, OCH3), 3.80 (s, 3H, OCH3); 13C NMR (CDCl3, 101 MHz) δ 196.7 
(Cc), 195.1 (Cc’), 164.0 (Cf’), 159.6 (Cf), 139.2 (Cg’), 133.8 (Ce), 132.6 (Cd), 132.1 (ArCH’), 
130.6 (Cg), 129.8 (ArCH’), 129.7 (ArCH), 129.0 (ArCH), 128.4 (Ce’), 126.7 (ArCH), 125.4 
(ArCH’), 119.9 (q, 1JCF = 322.4, CF3), 115.2 (ArCH), 114.3 (ArCH’), 60.8 (Ca), 60.7 (Ca’), 
55.6 (OCH3’), 55.4 (OCH3), 50.6 (Cb’), 50.4 (Cb); 19F NMR (CDCl3, 377 MHz) δ –75.07. 
6.4.8. Attempts to improve the semipinacol rearrangement reaction 
2,2,2-Trifluoro-1-(3-(1-hydroxycyclohexyl)-3-iodoazetidin-1-yl)ethan-1-one, 246 
 
To a round bottom flask containing a mixture of crude 197j (1.0 mmol, 1.0 equiv) and sodium 
iodide (300 mg, 2.0 mmol, 2.0 equiv) under an inert atmosphere was added anhydrous 
acetonitrile (10 mL). The flask was cooled to 0 °C and trifluoroacetic anhydride (0.16 mL, 




aqueous sodium bicarbonate solution (20 mL) and ethyl acetate (20 mL) were added, and the 
reaction mixture transferred to a separating funnel. The phases were separated, and the aqueous 
phase was extracted with ethyl acetate (3 × 20 mL) and the combined organic phases were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
reaction mixture was purified by flash column chromatography (99:1 → 80:20 
pentane/acetone) to give 246 (188 mg, 50% yield) as a colourless oil. 
RF 0.58 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 3487, 2923, 2860, 1677, 1248, 1201, 
1163; HRMS (ESI): Calcd. for C11H15NO2F3I
+ ([M+H]+) m/z 378.0172, found m/z 378.0176 
1H NMR (CDCl3, 400 MHz) δ 5.11 (d, 
2JHH = 10.9, 1H, CaH), 4.81 (d, 
2JHH = 11.9, 1H, CaH), 
4.69 (dt, 2JHH = 10.8, 
4JHH = 1.5, 1H, CaH), 4.47 (dd, 
2JHH = 11.9, 
4JHH = 1.8, 1H, CaH), 2.13 
(br. s, 1H, OH), 1.83 – 1.44 (m, 9H, 2 × CeH2, 2 × CdH2, CfH), 1.14 (dtt,
 2JHH = 12.9, 
3JHH = 
12.9, 3.7, 1H, CfH); 13C NMR (CDCl3, 101 MHz) δ 156.4 (q, 
2JCF = 37.8, R2NC(O)CF3), 116.0 
(d, 1JCF = 288.1, CF3), 73.8 (Cc), 66.4 (q, 
4JCF = 2.3, Ca), 63.7 (Ca), 43.4 (Cb), 32.9 (Cd), 32.4 




To a round bottom flask containing iodohydrin 246 (0.1 mmol, 1.0 equiv) under an inert 
atmosphere was added anhydrous THF (1 mL). The flask was cooled to 0 °C before the addition 
of 2,6-lutidineA (14 μL, 0.12 mmol, 1.2 equiv) and silver perchlorate (25 mg, 1.2 mmol, 
1.2 equiv). The reaction was warmed to room temperature and stirred overnight. Water (10 mL) 
and ethyl acetate (10 mL) were added, and the reaction mixture transferred to a separating 
funnel. The phases were separated, and the aqueous phase was extracted with ethyl acetate 
(3 × 10 mL) and the combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. The crude reaction mixture was purified by flash 
column chromatography (98:2 → 85:15 pentane/acetone) to give three fractions containing: 
249, 241j and 248. 




RF 0.21 (95:5 pentane/ethyl acetate); IR (film) νmax/cm
-1: 3411, 2930, 
1685, 1460, 1252, 1204, 1146; HRMS (APCI): Calcd. for C11H14NO2F3
+ 
([M+H]+) m/z 250.1049, found m/z 250.1049;  
1H NMR (CDCl3, 400 MHz) δ 5.84 (tt, 
3JHH = 3.7, 
4JHH = 1.6, 1H, CdH), 4.52 (dt, 
2JHH = 10.1, 
4JHH = 1.5, 1H, CaH), 4.38 – 4.24 (m, 2H, 2 × CaH), 4.05 (dd, 
2JHH = 11.0, 
4JHH = 1.6, 1H, CaH), 
2.23 (br. s, 1H, OH), 2.15 – 2.07 (m, 2H, Ce H2), 2.06 – 2.02  (m, 2H, ChH2), 1.72 – 1.66 (m, 
2H, CgH2), 1.63 – 1.56 (m, 2H, CfH2); 13C NMR (CDCl3, 101 MHz) δ 156.5 (q, 
2JCF = 37.4, 
CF3C(O)NR2), 136.7 (Cc), 124.5 (Cd), 116.1 (d, 
1JCF = 288.1, CF3), 73.6 (Cb), 63.0 (q, 
4JCF 
= 1.9, Ca), 60.3 (Ca), 25.0 (Ce), 23.3 (Ch), 22.4 (Cg), 21.9 (Cf); 19F NMR (CDCl3, 377 MHz) δ 
–72.53. 
RF 0.67 (80:20 pentane/ethyl acetate); IR (film) νmax/cm
-1: 2937, 2862, 
1701, 1454, 1259, 1202, 1150; HRMS (APCI): Calcd. for C11H14NO2F3
+ 
([M+H]+) m/z 250.1049, found m/z 250.1043 
1H NMR (CDCl3, 400 MHz) δ 4.57 (dt, 
2JHH = 11.0, 
4JHH = 1.6, 1H, CaH), 4.53 (dt, 
2JHH = 
11.1, 2.0, 1H, CaH), 4.38 (dd, 
2JHH = 12.0, 
4JHH = 2.0, 1H, CaH), 4.31 (d, 
2JHH = 12.0, 1H, CaH), 
1.81 – 1.70 (m, 2H, 2 × CeH), 1.66 – 1.51 (m, 4H, 2 × CeH, CfH2), 1.50 – 1.44 (m, 4H, 2 × 
CdH2); 13C NMR (CDCl3, 101 MHz) δ 156.1 (q, 
2JCF = 37.4, CF3C(O)NR2), 116.02 (d, 
1JCF = 
288.1), 64.4 (Cb), 63.7 (Cc), 58.1 (Ca), 55.7 (Ca), 30.9 (Cd), 30.7 (Cd), 25.0 (Cf), 24.5 (Ce), 24.5 
(Ce); 19F NMR (CDCl3, 377 MHz) δ –72.80. 
6.4.9. General procedure H for the synthesis of spiro epoxy azetidines 
 
To a round bottom flask containing a mixture of the azabicyclo[1.1.0]butyl carbinol 
(0.25 mmol, 1.0 equiv) and sodium iodide (75 mg, 0.50 mmol, 2.0 equiv) under an inert 
atmosphere was added anhydrous acetonitrile (2.5 mL). The flask was cooled to 0 °C and 
benzyl chloroformate (40 μL, 0.30 mmol, 1.2 equiv) was added with stirring. After 15 minutes 
at 0 °C, potassium carbonate (69 mg, 0.50 mmol, 2.0 equiv) was added followed by anhydrous 
methanol (2.5 mL) and the reaction was warmed to room temperature. The progress of the 
reaction was monitored by TLC and usually found to be complete within 2 hours at room 




saturated aqueous sodium bicarbonate solution (10 mL) were added, and the reaction mixture 
transferred to a separating funnel. The phases were separated, and the aqueous phase was 
extracted with diethyl ether or ethyl acetate (3 × 20 mL) and the combined organic phases were 
washed with brine, dried (MgSO4), filtered and concentrated under reduced pressure. 
6.4.10. General procedure I for the synthesis of spiro epoxy azetidines 
 
To a round bottom flask containing a mixture of the azabicyclo[1.1.0]butyl carbinol 
(0.25 mmol, 1.0 equiv) and sodium iodide (75 mg, 0.5 mmol, 2.0 equiv) under an inert 
atmosphere was added anhydrous acetonitrile (2.5 mL). The flask was cooled to 0 °C and 
benzyl chloroformate (40 μL, 0.30 mmol, 1.2 equiv) was added with stirring. After 15 minutes 
at 0 °C, saturated aqueous sodium bicarbonate solution (10 mL) and diethyl ether or ethyl 
acetate (10 mL) were added, and the reaction mixture transferred to a separating funnel. The 
phases were separated, and the aqueous phase was extracted with diethyl ether or ethyl acetate 
(3 × 20 mL) and the combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure.  
After isolation and characterisation, the iodohydrin was transferred to a round bottom flask and 
potassium carbonate (69 mg, 0.50 mmol, 2.0 equiv) was added. Under and inert atmosphere, 
anhydrous methanol (2.5 mL) was added, and the reaction was stirred at room temperature for 
30 minutes. Saturated aqueous sodium bicarbonate solution (10 mL) and diethyl ether or ethyl 
acetate (10 mL) were added, and the reaction mixture transferred to a separating funnel. The 
phases were separated, and the aqueous phase was extracted with diethyl ether or ethyl acetate 
(3 × 20 mL) and the combined organic phases were washed with brine, dried (MgSO4), filtered 
and concentrated under reduced pressure. 
6.4.11. Scope of the epoxide formation reaction 
Benzyl 2-methyl-2-phenyl-1-oxa-5-azaspiro[2.3]hexane-5-carboxylate, 250a 
Prepared following general procedure 3a using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-phenylethan-1-ol 197a (0.25 mmol) and 




flash column chromatography (98:2 → 85:15 pentane/acetone) to give 250a (74 mg, 96% 
yield) as a colourless oil. 
RF 0.5 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2959, 2871, 1711, 1445, 1405, 1351; 
HRMS (ESI): Calcd. for C19H19NO3Na
+ ([M+Na]+) m/z 332.1257, found m/z 332.1255; 
1H NMR (CDCl3, 400 MHz) δ 7.35 – 7.25 (m, 8H, ArCH), 7.25 – 7.17 (m, 2H, ArCH), 5.08 
(s, 2H, ROCH2Ph), 4.35 (dd, 
2JHH = 10.4, 
4JHH = 1.5, 1H, CaH), 4.26 (ddd, 
2JHH = 10.5, 
4JHH = 1.6, 0.8, 1H, CaH), 4.12 (ddd, 
2JHH = 10.6, 
4JHH = 1.1, 0.8, 1H, CaH), 3.76 (dd, 
2JHH = 10.5, 
4JHH = 1.6, 1H, CaH), 1.63 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 156.3 
(R2NC(O)OR), 138.0 (ArC), 136.5 (ArC), 128.6 (ArCH), 128.6 (ArCH), 128.3 (ArCH), 128.2 
(ArCH), 128.0 (ArCH), 125.5 (ArCH), 67.1 (ROCH2Ph), 66.0 (Cb), 62.9 (Cc), 56.2 (br., 2 × 
Ca), 19.3 (CH3).   
tert-Butyl 3-(1-(1-((benzyloxy)carbonyl)-3-iodoazetidin-3-yl)-1-hydroxyethyl)-1H-indole-
1-carboxylate, 8d’ and benzyl 2-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)-2-methyl-1-oxa-
5-azaspiro[2.3]hexane-5-carboxylate, 250d 
Prepared following general procedure I using the crude tert-Butyl 3-(1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-hydroxyethyl)-1H-indole-1-carboxylate 197d (0.25 mmol). 
The crude reaction mixture was purified by flash column chromatography (98:2 → 85:15 
pentane/acetone) and further purified by flash column chromatography (100:0 → 95:5 
DCM/methanol) to give 242d (88 mg, 61% yield) as a colourless oil. After the addition of 
potassium carbonate and methanol, the crude mixture did not require purification and gave 
250d (69 mg, 62% yield) as a colourless oil. 
RF 0.32 (98:2 pentane/methanol); IR (film) νmax/cm
-1: 3429, 
2977, 1690, 1449, 1368, 1254, 1151; HRMS (ESI): Calcd. for 
C26H29IN2O5Na
+ ([M+Na]+) m/z 599.1013, found 
m/z 599.0990; 
1H NMR (CDCl3, 400 MHz) δ 8.06 (d, 
3JHH = 8.3, 1H, ArCH), 7.85 (d, 
3JHH = 7.9, 1H, ArCH), 
7.59 (s, 1H, CeH), 7.29 – 7.07 (m, 7H, ArCH), 4.93 (s, 2H, ROCH2Ph), 4.83 (app. d, 
2JHH = 10.0, 2H, 2 × CaH), 4.45 (dd, 
2JHH = 10.0, 
4JHH = 1.2, 1H, CaH), 4.33 (dd, 
2JHH = 10.3, 
4JHH = 1.2, 1H, CaH), 2.64 (br. s, 1H, OH), 1.78 (s, 3H, CH3), 1.60 (s, 9H, Cg(CH3)3); 13C NMR 
(CDCl3, 101 MHz) δ 156.3 (Ch), 149.6 (Cf), 136.3 (ArC), 135.6 (ArC), 128.7 (ArC), 128.6 




121.5 (Cd), 115.4 (ArCH), 84.4 (Cg), 76.2 (Cc), 67.1 (ROCH2Ph), 65.2 (br., 2 × Ca), 45.3 (Cb), 
28.3 (Cg(CH3)3), 27.3 (CH3).   
 
IR (film) νmax/cm
-1: 2978, 1709, 1450, 1372, 1243, 1153; HRMS 
(ESI): Calcd. for C26H28N2O5Na
+ ([M+Na]+) m/z 471.1890, found 
m/z 471.1907; 
1H NMR (CDCl3, 400 MHz) δ 8.16 (d, 
3JHH = 8.4, 1H, ArCH), 
7.65 (dt, 3JHH = 7.9, 
4JHH = 1.1, 1H, ArCH), 7.53 (s, 1H, CeH), 
7.33 (m, 6H, ArCH), 7.23 (ddd, 3JHH = 8.2, 7.2, 
4JHH = 1.1, 1H, 
ArCH), 5.09 (s, 2H, ROCH2Ph), 4.42 (dd, 
2JHH = 10.4, 
4JHH = 1.5, 1H, CaH), 4.32 (ddd, 
2JHH = 
10.4, 4JHH = 1.5, 0.8, 1H, CaH), 4.20 (ddd, 
2JHH = 10.6, 
4JHH = 1.5, 0.8, 1H, CaH), 3.88 (dd, 
2JHH = 10.6, 
4JHH = 1.5, 1H, CaH), 1.71 (s, 3H, CH3), 1.68 (s, 9H, Cg(CH3)3); 13C NMR (CDCl3, 
101 MHz) δ 156.3 (Ch), 149.4 (Cf), 136.4 (ArC), 135.7 (ArC), 128.6 (ArCH), 128.2 (ArC), 
128.2 (ArCH), 128.1 (ArCH), 124.9 (ArCH), 124.0 (Ce), 123.0 (ArCH), 120.2 (ArCH), 118.5 
(Cd), 115.5 (ArCH), 84.3 (Cg), 67.1 (ROCH2Ph), 65.6 (Cb), 60.4 (Cc), 56.3 (br., Ca), 56.0 (br., 
Ca), 28.3 (Cg(CH3)3), 20.3 (CH3).   
Benzyl 2-(6-bromopyridin-3-yl)-2-methyl-1-oxa-5-azaspiro[2.3]hexane-5-carboxylate, 
250f 
Prepared following general procedure H using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)-1-(6-bromopyridin-3-yl)ethan-1-ol 197f 
(0.25 mmol) and CbzCl (40 μL, 1.2 equiv). The crude reaction mixture 
was purified by flash column chromatography (95:5 → 80:20 
pentane/acetone) to give 250f (64 mg, 66% yield) as a white solid. 
RF 0.35 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2967, 1737, 1715, 1454, 1408, 1353, 
1216; HRMS (ESI): Calcd. for C18H17BrN2O3Na
+ ([M+Na]+) m/z 411.0315, found 
m/z 411.0317 
1H NMR (CDCl3, 400 MHz) δ 8.30 (dd, 
4JHH = 2.5, 
5JHH = 0.8, 1H, CeH), 7.46 (dd, 
3JHH = 8.3, 
5JHH = 0.8, 1H, CgH), 7.37 (dd, 
3JHH = 8.3,
 4JHH = 2.5, 1H, CfH), 7.35 – 7.28 (m, 5H, ArCH), 
5.09 (s, 2H, ROCH2Ph), 4.36 (dd, 
2JHH = 10.5, 
4JHH = 1.6, 1H, CaH), 4.27 (ddd, 
2JHH = 10.5, 
4JHH = 0.8, 0.8, 1H, CaH), 4.13 (ddd, 
2JHH = 10.5,
 4JHH = 0.8, 0.8, 1H, CaH), 3.77 (dd, 
2JHH = 10.5,
 4JHH = 1.6, 1H, CaH), 1.64 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 156.2 




128.3 (ArCH), 128.2 (ArCH), 127.9 (Cg), 67.3 (ROCH2Ph), 66.3 (Cc), 60.9 (Cd), 55.9 (br., Ca), 
55.8 (br., Ca), 18.9 (CH3).   
Benzyl 11-oxa-2-azadispiro[3.0.5.1]undecane-2-carboxylate, 250j 
Prepared following general procedure H using the crude 1-(1-
azabicyclo[1.1.0]butan-3-yl)cyclohexan-1-ol 197j (0.25 mmol) and 
CbzCl (40 μL, 1.2 equiv). The crude reaction mixture was purified 
by flash column chromatography (95:5 → 80:20 pentane/acetone) 
to give 250j (64 mg, 90% yield) as a colourless oil. 
RF 0.35 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2933, 2855, 1712, 1448, 1407, 1354, 
1216; HRMS (ESI): Calcd. for C17H21NO3Na
+ ([M+Na]+) m/z 310.1414, found m/z 310.1412; 
1H NMR (CDCl3, 400 MHz) δ 7.42 – 7.28 (m, 2H, ArCH), 5.12 (s, 2H, ROCH2Ph), 4.22 (d, 
2JHH = 11.0, 1H, 2 × CaH), 4.17 (d, 
2JHH = 11.0, 1H, 2 × CaH), 1.79 – 1.67 (m, 2H, 2 × CeH), 
1.61 – 1.48 (m, 4H, 2 × CeH, CfH2), 1.46 – 1.40 (m, 4H, 2 × CdH2); 13C NMR (CDCl3, 
101 MHz) δ 156.3 (R2NC(O)OR), 136.5 (Cg), 128.5 (ArCH), 128.2 (Cj), 128.1 (ArCH), 67.0 
(ROCH2Ph), 64.1 (Cb), 64.0 (Cc), 55.9 (br., 2 × Ca), 30.9 (2 × Cd), 25.1 (Cf), 24.6 (2 × Ce).   
2-Benzyl 7-(tert-butyl) 9-oxa-2,7-diazadispiro[3.0.35.14]nonane-2,7-dicarboxylate, 250l 
Prepared following general procedure H using the crude tert-
butyl 3-(1-azabicyclo[1.1.0]butan-3-yl)-3-hydroxyazetidine-1-
carboxylate 197l (0.25 mmol) and CbzCl (40 μL, 1.2 equiv). 
The crude reaction mixture was purified by flash column 
chromatography (98:2 → 85:15 pentane/acetone) to give 250l (82 mg, 91% yield) as a 
colourless oil. 
RF 0.39 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2969. 2942, 1697, 1454, 1390, 1352, 
1143; HRMS (ESI): Calcd. for C19H24N2O5Na
+ ([M+Na]+) m/z 383.1577, found m/z 383.1583; 
1H NMR (CDCl3, 400 MHz) δ 7.39 – 7.28 (m, 5H, ArCH), 5.12 (s, 2H, ROCH2Ph), 4.20 (s, 
4H, 2 × CaH2), 4.11 (s, 2H, 2 × CdH2), 1.45 (s, 9H, Cf(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 
156.3 (Cg), 156.0 (Ce), 136.3 (ArC), 128.6 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 80.5 (Cf), 
67.3 (ROCH2Ph), 61.3 (Cc/Cb), 61.3 (Cc/Cb), 55.7 (br., 2 × Ca), 55.4 (br., 2 × Ca), 28.4 




Benzyl 2-phenyl-1-oxa-5-azaspiro[2.3]hexane-5-carboxylate, 250n 
Prepared following general procedure H using the crude (1-
Azabicyclo[1.1.0]butan-3-yl)(phenyl)methanol 197n (0.25 mmol) 
and CbzCl (40 μL, 1.2 equiv). After the addition of potassium 
carbonate and methanol, the reaction was stirred for 42 hours at room 
temperature. The crude reaction mixture was purified by flash column chromatography (95:5 
→ 80:20 pentane/acetone) to give 250n (59 mg, 80% yield) as a colourless oil. 
RF 0.46 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2945, 1735, 1712, 1446, 1409, 1354, 
1217; HRMS (ESI): Calcd. for C18H17NO3Na
+ ([M+H]+) m/z 318.1101, found m/z 318.1103; 
1H NMR (CDCl3, 400 MHz) δ 7.40 – 7.29 (m, 8H, ArCH), 7.17 – 7.10 (m, 2H, ArCH), 5.11 
(s, 2H, ROCH2Ph), 4.43 (dd, 
2JHH = 10.4, 
4JHH = 1.5, 1H, CaH), 4.36 (d, 
2JHH = 10.4, 1H, CaH), 
4.31 (dt, 2JHH = 10.5, 
4JHH = 1.0, 1H, CaH), 4.01 (s, 1H, CcH), 3.97 (dd, 
2JHH = 10.5, 
4JHH = 1.6, 
1H, CaH); 13C NMR (CDCl3, 101 MHz) δ 156.2 (R2NC(O)OR), 136.4 (ArC), 134.5 (ArC), 
128.7 (ArCH), 128.7 (ArCH), 128.6 (ArCH), 128.2 (ArCH), 128.2 (ArCH), 125.8 (ArCH), 
67.1 (ROCH2Ph), 62.6 (Cb), 60.1 (Cc), 57.2 (br., Ca), 55.9 (br., Ca).   
Benzyl 3-(1-hydroxy-1,3-diphenylprop-2-yn-1-yl)-3-iodoazetidine-1-carboxylate, 242p 
and benzyl 2-phenyl-2-(phenylethynyl)-1-oxa-5-azaspiro[2.3]hexane-5-carboxylate 250p 
Prepared following general procedure I using the crude 1-(1-azabicyclo[1.1.0]butan-3-yl)-1,3-
diphenylprop-2-yn-1-ol 197p (0.25 mmol). The crude reaction mixture was purified by flash 
column chromatography (100:0 → 95:5 DCM/ethyl acetate) to give 242p (121 mg, 98% yield) 
as a colourless oil. After the addition of potassium carbonate and methanol, the crude mixture 
did not require purification and gave 250p (85 mg, 86% yield) as a colourless oil. 
RF 0.46 (95:5 DCM/ethyl acetate); IR (film) νmax/cm
-1: 
3339, 2969, 1737, 1715, 1685, 1420, 1354, 1216; HRMS 
(ESI): Calcd. for C26H22INO3Na
+ ([M+Na]+) m/z 546.0537, 
found m/z 546.0510; 
1H NMR (CDCl3, 400 MHz) δ 7.70 (dd, 
3JHH = 7.4, 
4JHH = 2.3, 2H, ArCH), 7.51 – 7.41 (m, 
2H, ArCH), 7.40 – 7.21 (m, 11H, ArCH), 5.16 (d, 2JHH = 10.2, 1H, CaH), 5.09 (d, 
2JHH = 10.2, 
1H, CaH), 5.00 (s, 2H, ROCH2Ph), 4.47 (d, 
2JHH = 10.0, 1H, CaH), 4.45 (d, 
2JHH = 10.0, 1H, 
CaH), 3.38 (s, 1H, OH); 13C NMR (CDCl3, 101 MHz) δ 156.4 (R2NC(O)OR), 140.5 (ArC), 




(ArCH), 128.1 (ArCH), 128.0 (ArCH), 127.3 (ArCH), 121.6 (ArC), 88.2 (Ce), 86.8 (Cd), 76.7 
(Cc), 67.1 (ROCH2Ph), 65.1 (br., 2 × Ca), 41.4 (Cb).   
IR (film) νmax/cm
-1: 2968, 2943, 1712, 1443, 1403, 1352, 1216; 
HRMS (ESI): Calcd. for C26H21NO3Na
+ ([M+Na]+) 
m/z 418.1414, found m/z 418.1428; 
1H NMR (CDCl3, 400 MHz) δ 7.53 (dd, 
3JHH = 7.9, 
4JHH = 1.7, 
2H, ArCH), 7.46 – 7.29 (m, 13H ArCH), 5.12 (s, 2H, ROCH2Ph), 
4.59 (dd, 2JHH = 10.7, 
4JHH = 1.6, 1H, CaH), 4.43 (ddd, 
2JHH = 10.7, 
4JHH = 0.7, 1H, CaH), 4.29 
(ddd, 2JHH = 10.7, 
4JHH = 0.7, 1H, CaH), 3.91 (dd, 
2JHH = 10.7, 
4JHH = 1.6 , 1H, CaH); 13C NMR 
(CDCl3, 101 MHz) δ 156.3 (R2NC(O)OR), 136.4 (ArC), 134.1 (ArC), 132.3 (ArCH), 129.4 
(ArCH), 128.9 (ArCH), 128.7 (ArCH), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 128.2 
(ArCH), 126.0 (ArCH), 121.5 (ArC), 87.3 (Ce), 83.8 (Cd), 68.6 (Cc), 67.3 (ROCH2Ph), 58.3 
(Cb), 56.8 (Ca), 55.6 (Ca).   
2,2,2-Trifluoro-1-(2-phenyl-2-(trifluoromethyl)-1-oxa-5-azaspiro[2.3]hexan-5-yl)ethan-
1-one, 252 
Prepared following general procedure H using 1-(1-
azabicyclo[1.1.0]butan-3-yl)-2,2,2-trifluoro-1-phenylethan-1-ol 197r 
(0.25 mmol) and TFAA (40 μL, 1.2 equiv) in place of CbzCl. The crude 
reaction mixture was purified by flash column chromatography (99:1 → 
85:15 pentane/acetone) to give 252 (40 mg, 49% yield) as a colourless oil. 
RF 0.34 (90:10 pentane/methanol); IR (film) νmax/cm
-1: 2950, 1704, 1514, 1494, 1451, 1333, 
1291, 1251, 1141; HRMS (APCI): Calcd. for C13H9NO2F6
+ ([M+H]+) m/z 326.0610, found 
m/z 326.0619; 
Rotamers observed. 
1H NMR (CDCl3, 400 MHz) δ 7.51 – 7.38 (m, 5H, ArCH), 4.88 (d, 
2JHH = 12.4, 1H), 4.83 (d, 
2JHH = 11.8, 1H), 4.69 (d, 
2JHH = 13.0, 1H), 4.61 (dd, 
2JHH = 13.1,
 4JHH = 2.1, 1H), 4.38 (dt, 
2JHH = 11.8, 
4JHH = 1.1, 1H), 4.27 (ddd, 
2JHH = 11.8, 
4JHH = 2.2, 1.2, 1H), 4.14 (d, 
2JHH = 12.7, 
0H), 4.09 (dd, 2JHH = 12.8, 
4JHH = 1.9, 1H); 13C NMR (CDCl3, 101 MHz) δ 156.1 (q, 
2JCF = 38.3, R2NC(O)CF3), 156.1 (q, 
2JCF = 38.3, R2NC(O)CF3), 130.4 (Cg), 129.2 (ArCH), 
129.2 (ArCH), 127.9 (Cd), 127.7 (Cd), 127.0 (ArCH), 127.0 (ArCH), 122.8 (q, 
1JCF = 278.5, 
CcCF3), 122.7 (q, 
1JCF = 279.1, CcCF3), 115.9 (q, 





287.6, R2NC(O)CF3), 64.4 (Cb), 64.3 (Cb), 62.5 (q, 
2JCF = 37.3, Cc), 62.5 (q, 
2JCF = 37.3, Cc), 
58.5 (m, Ca), 57.7 (m, Ca), 56.2, (m, Ca), 55.4 (Ca); 19F NMR (CDCl3, 377 MHz) δ –71.60 
(CcCF3), –71.63 (CcCF3), –72.78 (R2NC(O)CF3), –72.81 (R2NC(O)CF3).   
2,2,2-Trifluoro-1-(2-methyl-2-phenyl-1-oxa-5-azaspiro[2.3]hexan-5-yl)ethan-1-one, 253 
 Prepared following general procedure H using the crude 197a (0.25 mmol) 
and TFAA (40 μL, 1.2 equiv) in place of CbzCl. The crude reaction mixture 
was purified by flash column chromatography (98:2 → 85:15 
pentane/acetone) to give 253 (26 mg, 38% yield) as a colourless oil. Ketone 
241a was also isolated (24 mg, 36% yield). 
RF 0.49 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2969, 1738, 1446, 1365, 1229, 1216; 
HRMS (ESI): Calcd. for C13H12F3NO3Na
+ ([M+Na]+) m/z 294.0712, found m/z 294.0723; 
Rotamers observed. 
1H NMR (CDCl3, 400 MHz) δ 7.52 – 7.15 (m, 5H, ArCH), 4.71 (d, 
2JHH = 11.1, 1H, CaH), 
4.63 (d, 2JHH = 11.2, 1H, CaH), 4.51 (d, 
2JHH = 12.7, 1H, CaH), 4.47 (d, 
2JHH = 12.1, 1H, CaH), 
4.39 (d, 2JHH = 12.0, 1H, CaH), 4.24 (d, 
2JHH = 12.3, 1H, CaH), 4.10 (d, 
2JHH = 11.1, 1H, CaH), 
3.93 (d, 2JHH = 12.2, 1H, CaH), 1.69 (s, 6H, CH3); 13C NMR (CDCl3, 101 MHz) δ 156.2 (q, 
2JCF = 37.8, CF3C(O)NR2), 156.1 (q, 
2JCF = 37.8, CF3C(O)NR2), 137.3 (Cd), 137.2 (Cd), 128.9 
(ArCH), 128.8 (ArCH), 128.5 (ArCH), 125.5 (ArCH), 125.4 (ArCH), 116.1 (q, 1JCF = 287.8, 
CF3), 116.0 (q, 
1JCF = 287.8, CF3), 65.6 (q, 
4JCF = 1.8, Cb), 63.2 (Cc), 63.18 (Cc), 58.3 (q, 
3JCF 
= 2.0, Ca), 56.0 (Ca), 56.0 (Ca), 19.3 (CH3), 19.3 (CH3); 19F NMR (CDCl3, 377 MHz) δ –72.72, 
–72.78.   
2-Methyl-2-phenyl-5-tosyl-1-oxa-5-azaspiro[2.3]hexane, 254 
 
To a round bottom flask containing a mixture of crude 197a (0.25 mmol, 1.0 equiv) and sodium 
iodide (75 mg, 0.5 mmol, 2.0 equiv) under an inert atmosphere was added anhydrous 
acetonitrile (2.5 mL). The flask was cooled to 0 °C and tosyl chloide (57 mg, 0.30 mmol, 
1.2 equiv) was added with stirring. After 15 minutes at 0 °C, the reaction was warmed to room 




0.5 mmol, 2.0 equiv) was added followed by anhydrous methanol (2.5 mL) and the reaction 
stirred for 3 hours. Diethyl ether (10 mL) and saturated aqueous sodium bicarbonate solution 
(10 mL) were added, and the reaction mixture transferred to a separating funnel. The phases 
were separated, and the aqueous phase was extracted with diethyl ether (3 × 20 mL) and the 
combined organic phases were washed with brine, dried (MgSO4), filtered and concentrated 
under reduced pressure. The crude reaction mixture was purified by flash column 
chromatography (99:1 → 80:20 pentane/acetone) to give 254 (72 mg, 87% yield) as a 
colourless oil that crystallised upon freezing. 
RF 0.56 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2976, 2937, 1597, 1445, 1346, 1160; 
HRMS (APCI): Calcd. for C18H19NO3S
+ ([M+H]+) m/z 330.1158, found m/z 330.1160 
1H NMR (CDCl3, 400 MHz) δ 7.72 (d, 
3JHH = 8.2, 2H, 2 × CiH), 7.37 (d, J = 8.2, 2H, 2 × CjH), 
7.34 – 7.24 (m, 3H, 2 × CfH, CgH), 7.12 – 7.03 (m, 2H, 2 × CeH), 4.17 (d, 
2JHH = 10.2, 1H, 
CaH), 4.08 (d, 
2JHH = 10.2, 1H, CaH), 3.90 (d, 
2JHH = 10.3, 1H, CaH), 3.55 (d, 
2JHH = 10.3, 1H, 
CaH), 2.48 (s, 3H, ArCH3), 1.53 (s, 3H, CH3); 13C NMR (CDCl3, 101 MHz) δ 144.5 (Ch), 137.4 
(Cd), 131.6 (Ck), 129.9 (2 × Cj), 128.5 (2 × Ci), 128.4 (2 × Cf), 128.1 (Cg), 125.4 (2 × Ce), 64.1 
(Cb), 63.1 (Cc), 57.1 (Ca), 57.0 (Ca), 21.6 (ArCH3), 19.1 (CH3).   
tert-Butyl 2-methyl-2-phenyl-1-oxa-5-azaspiro[2.3]hexane-5-carboxylate, 255 
 
To a round bottom flask containing a mixture of crude 197a (0.25 mmol, 1.0 equiv) and sodium 
iodide (75 mg, 0.50 mmol, 2.0 equiv) under an inert atmosphere was added anhydrous 
acetonitrile (2.5 mL). The flask was cooled to 0 °C and di-tert-butyl decarbonate (70 μL, 
0.30 mmol, 1.2 equiv) was added with stirring and the reaction was then heated to 80 °C. After 
18 hours, the reaction was cooled to room temperature before the addition of saturated aqueous 
sodium bicarbonate solution (10 mL) and diethyl ether (10 mL) were added, and the reaction 
mixture transferred to a separating funnel. The phases were separated, and the aqueous phase 
was extracted with diethyl ether (3 × 20 mL) and the combined organic phases were washed 
with brine, dried (MgSO4), filtered and concentrated under reduced pressure. The crude 
reaction mixture was purified by flash column chromatography (99:1 → 90:10 




RF 0.56 (80:20 pentane/acetone); IR (film) νmax/cm
-1: 2974, 2874, 1702, 1446, 1388, 1366, 
1141; HRMS (ESI): Calcd. for C16H21NO3Na
+ ([M+Na]+) m/z 298.1414, found m/z 298.1411; 
1H NMR (CDCl3, 400 MHz) δ 7.35 (tt, 
3JHH = 6.8, 
4JHH = 1.6, 2H, 2 × CfH), 7.34 – 7.26 (tt, 
3JHH = 7.29, 
4JHH = 1.5  1H, CgH), 7.25 (m, 2H, 2 × CeH), 4.27 (dd, 
2JHH = 10.4, 
4JHH = 1.6, 
1H, CaH), 4.18 (ddd, 
2JHH = 10.4, 
4JHH = 1.6, 0.8, 1H, CaH), 4.04 (ddd, 
2JHH = 10.5, 
4JHH = 1.6, 
0.8, 1H, CaH), 3.68 (dd, 
2JHH = 10.5, 
4JHH = 1.6, 1H, CaH), 1.65 (s, 3H, CH3), 1.42 (s, 9H, 
Ch(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 156.1 (R2NC(O)OR), 138.3 (Cd), 128.6 (2 × Cf), 
127.9 (Cg), 125.6 (2 × Ce), 80.1 (Ch), 66.0 (Cb), 62.8 (Cc), 55.9 (br., 2 × Ca), 28.4 (Ch(CH3)3), 
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